Announcements

2 April 2024
MDPI Insights: The CEO's Letter #10 - South Korea, IWD, U2A, Japan

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts


Left to right: Dr. Jisuk Kang (Scientific Officer, MDPI), Stefan Tochev (CEO, MDPI), and Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), during media meetings at Prain Agency office in Seoul, South Korea.

Visit to Seoul, South Korea

During my recent visit to South Korea, I had the privilege of meeting various stakeholders, including representatives of government, research institutions, and academia, to understand their needs and communicate MDPI’s commitment to accessible science. Accompanied by my colleagues Dr. Giulia Stefenelli and Dr. Jisuk Kang, I engaged with the Korean scientific community, which is increasingly embracing open access (OA).

As the leading OA publisher in South Korea, MDPI is trusted by local authors and in 2023 enjoyed an approximately 30% share of the OA market. South Korea ranks sixth globally for MDPI in terms of research papers submitted and published.

MDPI and South Korea by Numbers

As at 30 March, over 76,000 MDPI articles have been authored by individuals affiliated with Korean institutions. We have over 1,800 active editorial board members (EBMs) from South Korea, with more than 880 EBMs having an H-index between 26 and 50, including 10 serving as Chief Editors.

“South Korea is the sixth-largest contributor to our total publications”

Over the past five years (2019–2023), nearly 120,000 authors affiliated with South Korean institutes have published with MDPI. Specifically in 2023, we received approximately 25,000 submissions from South Korean authors, publishing close to 13,000 articles, resulting in a rejection rate of 47.4%, which is not far below MDPI’s overall rejection rate of 56.4% in 2023.

Institutional Partnerships with South Korea

I am pleased to share that MDPI has more than 825 institutional partnerships worldwide, with 12 in South Korea, including Kyunghee University, Chung-Ang University, and Inha University, among others.


Left to right: Dr. Jisuk Kang (Scientific Officer, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), and Stefan Tochev (CEO, MDPI) fielding media questions at Prain PR Agency office in Seoul, South Korea.

Over the past three years (2021–2023), we have had some of the most prestigious academic universities ranked among the top 10 Korean institutions publishing with MDPI. Seoul National University had the highest number of publications with MDPI during those three years, publishing nearly 6,000 papers. Universities such as Korea University and Yonsei University also rank among the top 10 Korean institutions publishing with MDPI.

MDPI Hosts Seminar for Academia and Media

As the world’s leading OA publisher, MDPI is actively democratizing science. This is reflected in the seminars we hosted on 21 March to address questions about our editorial processes and ethical standards. The visit garnered media coverage, reflecting our mission to providing high-quality services and fostering open dialogue in the community.

“MDPI is actively democratizing science”

MDPI in the News


Stefan Tochev (CEO, MDPI) leading a seminar on OA and MDPI at Prain PR Agency office in Seoul, South Korea.

Media coverage generated by our visit to Seoul included the following stories:

“Open access is an unstoppable trend…it will lead the development of the knowledge ecosystem.”

“Papers that the public needs, anyone can use quickly… low-quality publishing is a misunderstanding.”

I greatly appreciate the contributions of everyone who took the time to meet with us, share their stories, and hold us accountable for continuing to provide high-quality publishing services while identifying areas for improvement. I am also excited to announce that we have opened an MDPI office in Seoul and will release a press release on MDPI.com, with details, by the end April 2024. The purpose of the office is to establish a local presence to connect with and support the South Korean academic community through institutional partnerships, conferences, author workshops, stakeholder communications, and more.

Impactful Research

Featured Articles on Women’s Leadership and Healthcare

In celebration of International Women’s Day (8 March 2024), MDPI curated a collection of research articles on various topics, including women’s leadership, reproductive health, preventive healthcare, and a selection of articles from our journal Women.

Women’s Leadership

Women’s Reproductive Health

Women’s Preventive Healthcare

Featured Articles in MDPI Journal Women

Below are a few articles from Women, our journal focused on women’s health, the social determinants of health, and the healthcare system that serves women. The aim of Women is to encourage academics to publish their experimental and theoretical results in detail, to aid reproducibility, and in an engaging style, to aid comprehensibility.

Inside MDPI

 

Championing Women’s Healthcare and Access to Healthcare Information

MDPI colleagues from our offices joined in celebrating #IWD2024. In doing so, we emphasized key missions that encompass:

  • Empowering women to assume leadership and decision-making roles in both business and science.
  • Helping women and girls make informed decisions about their health.
  • Recruiting and developing female talent and fostering inclusive workplace environments.

“We are thrilled to recognize the accomplishments of women scientists”

I am proud to see our colleagues enthusiastically supporting the International Women’s Day call to ‘Inspire Inclusion!’ The heart-hands in the collage below symbolize our appreciation of the achievements of women researchers and the recognition of the trailblazers who have courageously made a mark on societies past and present.

We are thrilled to recognize the accomplishments of women scientists through our many MDPI awards and by highlighting success stories. As inspirational figures, female scientists are paving the way for the next generation of women aspiring to pursue careers in engineering, life sciences, computing, and various other STEM fields.

“I consider myself lucky because I work with incredibly talented women who inspire me every day.”
– Dr. Alessandra Pasut, Winner of MDPI's ‘Biology 2023 Young Investigator Award’

“It’s really important to find a supportive and enabling environment in which to do your science; it would have a big impact on you as a person and on your scientific outputs.”
– Dr. Rhea Longley, Winner of the ‘Pathogens 2023 Young Investigator Award’

Open-access publishing, in particular, allows early-career women researchers to share their work more widely, potentially attracting mentorship opportunities and collaborations. This support is crucial for career development and advancement.

Coming Together for Science

MDPI Joins United2Act in Collective Fight to Stop Paper Mills

In my February 2024 CEO Letter, I highlighted some of our recent initiatives aimed at bolstering our commitment to research integrity, including joining the STM Integrity Hub and expanding our Research Integrity and Publication Ethics team (RIPE). Continuing our efforts in coming together for science, I am pleased to share our participation in the United2Act initiative.

The text below is taken from our official announcement:

United2Act represents an international group of stakeholders in the publishing industry committed to addressing the collective challenge posed to research integrity by paper mills.

Scientists and academic publishers have increasingly noted the alarming proliferation of paper mills, recognized as fraudulent entities seeking to manipulate the publication process for financial profit. These entities engage in fraudulent practices such as falsifying or fabricating data, selling co-authorship of fake papers, manipulating peer review, and including inappropriate citations. These actions pose a significant threat to the integrity of the scholarly record, prompting widespread concern among those involved in the academic community.

MDPI has been actively contributing to combat the undermining of the scientific record. Our editors employ a set of tools to detect potential ethical breaches within a manuscript and to tackle the issue of fake papers.

United2Act’s consensus statement is the outcome of a virtual summit held in May 2023. It involved the participation of research bodies, publishers, researchers/sleuths, universities, and publishing infrastructure from 15 countries and resulted in a Consensus Statement outlining five key areas of action for all stakeholders:

  • Education and awareness
  • Improve post-publication corrections
  • Facilitate and organise research on paper mills
  • Enable the development of trust markers
  • Facilitate dialogue between stakeholders

MDPI is committed to promoting transparency and integrity in scholarly publishing and is continuing to work closely with the scientific community toward this goal.

Closing Thoughts


Left to right: Ryo Hirayama (Marketing Specialist, MDPI), Takashi Sasabe (Marketing Specialist, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), Dr. Izumi Yamamoto (Marketing Manager, MDPI), and Stefan Tochev (CEO, MDPI), at MDPI’s office in Tokyo, Japan.

Visit to Tokyo and Kyoto, Japan

In March, I had the opportunity to visit our Tokyo office and engage with stakeholders in Tokyo and Kyoto. During the visit, I also recorded a video message to welcome Japanese scholars working with MDPI and to highlight our operations in Japan.

We held meetings with Editors-in-Chief, librarians, scholars, and external consultants to gather feedback on our efforts to enhance our reputation and explore additional steps we can take in that direction. Japan's rich cultural heritage, characterized by tradition, respect, and formality, provided valuable insights into meeting the publishing needs specific to Japan.

Japan’s Open Access statistics

Over the years, we have seen a shift from subscription-only to gold OA publishing in Japan, despite the lack of an official mandate. Here are some statistics:

  • 2012: 68% of articles were subscription-only, 6% were green Open Access, and 8% were gold Open Access.
  • 2016: 55% of articles were subscription-only, 6% were green Open Access, and 20% were gold Open Access.
  • 2022: 43% of articles were subscription-only, 7% were green Open Access, and 39% were gold Open Access.

To learn more about the history of OA in Japan as well as about future trends, please read this blog post.

“Japan is the ninth-largest contributor to our total publications”


Left to right: Stefan Tochev (CEO, MDPI), Dr. Izumi Yamamoto (Marketing Manager, MDPI), and Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI) visiting Kyoto University in Kyoto, Japan.

MDPI and Japan by Numbers

As at 1 April, over 50,000 MDPI articles have been authored by scholars affiliated with Japanese institutions, making the country the ninth-largest contributor to our total publications. Over the past three years (2020–2023), nearly 90,000 authors affiliated with Japanese institutes have published with MDPI, and we have collaborated with over 4,600 Guest Editors from Japan.

In 2023, we published over 8,200 papers from authors associated with Japanese institutions. MDPI collaborates with 41 institutional partnerships in Japan, including the University of Tokyo, Hokkaido University, and Nagoya University. We have over 2,100 active EBMs from Japan, more than 1,050 EBMs having an H-index between 26 and 50, including 13 serving as Editors-in-Chief.

General Feedback – a side note

A general takeaway from our discussions with stakeholders from around the world is that negative perceptions of MDPI often stem from misinformation, misconceptions, or misunderstandings about MDPI and our practices. While we acknowledge our mistakes and work diligently to address them, maintaining a strong editorial procedure and robust peer-review process, I find that educating stakeholders about our how we do what we do and our ongoing improvements tends to help shift opinions.

That said, we recognize the importance of addressing individual concerns. We take feedback seriously and are continuously working to get better while not compromising the core principles that millions of authors appreciate about MDPI.

Stefan Tochev
Chief Executive Officer
MDPI AG

28 March 2024
Viruses | “Viruses 2024—A World of Viruses” Conference Held Successfully

Viruses pose a continuous threat to global health, making their study an ongoing imperative in scientific research. 

Following the successful MDPI Viruses conferences held in Basel (2016), Barcelona (2018 and 2020), and online (2022), the 2024 edition recently convened in Barcelona, Spain from 14 to 16 February. Entitled “Viruses 2024 – A World of Viruses”, this conference served as a platform for international expert scientists and researchers to disseminate their latest discoveries in viral pathogenesis and immune response. 

Covering a wide array of topics including molecular and cellular biology, immunology, epidemiology, and public health, this conference facilitated meaningful discussions on the most pertinent issues in current virology.

The Auditorium and Convention Center—AXA

The event was jointly organized by MDPI and the journal Viruses (ISSN: 1999-4915), with support from the American Society for Virology, the Spanish Society of Virology, the Australasian Virology Society, and the World Society for Virology as collaborating societies. 

With 241 attendees from 40 different countries and 190 abstracts received, the congress achieved remarkable participation. Led by Dr. Eric Freed (Editor-in-Chief of Viruses from the National Cancer Institute, NIH—Frederick, MD, USA) and Dr. Albert Bosch (University of Barcelona, Spain), the scientific committee organized sessions covering a diverse range of topics in virology research:

  • General topics in virology;
  • Antiviral therapies, vaccines, and host defenses;
  • Antiviral innate immunity;
  • The structure and mechanisms of viral replication;
  • Virus–host interactions;
  • Pathogenesis and viral evolution. 

Participants during the conference 

In this post, we will provide you with the highlights of the three days of the “Viruses 2024 – A World of Viruses” conference. 

Opening Presentations
The conference began with one of the most anticipated talks by all participants and the one that brought together the largest number of attendees in the auditorium: the presentation of Dr. Charles M. Rice (Rockefeller University, New York, USA) as a guest speaker.  

Dr. Charles M. Rice during his presentation 

Dr. Rice is a leading figure in Flaviviridae research, particularly in hepatitis C virus (HCV) studies. His extensive career has contributed significantly to our understanding of HCV protein biogenesis and structure. His research group developed the first infectious molecular clone of HCV, along with essential cell culture systems and animal models for studying virus replication and antiviral treatments. 

With over 500 published articles, Dr. Rice's pivotal role in HCV discovery and hepatitis treatment earned him the 2020 Nobel Prize in Physiology or Medicine (shared with Harvey James Alter and Michael Houghton). 

In his opening presentation, Dr. Rice provided a captivating overview of HCV identification history and the quest for a global cure. He also discussed recent advancements in hepatitis B virus (HBV) research, addressing its significant impact on global health. 

Dr. Luis Enjuanes during his presentation 

The second keynote was delivered by Dr. Luis Enjuanes (National Center for Biotechnology, CNB-CSIC, Madrid, Spain), a highly experienced researcher with over 35 years of expertise in coronavirus studies. His current focus lies in investigating the replication mechanisms, transcription, virulence, and virus–host interactions of coronaviruses. 

In his engaging presentation, Dr. Enjuanes provided insights into the origin and spread of the virus responsible for the recent COVID-19 pandemic. He highlighted the latest scientific evidence, indicating a zoonotic origin of the SARS-CoV-2 virus. 

Impressions of Attendees


Dr. Eric Freed

Dr. Eric Freed, Editor-in-Chief of the Viruses journal, delivered an enlightening presentation on the ongoing challenges in controlling the HIV/AIDS pandemic. Reflecting on the congress, he expressed his satisfaction with the diverse array of oral presentations:

“We have had a fantastic group of speakers, Nobel Prize laureate (Dr. Rice) and Dr. Enjuanes, along with an excellent variety of guest speakers and some outstanding Ph.D. and postdoc students who have presented excellent work, oral presentations, and posters on their research.” 

Professor Mikael Skurnik, associate editor of the journal Viruses, presented his work on the enigmatic Jumbo YerA41 bacteriophage from Yersinia YerA41 to open the session on the structure and mechanisms of viral replication. During his interview, he humorously remarked, “Since most of my colleagues work with plant or animal viruses, and I work with bacterial viruses and bacteriophages, I sometimes feel a little lonely here.” He further added, “This conference provides an excellent opportunity to witness the progress in virology research, which is truly inspiring.”  

Professor Mikael Skurnik during his presentation 

Nefer Candance Dossou 

Nefer Candance Dossou was the last speaker of the conference, closing the session on viral pathogenesis and evolution. “The best thing for me is the quality of the guest speakers. The presentation by Dr. Charles M. Rice, who received the Nobel Prize in 2020, has been one of the best moments of this congress.” 

Poster Sessions
The two poster sessions took place on the second and third days of the conference. During the lunch break and afternoon, many attendees took the chance to familiarize themselves with the poster presentations. It was a perfect occasion for Ph.D. students and young researchers to engage in discussions regarding their projects in the fascinating world of virology in an inspiring environment. 

Poster session 

Awards Ceremony
Another highlight of the conference was the Viruses awards ceremony. Dr. Carolien van de Sandt was presented with the commemorative plaque of the Viruses 2022 Early Career Investigator award, along with CHF 1000, by the Editor-in-Chief of Viruses, in recognition of her exceptional achievements as a young researcher. Dr van de Sandt is interested in the mechanisms underlying the gain and loss of virus-specific CD8+ T-cell function across the human lifespan and in high-risk groups. Her research is of great importance for the development of broadly protective vaccine strategies that aim to harness CD8+ T-cells. 

Dr. Carolien van de Sandt receiving the plaque commemorating the Viruses 2022 Early Career Investigator award 

Additionally, the winners for Best Poster and Best Oral Presentation were announced to recognize the most outstanding works presented during the three days of the conference. Matty Allan received the Best Poster award for his work entitled “Long-Range RNA:RNA Base Pairing Regulates Active Conformations of Frameshift Stimulating Elements in Coronaviruses” (awarded EUR 300). Rebekah Gullberg was awarded the Best Oral Presentation for her talk on “SARS-CoV-2 Virus-Like Particles Reveal Chaperones of Viral Assembly” (endowed with EUR 500). These awards not only celebrate the achievements of the winners but also serve as inspiration and motivation for the rest of the attendees toward scientific excellence. 

Matty Allan receiving the award for Best Poster  

Rebekah Gullberg receiving the Best Oral Presentation certificate 

Special Issue: “Viruses 2024—A World of Viruses”

We would like to highlight that the participants of this conference can submit their work to the collection “Viruses 2024 – A World of Viruses” edited by Dr. Freed in the Viruses journal. 

Symposium participants, as well as all researchers working in the field, are cordially invited to contribute original research papers or reviews to this Special Issue of Viruses. You can find more information here

The Viruses journal is indexed in the main databases: Scopus, SCIE (Web of Science), and PubMed, among others. Its current Impact Factor is 4.7 (2022) and it has a Citescore of 7.1 (2022). 

The MDPI conference team that participated in the event 

You can also explore the vibrant atmosphere of the conference through our video recap by clicking here

The Viruses conference has established itself as a leading event in the field of virology for researchers worldwide. We look forward to the next edition of Viruses 2026!

27 March 2024
Viruses | Highly Cited Reviews in 2022

1. “Current Trend in Antiviral Therapy for Chronic Hepatitis B”
by Rong-Nan Chien and Yun-Fan Liaw
Viruses 2022, 14(2), 434; https://doi.org/10.3390/v14020434
Available online: https://www.mdpi.com/1999-4915/14/2/434


2. “Viral Shrimp Diseases Listed by the OIE: A Review”
by Dain Lee, Young-Bin Yu, Jae-Ho Choi, A-Hyun Jo, Su-Min Hong, Ju-Chan Kang and Jun-Hwan Kim
Viruses 2022, 14(3), 585; https://doi.org/10.3390/v14030585
Available online: https://www.mdpi.com/1999-4915/14/3/585

3. “COVID-19 at a Glance: An Up-to-Date Overview on Variants, Drug Design and Therapies”
by Domenico Iacopetta, Jessica Ceramella, Alessia Catalano, Carmela Saturnino, Michele Pellegrino, Annaluisa Mariconda, Pasquale Longo, Maria Stefania Sinicropi and Stefano Aquaro
Viruses 2022, 14(3), 573; https://doi.org/10.3390/v14030573
Available online: https://www.mdpi.com/1999-4915/14/3/573

4. “Antiviral Drug Discovery for the Treatment of COVID-19 Infections”
by Teresa I. Ng, Ivan Correia, Jane Seagal, David A. DeGoey, Michael R. Schrimpf, David J. Hardee, Elizabeth L. Noey and Warren M. Kati
Viruses 2022, 14(5), 961; https://doi.org/10.3390/v14050961
Available online: https://www.mdpi.com/1999-4915/14/5/961

5. “Monkeypox, a Literature Review: What Is New and Where Does This concerning Virus Come From?”
by Giorgio Tiecco, Melania Degli Antoni, Samuele Storti, Lina Rachele Tomasoni, Francesco Castelli and Eugenia Quiros-Roldan
Viruses 2022, 14(9), 1894; https://doi.org/10.3390/v14091894
Available online: https://www.mdpi.com/1999-4915/14/9/1894

6. “SARS-CoV-2: Evolution and Emergence of New Viral Variants”
by Verónica Roxana Flores-Vega, Jessica Viridiana Monroy-Molina, Luis Enrique Jiménez-Hernández, Alfredo G. Torres, José Ignacio Santos-Preciado and Roberto Rosales-Reyes
Viruses 2022, 14(4), 653; https://doi.org/10.3390/v14040653
Available online: https://www.mdpi.com/1999-4915/14/4/653

7. “Hepatitis B Virus-Associated Hepatocellular Carcinoma”
by Giacomo Emanuele Maria Rizzo, Giuseppe Cabibbo and Antonio Craxì
Viruses 2022, 14(5), 986; https://doi.org/10.3390/v14050986
Available online: https://www.mdpi.com/1999-4915/14/5/986

8. “ACE2-Independent Alternative Receptors for SARS-CoV-2”
by Suhyeon Lim, Monica Zhang and Theresa L. Chang
Viruses 2022, 14(11), 2535; https://doi.org/10.3390/v14112535
Available online: https://www.mdpi.com/1999-4915/14/11/2535

9. “An Updated Review on SARS-CoV-2 Infection in Animals”
by Shujuan Cui, Yimeng Liu, Jiachen Zhao, Xiaomin Peng, Guilan Lu, Weixian Shi, Yang Pan, Daitao Zhang, Peng Yang and Quanyi Wang
Viruses 2022, 14(7), 1527; https://doi.org/10.3390/v14071527
Available online: https://www.mdpi.com/1999-4915/14/7/1527

10. “In Vitro Techniques and Measurements of Phage Characteristics That Are Important for Phage Therapy Success”
by Tea Glonti and Jean-Paul Pirnay
Viruses 2022, 14(7), 1490; https://doi.org/10.3390/v14071490
Available online: https://www.mdpi.com/1999-4915/14/7/1490

4 March 2024
MDPI Insights: The CEO's Letter #9 - Romania, Research Integrity, Viruses

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts


Reka Kovacs (Deputy Office Manager, MDPI), Stefan Tochev (CEO, MDPI), and Sandra Ana Spatariu (Office Manager, MDPI) at the MDPI office in Cluj, Romania.

MDPI’s Impact on Romania

In February, I visited our office in Cluj, Romania. I worked closely with our senior office managers and various teams, including the departments of training, marketing and conferences, as well as our journal relationship specialists, reviewing our service to the local scholarly community. During the visit, I also met with representatives from Babes-Bolyai University and the Technical University of Cluj-Napoca. Our multifunctional Romanian office plays an important role in supporting our collaborations with the local market as well as helping to meet MDPI’s overall business needs.


Feedback and strategy meeting with a group of MDPI’s Journal Relationship Specialists at the MDPI office in Cluj, Romania.

With 22,436 articles, Romania ranks as a top 20 contributing country to MDPI’s total number of papers published as at 28 February 2024. This highlights the importance of our collaboration with Romanian-affiliated authors and the growing opportunity to support their publishing needs. MDPI is one of the few academic publishers with a significant presence in Romania, boasting over 360 colleagues across our offices in Bucharest and Cluj. We are also proud to hire colleagues from local institutions to launch their careers within publishing.

Romania ranks as a top 20 contributing country.

The Numbers: 2019–2023

MDPI has seen a healthy increase in submissions from Romanian authors over the past three years, from 8,439 in 2021 to 11,866 by end of 2023, with most submissions going to journals such as Sustainability, Medicina, Diagnostics, IJMS, Applied Sciences, and JCM. From 2019 to 2023, MDPI published articles from 32,145 authors affiliated with Romanian institutions. Over those years, we have worked with Romanian Guest Editors on nearly 3,000 occasions to support their Special Issue and Topical collections.

With more than 300 Editorial Board Members from Romania, 34 appear on the board of Mathematics, 27 on Materials, 19 on Polymers, 18 on Coatings, and 16 on Molecules, while three serve as Section Editors-in-Chief (SEiC) on our journals Coatings (3.4 IF, 4.6 Citescore), Magnetochemistry (2.7 IF, 3.5 Citescore), and Chemosensors (4.2 IF, 3.9 Citescore).

Institutional Open Access Programs

Our commitment to working with institutions is evident in Romania, where we have established eight Institutional Open Access Programs (IOAP) with esteemed institutions such as the University of Bucharest, the University of Medicine and Pharmacy Cluj-Napoca, and most recently the National Institute for Laser, Plasma and Radiation Physics.

Our growth and presence in Romania are a true testament.

We also have IOAP agreements with Babes-Bolyai University and the Technical University of Cluj-Napoca, where I had the opportunity to meet senior stakeholders during my visit. Below are a few photos capturing our meeting with Prof. Radu Silaghi-Dumitrescu (Head of Faculty of Chemistry, Babes-Bolyai University) at the MDPI office in Cluj, Romania, along with a photo from our meeting with Vice Deans Nicoleta Cobarzan, Nicoleta Ilies, and Hoda Gavril, from the faculty of Civil Engineering at the Technical University of Cluj, Romania.


Our growth and presence in Romania are a true testament to the service we provide to the scholarly community and the relationships we foster in that region. We look forward to continuing to support Romanian scholars and institutions by providing a valuable and trusted experience with MDPI, the leader in open access publishing.

Impactful Research

MDPI Joins the STM Integrity Hub

MDPI has long been a supporter and partner of STM, with our involvement ranging from sponsoring and attending events to helping organize event programs. By joining the STM Integrity Hub, we aim to further our commitment to STM initiatives aimed at safeguarding the integrity of science.

“We are pleased to welcome MDPI as the 35th organisation participating in the Hub. This expansion is critical, as every new member enhances our capacity to prevent fraudulent submissions from entering the academic record.”

Joris van Rossum, Director of Research Integrity, STM

MDPI operates in full alignment with STM Integrity Hub's values of shared data and experiences. We strongly believe in collaboration and open exchange for the purposes of creating a holistic approach to support research integrity at MDPI itself and across the entire academic publishing industry. The Integrity Hub is an excellent example of how publishers can come together to jointly address industry-wide challenges related to research integrity, such as manuscripts that breach research integrity standards and paper-mills.

I look forward to our Research Integrity and Publication Ethics Team (RIPE) team immersing themselves in this initiative, exchanging information, best practices, and tools for the benefit of the entire scholarly ecosystem. We believe that ethical publishing standards should be implemented across the board, and we aim to be rigorous in our approach, addressing research integrity issues and improving the impact of published research.

Inside MDPI

MDPI Expands Research Integrity and Publication Ethics Team (RIPE)

In addition to external collaborations and joint initiatives aimed at further strengthening our commitment to research integrity, we are also enhancing our internal efforts. This includes improving our processes and guidelines and expanding our teams and departments to ensure quality assurance throughout our publishing process.

We are pleased to announce the expansion of our Research Integrity and Publication Ethics Team (RIPE) at MDPI. The RIPE team has recently welcomed new colleagues, each bringing unique skills and a personal commitment to prioritize ethical considerations in all our work.

The demand for research integrity and high ethical standards in academic publishing is steadily rising across our industry. Our expanded RIPE team will work to enhance and align our practices with industry best practices, ensuring excellence in research integrity and publication ethics.


Stefan Tochev (CEO, MDPI) introduces Dr. Tim Tait-Jamieson (Research Integrity Lead, MDPI) for his presentation on MDPI’s Retraction and Approval Process to a group of Journal Relationship Specialists at the MDPI office in Cluj, Romania: “The demand for research integrity and publication ethics is steadily rising across our industry.”

Introducing our Research Integrity and Publication Ethics Team

Led by Dr. Tim Tait-Jamieson (Research Integrity Lead), the RIPE team comprises Dr. Ivana Resanovic (Research Integrity Manager), Dr. Lavinia Rogojina (Research Integrity Manager), Ms. Diana Apodaritei (Research Integrity Specialist), Dr. Zoltan Mihaly (Research Integrity Specialist), Mr. Aleksandar Đukić (Research Integrity Specialist), Ms. Ana Stankovic (Research Integrity Specialist), and Ms. Anna Pena (Publication Ethics Assistant).

Please click here to access everything that you need to know about MDPI’s Research and Publication Ethics.

With this span of complementary roles, the RIPE team collaborates directly with journal editorial teams and works closely with various departments, including our Scientific Office Board and our Journal Relationship Specialists. The team’s primary objectives are to help prevent issues regarding research integrity and publication ethics during peer review, uphold MDPI’s ethics policies, adhere to industry standards, and resolve publication ethics and research integrity issues and complaints.

Quality Updates to Special Issues Oversight

At MDPI, we are committed to reviewing policies pertaining to the quality of research. In this blog post, Shaheena Patel (Communications Associate, MDPI), outlines two recent updates to MDPI journal processes. These updates pertain to Special Issue (SI) quality guidelines, in line with criteria provided by COPE and DOAJ. Alongside the SI updates, details regarding the new minor corrections policy introduced in 2024 are provided in the blog.

The two updates we implemented include greater oversight and the verification of Guest Editor credentials. These guidelines require that Editors-in-Chief (EiCs) and Editorial Board Members (EBMs) take responsibility for overseeing SIs.

PS. Thank you, James Butcher, for featuring this up in your 67th issue of the Journalogy newsletter.

Read more:

Coming Together for Science

Viruses 2024 – A World of Viruses

I am pleased to share the success of our MDPI conference Viruses 2024 – A World of Viruses, held 14-16 February, in Barcelona. With 240 registrations, this event brought together top scientists, researchers, and industry experts from 40 countries to share their findings on the latest developments in viral pathogenesis and immune responses.

Attendees gathered for the 5th edition of the Viruses’ conference, where we hosted influential keynote speeches from Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes, along with 14 invited speakers, 47 selected speakers, and nine flash poster presenters, to discuss the most significant issues in virology today.

Recap on the #Viruses2024 Conference

Take a look at the key moments from MDPI’s Viruses event and please join us in commemorating a gathering for global knowledge and cooperation. A heartfelt thank-you to all attendees; their passion and engagement played a crucial role in making this event an engaging success!

Below are calls to action from the keynote speakers encouraging collaboration and communication:

“There’s never been a better time than now to really take the power that we have both in terms of basic research and also in biotech and pharma to develop antiviral agents.” - Dr. Charles M. Rice, The Rockefeller University, New York, USA

“The collaboration between labs is absolutely essential. Improving initial detection and improving communication is a must for all of us working in science.” - Prof. Dr. Luis Enjuanes, National Center of Biotechnology (CNB-CSIC), Madrid, Spain

Our thanks go to our sponsors and partnering societies, our Viruses journal and editorial team, our Barcelona colleagues, and the social media, conference and other MDPI teams for making this event a memorable occasion. View the event gallery here.

Upcoming In-Person Event

24–26 April, 2024
4th MMCS – Harnessing the Power of New Drug Modalities
Location: Barcelona, Spain

Esteemed speakers at MMCS 2024 include Prof. Arun K. Ghosh, the mind behind the Darunavir molecule, and Prof. Paul Brennan, CSO of Alzheimer's Research UK Oxford Drug Discovery Institute.

Find more upcoming MDPI events here.


Organize Your Event with MDPI’s Sciforum

Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.

Closing Thoughts

Researcher to Reader (R2R) Conference

From 20–21 February 2024, I had the pleasure of attending the Researcher to Reader (R2R) conference in London, which MDPI has proudly sponsored over the years. The conference programme offered a variety of session formats, including workshops, panel discussions, debates, interviews, presentations, and lightning talks, with opportunities to discuss relevant topics.

We take pride in supporting the scientific community, bringing researchers across the world together to network, exchange ideas and share the latest in science and publishing. In 2023, MDPI invested close to 2 million CHF in sponsoring over 2,000 scientific and publishing-related conferences worldwide.

R2R Peer Review Innovations Workshop

I found the R2R conference to be engaging, with the workshops being particularly enjoyable. My colleague Giulia Stefenelli (Chair of Scientific Office Board) and I participated in the “Peer Review Innovations” workshop, which spanned four sessions over the two days. These sessions explored the future of peer review and how we can improve the peer review process for everyone involved. Notably, the large majority of attendees expressed their opinion that peer review, as currently practiced, requires significant improvement. Together, we collaborated on potential immediate and long-term improvements and innovative processes, aiming to create an ecosystem beneficial to all stakeholders by strengthening submission systems with the aim of reducing threats and making authors more responsible for their work. We also discussed the opportunity for academic institutions to better scrutinize the quality of the work produced and submitted to journals.

Our group comprised publishers, software providers, librarians, and more, bringing diverse perspectives to the discussions. These interactions were relevant to MDPI’s ongoing conversations, providing insights to our efforts. The session also made me appreciate that MDPI is doing well, as the group discussions included the subject of various quality checks that we have already embedded in our processes, ensuring that we keep abreast of industry standards.

The need for an optimized system to incentivize the activities of editors and reviewers was also a focus of discussion, as well as the support that reviewers need from publishers via the provision of strong reports through fixed forms, questionnaires and training.

At MDPI, we are currently auditing our reviewer program to improve reviewer recognition, guidelines, and methods for identifying suitable reviewers, while maintaining our commitment to quality and timeliness.

Congratulations to Mark Carden, Conference Director, and the R2R team for organizing a productive and successful event. PS: The break times were greatly appreciated as well!

Stefan Tochev
Chief Executive Officer
MDPI AG

28 February 2024
Prof. Dr. Alexander Gorbalenya Appointed Associate Editor of Section “General Virology” in Viruses


We are pleased to announce that Prof. Dr. Alexander Gorbalenya has been appointed Associate Editor of the “General Virology” Section of Viruses (ISSN: 1999-4915).

Name: Prof. Dr. Alexander Gorbalenya
Homepage: https://www.universiteitleiden.nl/en/staffmembers/alexander-gorbalenya#tab-1
Affiliation: Department of Leiden University Center of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands
Interests: comparative virus genomics; virus discovery; virus evolution; virus taxonomy; proteolytic processing in viruses; structure and function of nidovirus enzymes

Prof. Dr. Alexander Gorbalenya is Professor Emeritus of medical microbiology, particularly virus bioinformatics, and the former Head of the Virus Evolution and Bioinformatics lab in the Research Section. He held the Leiden University Fund Chair in Applied Bioinformatics in Virology (2009–2017) and was Vice President of the International Committee on Virus Taxonomy (2011–2017).

We are honored that we have the opportunity to introduce Prof. Dr. Alexander Gorbalenya to our editorial team, and we are confident that, with the guidance of our new Associate Editor, we will continue to improve the reputation and quality of Viruses.

For more information about the “General Virology” Section, please visit the following link:
https://www.mdpi.com/journal/viruses/sectioneditors/General_Virology.

31 January 2024
MDPI Insights: The CEO's Letter #8 - Altmetric and Flat Fee Agreement

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI and Digital Science Meeting

At MDPI, we are committed to providing our authors with the essential tools to publish, promote, and track their research. In line with this commitment, we have established a longstanding collaboration with Digital Science, a company specializing in research data and analytical insights for the research community. Our collaboration integrates their Altmetric tool, offering us and our authors the ability to track a variety of sources that monitor and report attention surrounding publications.

As part of our collaboration, we recently hosted Cathy Holland, Director of Global Publisher Business Development, and Helen Cooke, Managing Director of Publisher Sales, from Digital Science, at our MDPI headquarters in Basel, Switzerland.


Left to right: Facundo Santomé (Senior Marketing Manager, MDPI), Constanze Shelhorn (Indexing Manager, MDPI), Cathy Holland (Director of Global Publisher Business Development, Digital Science), Helen Cooke (Managing Director of Publisher Sales, Digital Science), and Stefan Tochev (CEO, MDPI) in front of MDPI headquarters in Basel, Switzerland.

During our meeting, we discussed MDPI’s publishing philosophy and explored further avenues for collaboration. We look forward to continuing our partnership with Digital Science, aiming to improve our services yet further and meet the needs of our authors more closely than ever.

What is Altmetric?

You will notice that MDPI articles feature an Altmetric score, a colourful doughnut capturing the score in the upper right corner of the article page. This score represents ‘alternative metrics,’ as distinct from traditional metrics such as Impact Factor, CiteScore, and Scimago Journal Rank.

Altmetrics complement traditional citation-based metrics by capturing online discussions related to a specific research topic. By analyzing both sets of data, we can obtain a comprehensive understanding of the attention a particular research output receives and the sources in which it is mentioned.

“Almetric provides visual insights into where research is being discussed”

Sources Tracked by Altmetric


Altmetric badge showing the Altmetric score and colour-coded mention sources.

Altmetric monitors various sources, categorizing them into segments such as policy documents, peer reviews, Wikipedia, news and blogs, and social media, among other sources. Each category is identifiable by a specific colour.

The Altmetric badge provides visual insights into where the research is being discussed. A more colourful badge indicates broader mentions across multiple platforms. Such tracking enables us to gauge the extent of an article’s online dissemination, noting that increased visibility may correlate with higher citation rates.

Read more:

Impactful Research

Ten High-Altmetric Articles Published by MDPI

As at 30 January 2024, Altmetric has tracked 670,500 MDPI research outputs from MDPI, resulting in over 4.3 million mentions. This includes over 71,894 mentions in policy and patents and 294,714 mentions in news and blogs, with some achieving an Altmetric score as high as 28,754.

So, what is a good Altmetric score? There are various ways to put this score into context. You can find out more about the score in context and how to evaluate your work by this means.

Here are ten MDPI papers ranking in the top 5% of all research outputs scored by Altmetric.

“Accuracy in Wrist-Worn, Sensor-Based Measurements of Heart Rate and Energy Expenditure in a Diverse Cohort”

J. Pers. Med. 2017, 7(2), 3; https://doi.org/10.3390/jpm7020003

Altmetric page: https://mdpi.altmetric.com/details/20477344

Altmetric shows that this article appeared in 253 news stories from 209 outlets including Forbes, BBC, and Fox News.

“Daylight Saving Time and Acute Myocardial Infarction: A Meta-Analysis”

J. Clin. Med. 2019, 8(3), 404; https://doi.org/10.3390/jcm8030404

Altmetric page: https://mdpi.altmetric.com/details/57654628

Altmetric shows that this article appeared in 295 news stories from 207 outlets including Forbes, The Atlantic, and New York Times.

“The Preliminary Analysis of Cave Lion Cubs Panthera spelaea (Goldfuss, 1810) from the Permafrost of Siberia”

Quaternary 2021, 4(3), 24; https://doi.org/10.3390/quat4030024

Altmetric page: https://mdpi.altmetric.com/details/111086701

Altmetric shows that this article appeared in 182 news stories from 134 outlets including CBC News, CNN, and National Geographic.

“Not the Cat’s Meow? The Impact of Posing with Cats on Female Perceptions of Male Dateability”

Animals 2020, 10(6), 1007; https://doi.org/10.3390/ani10061007

Altmetric page: https://mdpi.altmetric.com/details/83796184

Altmetric shows that this article appeared in 124 news stories from 98 outlets including VICE, CNN and The Guardian.

“Behaviour and Welfare Impacts of Releasing Elephants from Overnight Tethers: A Zimbabwean Case Study”

Animals 2022, 12(15), 1933; https://doi.org/10.3390/ani12151933

Altmetric page: https://mdpi.altmetric.com/details/133463915

Altmetric shows that this article appeared in 192 news stories from 186 outlets.

How do I use altmetrics?

Altmetric Explorer provides a detailed step-by-step guide and instruction video for first-time users of the tool. The guide includes useful diagrams that make it easy to get started.

Sharing Research Online

For research to be tracked across different sources, Altmetric needs a research output with a persistent identifier: a DOI, ISBN, PubMed ID, handle ID, etc. When sharing research, it is important to include a link to the original research output.

“An Update on Eukaryotic Viruses Revived from Ancient Permafrost”

Viruses 2023, 15(2), 564; https://doi.org/10.3390/v15020564

Altmetric page: https://mdpi.altmetric.com/details/142929875

Altmetric shows that this article appeared in 250 news stories from 180 outlets including CTV, Fox News, and CNN.

“The Global Problem of Insufficient Sleep and Its Serious Public Health Implications”

Healthcare 2019, 7(1), 1; https://doi.org/10.3390/healthcare7010001

Altmetric page: https://mdpi.altmetric.com/details/53406248

Altmetric shows that this article appeared in 252 news stories from 168 outlets including BBC, Harvard Business Review, and Forbes.

“A Detailed Review Study on Potential Effects of Microplastics and Additives of Concern on Human Health”

Int. J. Environ. Res. Public Health 2020, 17(4), 1212; https://doi.org/10.3390/ijerph17041212

Altmetric page: https://mdpi.altmetric.com/details/86529137

Altmetric shows that this article appeared in 197 news stories from 150 outlets including BBC, The Tribune, and World Economic Forum.

“An Empirical Study of Chronic Diseases in the United States: A Visual Analytics Approach to Public Health”

Int. J. Environ. Res. Public Health 2018, 15(3), 431; https://doi.org/10.3390/ijerph15030431

Altmetric page: https://mdpi.altmetric.com/details/34714141

Altmetric shows that this article appeared in 232 news stories from 149 outlets including Forbes, New York Times, and Harvard Business Review.

“Garden Scraps: Agonistic Interactions between Hedgehogs and Sympatric Mammals in Urban Gardens”

Animals 2023, 13(4), 590; https://doi.org/10.3390/ani13040590

Altmetric page: https://mdpi.altmetric.com/details/142934305

Altmetric shows that this article appeared in 172 news stories from 168 outlets including BBC.

Inside MDPI

MDPI Annual Meeting Celebrations in China

On Thursday 25 January, over 1,300 MDPI colleagues from our two offices in Beijing gathered to kick off MDPI’s traditional ‘Annual Meetings.’ These celebrations take place in MDPI’s offices across China, including Dalian, Tianjin, Wuhan, and Nanjing.

The evenings include performances, informative talks and presentations, awards, and entertainment, providing an ideal platform to recognize our colleagues, celebrate their achievements, and set our sights on the future.

“It is essential that we stay connected and share best practices”

I sent a video congratulating everyone on their work and sharing our vision of building MDPI into the most trusted OA publisher, highlighting the roles each of us has to play in achieving that goal.

Unfortunately I could not join in person, but you may recall my recent trip, when I visited our offices in Beijing and Wuhan, which I look forward to visiting again this year.

Although our headquarters are in Basel, Switzerland, and we are expanding throughout Europe and North America, the majority of MDPI’s workforce is in China and throughout the Asia-Pacific region, including offices in Singapore, Thailand, Japan, and newly opened office in South Korea. It is essential that as a global organization, we stay connected and share best practices in order to grow collectively and continue providing the exceptional service to our authors.

The Annual Meeting is a moment to reflect and enjoy the year’s hard work and dedication.

I extend our best wishes to all for the Chinese New Year (Xīnnián kuàilè)!

Coming Together for Science

MDPI and TU Delft Adopt Flat Fee Model in Extended Partnership

We are excited to announce a renewed three-year partnership with Delft University of Technology (TU Delft) in the Netherlands. This collaboration introduces a fixed lump-sum fee, covering publishing costs from 2024 to 2026.

“This initiative reflects our dedication to transparent and inclusive publishing”

TU Delft-affiliated authors will enjoy cost-free publishing in any MDPI journal during this period, aligning with our commitment to removing barriers for open access publishing. The agreement supports Plan S compliance and facilitates a seamless publishing process for TU Delft corresponding authors. This initiative reflects our dedication to transparent and inclusive publishing, providing stability and predictability both for authors and for institutions.

For further details on our Institutional Open Access Program (IOAP), please contact us.

Benefits to MDPI’s IOAP

At MDPI we have a long tradition of partnerships, including our Institutional Open Access Program (IOAP). IOAP supports institutions through simplification, access, transparency, APC discounts, and institutional repository deposits. The program simplifies administrative processes, offers central payment, and allows easy opting in and out. Participants gain free access to Susy, MDPI’s online submission system, with extensive article metadata and exportable data. APC discounts and Book Processing Charge discounts are available for affiliated authors. Automated deposits to institutional repositories and streamlined matching of papers to IOAP participants enhance the overall experience.

For further information, see our IOAP FAQ.

Closing Thoughts

Reflections on the 2024 APE Conference

MDPI was proud to co-sponsor the Academic Publishing in Europe (APE) 2024 Conference that took place in Berlin, Germany, from 9–10 January 2024.

The conference theme, ‘Keep the Conversation Going!’, explored the evolving landscape of scholarly communication. APE is one of the key conferences I make a point to attend each year. January offers a valuable opportunity to engage with new contacts, reconnect with familiar faces, and participate in impactful discussions and presentations among professionals, scholars, and practitioners in the field.

“It's fascinating to see how other publishers are leveraging AI”

Highlights

Some of the standout panels for me include: the role of the UN Sustainable Development Goals (SDGs) within the publishing industry. It was encouraging to hear the current status quo, though I was eager also to learn about the exciting projects planned for 2024 and beyond. These will allow us to track progress in subsequent years. At MDPI, we remain committed to promoting Open–Access (OA) content on SDGs through scientific articles and books. Furthermore, we extend our commitment to sustainability by financially supporting researchers through initiatives such as the World Sustainability Award and the Emerging Sustainability Leader Award, as well as waiving the APC for feature papers on each SDG.

In recent years, discussions on AI have become increasingly prominent at such conferences. It’s fascinating to see how other publishers are leveraging AI to meet the evolving needs of their audiences while at the same time using it to safeguard the scientific process. Other engaging panels that I enjoyed included updates on transformation beyond transformative agreements, the principles of lean change, incentive structures related to research integrity, and the panel on reviewer incentives.

“We can share best practices and lessons learned”

Incorporating MDPI’s Insights into Conferences

I must confess that I sometimes feel overlooked when MDPI is not invited to participate in crucial industry discussions. As the leading open access publisher and the third-largest publisher overall, we possess extensive experience in many of these areas and can offer valuable contributions to these discussions. We can share best practices, lessons learned, and our thinking about future trajectories. For instance, in panels discussing reviewer incentives, at MDPI we offer a discount voucher to reviewers for future submissions, reflecting our commitment to fostering a robust peer review process. In 2022 alone, MDPI collected over 1.4 million peer review reports, informing the decision-making processes of our editors. Given our expertise in these areas, it would be natural to include MDPI in such discussions. I therefore extend an invitation to future conference organizers to consider MDPI for speaking engagements and collaborative opportunities.

Stefan Tochev
Chief Executive Officer
MDPI AG

30 January 2024
Acknowledgment of the Reviewers of Viruses in 2023

In recognizing the exceptional efforts of our reviewers in 2023, we express our sincere gratitude for upholding the high standards of Viruses. Their commitment ensured the rigorous peer review that is integral to quality academic publishing.

In 2023, Viruses received 7922 review reports, from 4904 reviewers. This past year, we worked with reviewers from 99 countries and regions, reflecting the diversity in our collaboration with research communities. Their dedication shapes scholarly discourse and advances global research. The editorial team expresses gratitude for the vital role played by each reviewer in the Viruses family throughout 2023, and we look forward to their continued support in 2024.

The following are the reviewers who have consented to show their names:

A. Abdul Kader Jailani Kalhari Goonewardene
Abdulqadir Nashwan Kaliannan Durairaj
AbdulRahman Saied Kalichamy Alagarasu
Abhinay Gontu Kamaleldin B. Said
Abhishek Anant Kulkarni Karel Kostev
Abiola Adepoju Karel Petrzik
Abraham Pouliakis Karen Bohmwald
Ad De Groof Karen Kopciuk
Adalbert Schiller Karen Kyuregyan
Adam Brufsky Karim Benabdellah
Adam Oberstein Karl Boehme
Adam Whisnant Karoly Toth
Adarsh K. Gupta Katarina Resman Rus
Adetoun Asala Katarzyna Otulak
Adhikarimayum Lakhikumar Sharma Katherine Brown
Aditya Sharma Katie Ardipradja
Adrian Lita Katsunori Okazaki
Adriana Patricia Corredor-Figueroa Kazumoto Murata
Adriano Murrone Kazuo Itabashi
Adrien Breiman Keisuke Ishizawa
Afonso Almeida Ken Rosenthal
Agnieszka Bojarska-Junak Kennio Ferreira-Paim
Agostino Ognibene Kevin Bohannon
Ahmed Ali Kevin Danastas
Ahmed Elbestawy Khaled Alkharsah
Ahmed Mekkawy Ki Hyun Nam
Aiken Dao Kielan McAlinden
Ajay Akhade Kifayatullah Kakar
Akira Aoki Kim Van Vliet
Akira Nakanishi Kin Kui Lai
Akshaya Bhagavathula Klaus Hedman
Alain Le Faou Kok Hian Tan
Alda Natale Koki Taniguchi
Aldemir Branco Oliveira-Filho Konstantinos Protopapas
Alejandra García-Gasca Kouacou Konan
Alejandro Vallejo Krista Delviks-Frankenberry
Aleksander Mendyk Kristen Ogden
Alessandra Lamarca Kun Wen
Alessandra Oliva Kun Zhang
Alessandra Pierangeli Lalit Batra
Alessandro Strumia Lanjing Wei
Alessandro Tavelli Larry Croft
Alexander Alekseev László Hazai
Alexander Bolshoy Laura L. Gibson
Alexander Filatov Laura Medina-Puche
Alexander Ivanov Laura V. Sánchez-Orozco
Alexander Pasternak Laurent Bigarré
Alexander Sprygin Laurie Silva
Alexander Timoshenko Lauro Velazquez-Salinas
Alexander Zakhartchouk Lei Zhang
Alexandra Targovnik Leny Jose
Alfredo J. Lucendo Leonardo Velasco
Ali Abdallah Leszek Tylicki
Alice Monzani Lia Van Der Hoek
Aline Maria Da Silva Líbia Zé-Zé
Alison Talis Lima Lídia Gonçalves
Alkiviadis Vatopoulos Lidija Savić
Altijana Hromic-Jahjefendic Lidija Truncaite
Alvydas Malakauskas Lifeng Zhai
Amanda Seekings Lijuan Yuan
Amelina Albornoz Lin Xu
Amir Ghorbani Linbo Zhao
Amit Goel Linda J. Saif
Amit Kumar Lionel Frangeul
Amrita Saha Vadher Liv Bode
Amy MacNeill Logan Banadyga
Ana Belen Blazquez Martin Lorenzo Casalino
Ana Belen Ruiz-Garcia Lori Rice
Ana Carolina Ewbank Louie Mar Gangcuangco
Ana Cecília Ribeiro Cruz Luana Soares
Ana Cláudia Coelho Lubomira Nikolaeva-Glomb
Ana Espino Luc Swevers
Ana Vasić Luca Bertzbach
Anamika Pandey Luca Scapoli
Anand Kumar Pandey Luca Toti
Ananda Ayyappan Jaguva Vasudevan Lucia Stanciakova
Ananda Tiwari Luciana Costa
Anandi Rajan Luciane Amorim Santos
Anastasia Kotanidou Luigi Pistelli
Anatoly Zherdev Luis Adrián De Jesús González
Andi Krumbholz Luisa De Sordi
Andrea Cara Luisa Rubino
Andrea Fabbri Łukasz Grabowski
Andrea Guarino Łukasz Szeleszczuk
Andrea K. Thoma-Kress Maarit Suomalainen
Andrea Lipińska Maciej Zieliński
Andrea Tinelli Magdalena Dunowska
Andrea V. Peralta Magdalena Mizerska-Kowalska
Andreas Brodehl Magdalena Mroczek
Andreas Jekle Mahamud-Ur Rashid
Andreas Kuhn Mahdi Mahdipour
Andrej Cokan Mahmoud Ibrahim
Andreu Comas-Garcia Mahmoud Khalifa
Andrew Broadbent Mahmoud Singer
Andrew Freedman Maite Freitas Silva Vaslin
Andrew Omame Maksim Filipenko
Andrew Rice Małgorzata Kęsik-Brodacka
Andrew Vaillant Malgorzata Lobocka
Andrey Letarov Mandy Muller
Andrey Sgibnev Manfred Marschall
Angela Pearson Manfred Weidmann
Angus Oli Manish Dhawan
Aniello Maiese Manish Kumar
Anna Costagliola Manoj K. Sekhwal
Anna Dolgova Manoj Kumar
Anna Heitmann Manu Anantpadma
Anna Luganini Manuel Gomez Del Moral
Anna Matczuk Manuela Donalisio
Anna Rosa Garbuglia Marc Fuchs
Anna Shtro Marc Vasse
Anna Speranskaya Marcela Lizano
Anna Szakiel Marcelo Brigido
Anna Taglienti Marco Ciotti
Anna Timofeeva Marco Goeijenbier
Anna Vittoria Carluccio Marco Grodzki
Annalisa Chianese Marco Thomas
Annamaria Pratelli Marcos Romário Matos De Souza
Anne Hosmalin Maria Agallou
Annette Audigé Maria Angelica Guimarães
Antoinette C. Van Der Kuyl María Belén Álvarez Ortega
Antonella Olivero María Carmen Puertas
Antonieta Guerrero-Plata Maria Eugenia Gonzalez
Antonino Catara Maria Isaguliants
Antonio Bertoletti Maria King
Antonio Caputi Maria Lavilla
Antonio Mastino Maria Loureiro
Antonio Tiberini Maria Pia Ferraz
Antonio Toniolo Maria Plummer
Anu Paul Maria Tempesta
Anupam Mukherjee Maria Teresa Bruno
Apostolos Zaravinos Maria Vega Pittao
Aravinthkumar Jayabalan Maria Vittoria Mauro
Arianna Calistri Mariacristina Poliseno
Arianna De Mori Marianna Domán
Arianna M. Hurtado-Monzón Mariano Belaich
Armando Arias Mariarosaria Campise
Arrigo Cicero Marie Pizzorno
Artem Metlin Marija Pljesa-Ercegovac
Arthur Gruber Marilena Gregorini
Artur Słomka Marina Bobkova
Arturo Medrano-Soto Marina Ibragimova
Arun Srivastava Marina Strakhovskaya
Ashley Brown Marine Wasniewski
Atanu Khatua Marino Paroli
Athanasios A. Panagiotopoulos Marion Vermeulen
Athanasios Papakyriakou Marius Masiulis
Athina Geronikaki Mariza Morgado
Atsushi Kato Mark Calcott
Aurobind Vidyarthi Mark Krystal
Avinash Premraj Marko Noerenberg
Ayisa Rodrigues De Oliveira Markus Keller
Azat Gabdulkhakov Marshall Williams
Badr Alshomrani Marta Canuti
Bahaa Jawad Marta Szachniuk
Baicus Anda Marta Vascellari
Baik Lin Seong Martha Brown
Bambang Sugiharto Martijn D. B. Van De Garde
Banhi Biswas Martin Richter
Barbara Klupp Martin Svoboda
Barbara Ruaro Martina Smolic
Barbara Schnierle Martina Torricelli
Barbara Weck Marzia Pucci
Barry Alto Masaaki Miyazawa
Bart Tarbet Masahiro Niikura
Bas B. Oude Munnink Masahiro Yasuda
Basudev Paudyal Masakazu Tanaka
Beatrice Macchi Masayuki Ishikawa
Bela Balint Masfique Mehedi
Benhur Lee Mateusz Babicki
Benjamin Cull Mathieu Dubé
Benjamin Lamp Matias Castells
Benjamin Nilsson-Payant Matt Asare
Benoit Barbeau Matteo Riccò
Bernadett Papp Mauricio Comas-Garcia
Bernardo Bañuelos-Hernández Mauro Giacomelli
Bert Ely Mauro Viganò
Beth Thielen Mayo Yasugi
Betsy C. Herold Md. Abdus Sobur
Biao He Md. Nazmul Islam
Bidisha Mitra Md. Tanvir Rahman
Bihua Nie Meiling Yu
Bin Li Melinda Brindley
Binfeng Yin Melissa Barker-Haliski
Biswas Avik Mengmeng Zhao
Bo Wang Meredith Frazier
Bo Zhou Meret Ricklin
Bobo Mok Michael Amoa-Bosompem
Boguslawa Luzak Michael Bette
Boris Chernyak Michael Bukrinsky
Boris Kantor Michael Chapman
Boris Yakobson Michael Eller
Bradley Groveman Michael Liebman
Bratko Filipic Michael Perch
Brenda S. Konigheim Michael Rahe
Brendan Bell Michael Roggendorf
Brian Crook Michael Schreiber
Brian Lee Michael Winkler
Brian Salmons Michaela Gack
Brigitta Marcella Laksono Michal A. Rahat
Brigitte Hantusch Michele Tonelli
Bruna Ramos Mick Mulders
Byung-Hoon Jeong Mihaela Hostiuc
Cameron Tebbi Mihaela Kavran
Carla Masala Mihaela Luca
Carla Miranda Mihnea Bostina
Carla Zannella Min Guo
Carlos Cerdán Santacruz Minetaro Arita
Carlos Sandoval-Jaime Minghang Wang
Carlos São-José Mingsong Kang
Carmen Jerry Minsook Hwang
Carmina Gallardo Frontaura Mirjana Jerkic
Carmine Izzo Miroslav Glasa
Carol Chitko-McKown Modra Murovska
Carolina Pacca Mohamad S. Hakim
Carolyn Teschke Mohamed Hassan
Catherine Alex Mohamed Mahdi
Catherine Brown Mohammad Sadraeian
Catherine Eichwald Mohammed Noushad
Catherine Loc-Carrillo Mohammed Rohaim
Cécile-Marie Aliouat-Denis Mohd Imran
Celia Fernandez-Ortega Mohd Zulkifli Salleh
Chandrabose Selvaraj Moises Leon Juarez
Changjun Huang Mona Sadat Larijani
Changming Bai Monika Olech
Charles Foster Monika Rinder
Charlotte Preston Morgan Brisse
Cheng Chi Mubarak S. Karsany
Cheng Guo Mudan Zhang
Cheng Huang Muhammad Iqhrammullah
Cheng Yan Muhammad N. Zahid
Chengwu Zou Muhammad Naveed Anwar
Chiara Agostinis Muhammad Nawaz
Chih-Ching Chung Münir Aktaş
Chitra Upadhyay Myriam Ermonval
Christian Barbato Nadia Storm
Christian Laboisse Nadine Krüger
Christina L. Gardner Najim Alshahrani
Christine Blattner Nasim Izadi
Christophe Guillon Natalia Cheshenko
Christophe Vanpouille Natalia Kovalskaya
Christopher Bellas Natalia Lomakina
Christopher Denes Natália Marques
Chukwunonso Onyilagha Natalia Mazur-Panasiuk
Chung-Hsin Wu Natalia Soriano-Sarabia
Chutchai Piewbang Naveen Kumar
Claire Muslin Nemat Sokhandan-Bashir
Claudia Wylezich Neven Papić
Clinton Jones Nicholas Bradshaw
Côme Thieulent Nicholas Eyre
Concetta Castilletti Nick Juleff
Congyue Peng Nicolas Ruggli
Conxita Mestres Nicole Vidal
Corrado Pelaia Nicolò Brandi
Craig Brunetti Nicolò Fabbri
Cristian Baicus Nidia Arechiga-Ceballos
Cristian-Mihail Niculae Nikolai Nikitin
Cristina Mambet Nikolaos Giormezis
Crystall Swarbrick Nikolaos V. Sipsas
Dan Heller Nina Tikunova
Dana Sabir Nina Wolfrum
Daniel Cisterna Nirajkumar Makadiya
Daniel Gonzalez-Dunia Nityanand Jain
Daniel Pérez-Núñez Nobuhiru Suzuki
Daniel Potaczek Noelia Nuñez-Ortiz
Daniel Salamango Norbert J. Roberts Jr.
Daniel Scott Noula Shembade
Daniela Elena Serban Noura Dosoky
Daniele Focosi Noureddine Issaoui
Danijela Černe Nourolah Soltani
Danijela Miljanovic Nuno Taveira
Danillo Lucas Alves Esposito Nuria Torner
Danuta Januszkiewicz-Lewandowska Olga Ivanova
Dapeng Wang Olga Krestinina
Daria Danilenko Olga Matveeva
David Baum Oliver Planz
David Burke Oliver Van Oekelen
David Davido Olivier Escaffre
David Martin Ombretta Turriziani
David Ornelles Omid Rezahosseini
David Scheim Osama Atallah
David Scott McVey Osman Aktaş
Dawei Zhou Otávio Augusto Chaves
De Gaulle I. Chigbu Otávio Espíndola
Debashis Dutta Owais Khan
Deemah Dabbagh Pakieli H. Kaufusi
Demetrios Arvanitis Pamuk Bilsel
Denise Hemmings Panagiotis Katsoulos
Dennis Bideshi Panagiotis Tassis
Der-Shan Sun Paola Dall’Ara
Désirée Caselli Paola Sinibaldi
Dewald Schoeman Paolo Monini
Diane Addie Paolo Pozzi
Dianjun Cao Parikshit Bagchi
Dilber Ipek Kurtboke Partha Chandra
Dimitri Kakabadse Partha Ray
Dimitrios Skliros Pasquale Marrazzo
Dimitris Tsakogiannis Pasquale Saldarelli
Dinesh Devadoss Patrick Gérardin
Dinesh Gawande Patrizia Danesi
Djamal Brahim Belhaouari Paul Azzinaro
Dmitry Kireev Paul Hyman
Dmitry S. Karpov Paul Kupke
Dmytro Chumachenko Paul Rösch
Domenico Galante Paula Rozo-Lopez
Domenico Marson Paulo Zaini
Dominic Paquin Proulx Pavel Alexyuk
Dominik Radzki Pavel Nazarov
Donald E. Spratt Pavel Solopov
Donald M. Coen Pavle Banovic
Dongbo Jiang Paweł Bęczkowski
Dong-Yan Jin Paweł Wańkowicz
Douwe Sinderen Pawel Zmora
Dulani Meedeniya Pedro Ramos-González
Duomeng Yang Pedro Serra
Edgar Simulundu Peli Foka
Edmund Kozieł Pengfei Ding
Eduardo Gomez-Casado Pero Lučin
Eduardo Gutiérrez-Abejón Perumal Renukadevi
Efstathios S. Giotis Peter Evseev
Eileen Roulis Peter Gaskill
Elcio Leal Peter Nagy
Elena Criscuolo Petr Zeman
Elena Frolova Philip Serwer
Elena Ryabchikova Phillip Tai
Eleonora Cimini Phuong Thi Hoang
Elisa Cairrao Pietro Hiram Guzzi
Elizaveta Starodubova Piyush Baindara
Elliott Chiu Pradeep Uchil
Elrashdy Redwan Pragya Yadav
Elsa Damonte Prashant Sharma
Elton Vasconcelos Qiang Liu
Elvan Üstün Qibin Geng
Elvina Viennet Qin Xiang Ng
Elzbieta Kierzek Rafael Rivera-Bustamante
Emad Beshir Ata Rafaela Fernandes
Emily Edwards Rafaella Ioshino
Emma Mohr Raffaele Serra
Emmanouil Magiorkinis Raghunadharao Digumarti
Emmanuelle Muller Rahima Benhabbour
Engy Elekhnawy Rajiv Pathak
Enrique Domínguez-Álvarez Ramanjaneyulu Rayala
Erez Bar-Haim Ramin Raul Ossami Saidy
Eric Huet Randal N. Johnston
Eric Lau Raphaël Duval
Eric Romanowski Raphael Tze Chuen Lee
Eric S. Pringle Rashad El-Hind
Eric Schott Raul Machado
Erich Mackow Ravendra Chauhan
Ernesto Quesada Ravinder Kumar
Esperanza Gomez-Lucia Rebecca Creamer
Esteban Finol Rebecca DuBois
Estela Paz-Artal Rebecca Rose
Eugene Ryabov Rebecca Sumner
Eui Tae Kim Regragui Taki
Eunsil Park Reiner Ulrich
Éva Áy Reka Varnai
Eva Varallyay Renata Oliveira
Evandro Watanabe Rendi Jiang
Evangelia Antoniou René Huber
Evgenii Rubalskii Renu Khasa
Evgeny Ermakov Reza Khayat
Ewa Tomaszewska Rhitajit Sarkar 
Ewoud B. Compeer Ricardo Lucena
Ezequiel Fuentes-Pananá Ricardo Parreira
Fabian Giolitti Riccardo Moretti
Fábio Abade Dos Santos Riccardo Nevola
Fabio Fiorino Richard Williams
Fabio Possebon Rik De Swart
Fabio Romerio Rita Ribeiro
Fabrício S. Campos Ritthideach Yorsaeng
Fabrizio Angius Rob Hoeben
Faez Amokrane Nait Mohamed Robert Flisiak
Fanfan Zhang  Robert Nastasa
Fangfang Sun Robert Yung Liang Wang
Fangfeng Yuan Roberta Antonia Diotti
Fareeha Saadi Roberta Battistini
Fátima Amaro Roberto De Masi
Fatma Eldemery Rodrigo Rodrigues
Fayna Diaz-San Segundo Roger Grand
Federica Fogacci Roland Marquet
Federico Armando Roland Zell
Federico Marchesi Rollie Clem
Felicia Grasso Ronan Murphy
Fernando Ferreira Ronghong Hua
Filipe Abreu Ronit Sarid
Filomena Fonseca Rosa Suades
Filomena Napolitano Rosamaria Pennisi
Flor Helene Pujol Roseli Nomura
Florence Abravanel Rosilainy Fernandes
Florence Fouque Ross Larue
Florence Larrous Rossella Cacciola
Florence Nicot Rozeta Sokou
Florencia Cancela Ruben Cloete
Floris Breman Rudian Zhang
Francesco Maria Fusco Rudolf Valenta
Francesco Messina Ruining Wang
Francesco Mira Ruisong Yu
Francesco Sessa Rupy Matharu
Francisco Guillen-Grima Ryan Troyer
Francisco José Nunes Antunes Ryo Okada
Francisco Reynaldi Saeid Ghavami
Franco Mutinelli Saito Akatsuki
Franz-Georg Hanisch Sakshi Arora
Fusheng Si Salim Manoharadas
Gábor Kökény Samar Tharwat
Gábor Nagy Samer Al Ghour
Gabriela Condezo Samir Casseb
Gabriela Goujgoulova Samrat Kumar Dey
Gabriela Mellado-Sanchez Samrita Dogra
Gabriela Popa Samuel Campos
Gabriela Toomer Sanchita Das
Gaetan Ligat Sandip Chavan
Gang Ye Sandra Adams
Gautier Moroy Sandra Högler
Geoffrey Holm Sandrama Nadan
Georges Herbein Santa Rasa-Dzelzkaleja
Georgios Pappas Santiago Garcia-Vallve
Gergana Zahmanova Santiago Mirazo
Gerhard Steger Santosh Dhakal
German Botto Nuñez Santosh George
German Gornalusse Sara Louise Cosby
Gert Venter Sara Morón-López
Gervais Habarugira Sara Querido
Ghassan Ghssein Sarah Jackson
Gianluca Spiteri Sarah Kempster
Gianpiero Zamperin Satoru Watanabe
Gilbert Holyoak Saumya Anang
Gilbert Nchongboh Chofong Sayanta Bera
Gill Diamond Sayed Abdelwahab
Giorgio Gallinella Sayed Sartaj Sohrab
Giorgio Mangino Schuyler Van Engelenburg
Giovanni Battista Gaeta Sebastiano Cicco
Giulia Tarquini Sek-Man Wong
Giuseppe Bruno Semer Maksoud
Giuseppe Di Martino Sergei Chirkov
Gloria Ramirez-Nieto Sergei Nikolaevich Shchelkunov
Gonzalo Izaguirre Sergei Raev
Gordana Wozniak Knopp Sergey Iordanskiy
Graham Belsham Sergey Kapranov
Graham Burgess Sergey Morozov
Grazia Pavia Sergey Sedykh
Greg Brennan Sergey Tkachev
Grissell Tirado Seri Jeong
Grzegorz Grześk Shabana Bibi
Grzegorz Jakubiak Shagufta Perveen
Guanghui Wu Shalini Dogra
Guanglin Zhang Shangrong Fan
Guido Vanham Shaoquan Zheng
Gulce Sari Sharat Chandra
Gun Temeeyasen Sharon Andreason
Gustavo Caetano-Anollés Sheng Qin
Gustavo Silva Shengqun Deng
Guy Lemay Shengren Sun
Gwladys Gernoux Shengxi Chen
Hafez M. Hafez Shiba Dandpat
Hagen Frickmann Shifali Shishodia
Haidi Ramadan Shih-Chieh Shao
Haiyan Yang Shivalee Duduskar
Halilibrahim Ciftci Shu Yuan
Han Siong Toh Shuchen Feng
Hana Dobrovolny Shukho Kim
Hang Su Shuntai Zhou
Hanns Moshammer Shuya Yang
Hans-Gerhard Burgert Silvia Faccini
Hansjörg Lehnherr Silvia González
Hao Wang Simone König
Haolong Dong Singh Avishek
Hardik Dineshbhai Desai Slavica Kvolik
Harriet C. Groom Sohrab Ahmadivand
Haruka Abe Sonia Lozano Sepulveda
Hassanein Abozeid Sonia Moretti
Hayley Yaglom Sonsoles Salto-Alejandre
Hazem Elkady Sotirios N. Kiokias
He Sun Sowmyalakshmi Subramanian
He Zhang Sreekumar Othumpangat
Heba Zaghloul Srinivasa Reddy Bonam
Hector Rangel Srinivasan Palani
Hedvig Bölcskei Stefan Oliver
Heinzpeter Schwermer Stefan Vilcek
Hélène Sanfaçon Stefania Lauzi
Heliana Dundarova Stefano Pascarella
Helle Bielefeldt-Ohmann Stefano Rusconi
Hengchang Chen Stephan Pleschka
Henry Sutanto Stephen A. Rice
Herbert Treutlein Stephen Morris
Hidekazu Hiroaki Steven Baker
Hideo Wada Steven Van Borm
Hideto Fukushi Steven Zink
Hi-Eun Jung Stuart Dowall
Hiroaki Okamoto Subbiah Thamotharan
Hiroyasu Sakai Subha Das
Hisayoshi Kawahara Suchitra Mohanty
Ho-Jong Ju Sudhir Morla
Hon S. Ip Suman Alishetty
Hongbo Zhou Suman Lata Wattal
Hongzhuan Wu Suresh Varsani
Hua Wang Sutonuka Bhar
Hua-Ji Qiu Sveinung Sorbye
Hugo Ramírez Álvarez Sylvain De Breyne
Hye Kwon Kim Tae-Jin Choi
Hye Ryoung Kim Tahir Farooq
Hye-Ra Lee Takahiro Kawagishi
Hyun Jin Kwun Takahiro Sanada
Hyun-Ouk Kim Takashi Onodera
Hyun-Woo Park Takashi Yoshiyama
Ian Barr Takayuki Nitta
Ibrahim Sayed Takeshi Kawaguchi
Ida Steinberger-Levy Takuya Tada
Igor Andrade Santos Tal Noy Porat
Igor Babkin Talia Swartz
Igor Jurak Talita Resende
Igor Maksimov Tamás Letoha
Igor Oscorbin Tanel Punga
Ikbal Agah Ince Tanushree Dangi
Ilya M. Terenin Tao Wang
Ilze Strumfa Tao Zhu
Imaan Benmerzouga Tara M. Strutt
Iman Tavassoly Taro Urase
Ines Aguinaga-Ontoso Tatiana Komarova
Inês Bártolo Tatjana Vilibic-Cavlek
Ingo Drexler Tatsunori Nakano
Ingrid Friesema Tatsuo Kanda
Inna Solyanikova Tatsuya Yamazaki
Ioannis G. Kyriakoulis Tatyana Ilyicheva
Ioannis Giantsis Tea Glonti
Irena Ilic Teddy Lazebnik
Irena Tabain Terence Scott
Irene Görzer Terenzio Cosio
Irene Ramos Teruhime Ootoguro
Irene Righetto Tetsuro Ikegami
Irina Isakova-Sivak Thiago Murari
Irina Kiseleva Thomas Dandekar
Isabel Muñoz-Barroso Tianjie Pu
Italo Tempera Tim Mahony
Itzel López-Rosas Tim Sit
Ivan Gladwyn-Ng Tiziana Bachetti
Ivan Sabol Todd Smith
Ivana Lazarevic Tom Gallagher
Ivanildo Sousa Tomasz Krzysztof Oszako
Ivo Sirakov Tomozumi Imamichi
Iwao Kukimoto Tong Wang
J. Stephen Lodmell Tongjun Guo
Jacques Robert Toru Takimoto
Jacques Scheres Trevor Williams
Jaggi Ujjaldeep Triantafyllos Didangelos
Jaime Sancho Trudy G Morrison
James Chung-Wai Cheung Tsung-Chi Chen
James Gillespie Tuba Çiğdem Oğuzoğlu
James Harris Tudor Borza
James Van Etten Tudor Lucian Pop
Jana Sopkova De Oliveira Santos  Tutku Beduk
Janet Mans Tze-Kiong Er
Janet Nale Umberto Palatini
Janis Müller Umberto Rosani
Janja Trček Urmi Roy
Jaquelin Dudley Usama Abdelmohsen
Jarosław Walory Usama Ashraf
Jasminka Peršec Valerio Giaccone
Jay R. Radke Valerio Leoni
Jayeshbhai Chaudhari Vanessa Meier-Stephenson
Jean Bettoni Vangelis Daskalakis
Jean Daugrois Vanja Kaliterna
Jean Vanderpas Velmurugan Balaraman
Jean-Pierre Frossard Venkatesan Jayaprakash
Jean-Pierre Gagner Venkatraman Siddharthan
Jelena Prpić Verónica Truniger
Jennifer Corcoran Véronique Ziegler-Graff
Jennifer Moffat Vesna Milicevic
Jens Andre Hammerl Vicente Notario
Jeong Yoon Lee Vicente Pallás
Jeová Colares Victor M. Petrone-Garcia
Jerel A. Fields Vida Van Staden
Jeremy Camp Vikram Dalal
Jesse Arbuckle Vinay Shivanna
Jesse Deere Violetta Macioszek
Jessica Kevill Virginia Lotti
Jessy Vibin Virginie Doceul
Jesús Hernández Vishal Singh Negi
Jesús Zepeda-Cervantes Vishi Reddy
Ji Bao Vishma Pratap Sur
Jiafen Hu Vivaldo Gomes Da Costa
Jian Zhang Vivian De Oliveira
Jianchao Zhang Vivian O'Donnell
Jianing Chen Viviana Parreño
Jianjun Zhao Vladimir I. Timofeev
Jianpiao Cai Vladimir Savic
Jianzhu Liu Vladimir Yeremeev
Jiarong Jheng Volker Schmidt
Jiazhang Wei Volodymyr Oberemok
Jienyu Ding Vrinda Gote
Jieshi Yu Vyacheslav Yurchenko
Jiexiong Xie Waldemar Wagner
Jillian Myers Wanbiao Ma
Jimmy T. Efird Wei Ye
Jin Il Kim Wei-Fan Hsu
Jinlong Han Weiheng Su
Jinming Han Wei-June Chen
Jinyan Zhang Weiren Luo
Jinyang Zhang Wen Deng
Jiwei Ding Wenchao Sun
Joan L. Kenney Wenjun Zhu
Joana Vitallé Wojciech Rozek
Joanna Maj-Paluch Wolfram Gerlich
Joanne Hiebert Won Kyong Cho
Joe Mymryk Xiangjie Sun
Joel Ellwanger Xiaochun Peng
John Sinclair Xiaodong Xu
Joice Ruggeri Xiaofan Li
Jonathan Griffiths Xiaoming Lyu
Jonathan LeCureux Xiaoying Yu
Jonathan Rayner Xin Li
Joon Kee Lee Xinhong Chen
Jorge Padrão Xinran Liu
Jorlan Fernandes Xizhou Zhu
José A. Carrión Xudong Fan
Jose A. Garrote Xuefei Tan
José Affranchino Xuehong Wu
José Cuevas Xulin Chen
José Leopoldo Aguilar-Faisal Y. B. Basavaraj
Jose Ramos-Vivas Yahya Al Naggar
Josep Quer Yahya Gaafar
Joseph Westrich Yanal Murad
Josko Markic Yanan Liu
Joydip Sengupta Yihong Xiao
Jozef Bujarski Yinzhong Shen
Jozsef Dudas Yiwen Zhao
Juan Bárcena Yolande Thérèse Rose Proroga
Juan Degiuseppe Yong Gao Peng
Juan E. Ludert Yong Shao
Juan Fidel Osuna-Ramos Yong Teng
Juan Hernandez-Garcia Yongduo Sun
Juanita Van Heerden Yonggang Pei
Juhee Ahn Yoshiaki Yura
Julia Davydova Yousong Peng
Julian Freen-van Heeren Yu-Chung Chang
Julián Ruiz-Sáenz Yuefan Song
Julián Solís García del Pozo Yung-Cheng Lin
Julie Fox Yusra Habib Khan
Julio Plaza Díaz Yusuke Matsumoto
Jumari Snyman Yutaka Tagaya
Jun Arii Zbigniew Heleniak
Jun Chen Zhanying Hu
Jun Luo Zhaoxi Sun
Junfa Yuan Zhen Li
Junfeng Gao Zheng Chen
Jung-Eun Park Zhenlu Chong
Junichi Inaba Zhenyu Zhang
Junping Hong Zhijun Yu
Junqing Guo Zhonglei Wang
Juris Jansons Zifu He
Jutta Pikalo Zisis Kozlakidis
Kai Xu Zoltan Peterfi
Kai Zheng Zoltan Vajo
Kaichuang Shi Zoran Todorovic
Kaili Ma Zsolt Toth
Kai-Shu Ling Zulqurnain Khan

23 January 2024
Prof. Dr. Svetlana Y. Folimonova Appointed Associate Editor of Section “Viruses of Plants, Fungi and Protozoa” in Viruses


We are pleased to announce that Prof. Dr. Svetlana Y. Folimonova has been appointed Associate Editor of the Section “Viruses of Plants, Fungi and Protozoa” of Viruses (ISSN: 1999-4915).

Name: Prof. Dr. Svetlana Y. Folimonova
Homepage: https://plantpath.ifas.ufl.edu/people/faculty-pages/svetlana-folimonova/
Affiliation: Department of Plant Pathology, Plant Molecular and Cellular Biology Graduate Program, University of Florida, Gainesville, FL 32611, USA
Interests: RNA viruses; long noncoding RNAs; plant viruses; virus–host interactions; viral and bacterial diseases of citrus; citrus tristeza virus

Prof. Dr. Folimonova is a Professor at the University of Florida, USA. Her research program focuses on viral diseases of plants, in particular, diseases caused by the largest nonsegmented plant RNA virus, citrus tristeza virus. Prof. Dr. Folimonova’s primary research effort is concentrated on understanding the mechanisms of the infection process, host responses to viruses, improving methods of detection, and developing management strategies for viral diseases.

We are honored that we have the opportunity to introduce Prof. Dr. Svetlana Y. Folimonova to our editorial team, and we are confident that, with the guidance of our new Associate Editor, we will continue to improve the reputation and quality of Viruses.

For more information about the “Viruses of Plants, Fungi and Protozoa” Section, please visit the following link: https://www.mdpi.com/journal/viruses/sections/plant_viruses.

Viruses Editorial Office

18 January 2024
Viruses | Editor’s Choice Articles in 2023 (I)


“Evolving Horizons: Adenovirus Vectors’ Timeless Influence on Cancer, Gene Therapy and Vaccines”
by Prasad D. Trivedi, Barry J. Byrne and Manuela Corti
Viruses 2023, 15(12), 2378; https://doi.org/10.3390/v15122378
Available online: https://www.mdpi.com/1999-4915/15/12/2378

“Enhanced Susceptibility to Tomato Chlorosis Virus (ToCV) in Hsp90- and Sgt1-Silenced Plants: Insights from Gene Expression Dynamics”
by Irene Ontiveros, Noé Fernández-Pozo, Anna Esteve-Codina, Juan José López-Moya and Juan Antonio Díaz-Pendón
Viruses 2023, 15(12), 2370; https://doi.org/10.3390/v15122370
Available online: https://www.mdpi.com/1999-4915/15/12/2370

“The Functional Implications of Broad Spectrum Bioactive Compounds Targeting RNA-Dependent RNA Polymerase (RdRp) in the Context of the COVID-19 Pandemic”
by Brittany A. Comunale, Robin J. Larson, Erin Jackson-Ward, Aditi Singh, Frances L. Koback and Lilly D. Engineer
Viruses 2023, 15(12), 2316; https://doi.org/10.3390/v15122316
Available online: https://www.mdpi.com/1999-4915/15/12/2316

“An Inducible ESCRT-III Inhibition Tool to Control HIV-1 Budding”
by Haiyan Wang, Benoit Gallet, Christine Moriscot, Mylène Pezet, Christine Chatellard, Jean-Philippe Kleman, Heinrich Göttlinger, Winfried Weissenhorn and Cécile Boscheron
Viruses 2023, 15(12), 2289; https://doi.org/10.3390/v15122289
Available online: https://www.mdpi.com/1999-4915/15/12/2289

“Identification of Host Factors for Rift Valley Fever Phlebovirus”
by Velmurugan Balaraman, Sabarish V. Indran, Yonghai Li, David A. Meekins, Laxmi U. M. R. Jakkula, Heidi Liu, Micheal P. Hays, Jayme A. Souza-Neto, Natasha N. Gaudreault, Philip R. Hardwidge et al.
Viruses 2023, 15(11), 2251; https://doi.org/10.3390/v15112251
Available online: https://www.mdpi.com/1999-4915/15/11/2251

“Nanoluciferase Reporter Zika Viruses as Tools for Assessing Infection Kinetics and Antibody Potency”
by Yanqun Xu, Devin Vertrees, Yong He, Sanaz Momben-Abolfath, Xiaohong Li, Yambasu A. Brewah, Dorothy E. Scott, Krishnamurthy Konduru, Maria Rios and Evi B. Struble
Viruses 2023, 15(11), 2190; https://doi.org/10.3390/v15112190
Available online: https://www.mdpi.com/1999-4915/15/11/2190

Pteropus vampyrus TRIM40 Is an Interferon-Stimulated Gene That Antagonizes RIG-I-like Receptors”
by Sarah van Tol, Adam Hage, Ricardo Rajsbaum and Alexander N. Freiberg
Viruses 2023, 15(11), 2147; https://doi.org/10.3390/v15112147
Available online: https://www.mdpi.com/1999-4915/15/11/2147

“Diversity and Current Classification of dsRNA Bacteriophages”
by Sari Mäntynen, Meri M. Salomaa and Minna M. Poranen
Viruses 2023, 15(11), 2154; https://doi.org/10.3390/v15112154
Available online: https://www.mdpi.com/1999-4915/15/11/2154

“A Triple Gene-Deleted Pseudorabies Virus-Vectored Subunit PCV2b and CSFV Vaccine Protect Pigs against a Virulent CSFV Challenge”
by Ediane Silva, Elizabeth Medina-Ramirez, Selvaraj Pavulraj, Douglas P. Gladue, Manuel Borca and Shafiqul I. Chowdhury
Viruses 2023, 15(11), 2143; https://doi.org/10.3390/v15112143
Available online: https://www.mdpi.com/1999-4915/15/11/2143

“Polyomavirus Wakes Up and Chooses Neurovirulence”
by Arrienne B. Butic, Samantha A. Spencer, Shareef K. Shaheen and Aron E. Lukacher
Viruses 2023, 15(10), 2112; https://doi.org/10.3390/v15102112
Available online: https://www.mdpi.com/1999-4915/15/10/2112

“Small Heat Shock Protein (sHsp22.98) from Trialeurodes vaporariorum Plays Important Role in Apple Scar Skin Viroid Transmission”
by Savita Chaudhary, Vijayanandraj Selvaraj, Preshika Awasthi, Swati Bhuria, Rituraj Purohit, Surender Kumar and Vipin Hallan
Viruses 2023, 15(10), 2069; https://doi.org/10.3390/v15102069
Available online: https://www.mdpi.com/1999-4915/15/10/2069

10 January 2024
Viruses Papers Released in 2023 Receive “Highly Cited Papers” Distinction in Web of Science

As of July/August 2023, 16 papers from Viruses (ISSN: 1999-4915) released in 2023 received enough citations to place them in the top 1% of the academic field of microbiology based on a highly cited threshold for the field and publication year.

The Viruses Editorial Office sincerely congratulates all the authors and hopes that they continue to have an academically productive relationship with the journal.

Decreased Clinical Severity of Pediatric Acute COVID-19 and MIS-C and Increase of Incidental Cases during the Omicron Wave in Comparison to the Delta Wave
by Patrick O. Kenney, Arthur J. Chang, Lorna Krabill and Mark D. Hicar
Viruses 2023, 15(1), 180; https://doi.org/10.3390/v15010180

Molnupiravir and Nirmatrelvir/Ritonavir: Tolerability, Safety, and Adherence in a Retrospective Cohort Study
by Maria Mazzitelli, Daniele Mengato, Lolita Sasset, Anna Ferrari, Samuele Gardin, Vincenzo Scaglione, Nicola Bonadiman, Lucrezia Calandrino, Silvia Cavinato, Sabrina Trivellato et al.
Viruses 2023, 15(2), 384; https://doi.org/10.3390/v15020384

Impact of Early SARS-CoV-2 Antiviral Therapy on Disease Progression
by Andrea De Vito, Agnese Colpani, Laura Saderi, Mariangela Puci, Beatrice Zauli, Vito Fiore, Marco Fois, Maria Chiara Meloni, Alessandra Bitti, Cosimo Di Castri et al.
Viruses 2023, 15(1), 71; https://doi.org/10.3390/v15010071

Tixagevimab/Cilgavimab in SARS-CoV-2 Prophylaxis and Therapy: A Comprehensive Review of Clinical Experience
by Karolina Akinosoglou, Emmanouil-Angelos Rigopoulos, Georgia Kaiafa, Stylianos Daios, Eleni Karlafti, Eleftheria Ztriva, Georgios Polychronopoulos, Charalambos Gogos and Christos Savopoulos
Viruses 2023, 15(1), 118; https://doi.org/10.3390/v15010118

TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection
by Kristin Metzdorf, Henning Jacobsen, Marina C. Greweling-Pils, Markus Hoffmann, Tatjana Lüddecke, Felicitas Miller, Lars Melcher, Amy M. Kempf, Inga Nehlmeier, Dunja Bruder et al.
Viruses 2023, 15(2), 271; https://doi.org/10.3390/v15020271

Cardiac Arrhythmias in Post-COVID Syndrome: Prevalence, Pathology, Diagnosis, and Treatment
by Aydin Huseynov, Ibrahim Akin, Daniel Duerschmied and Rüdiger E. Scharf
Viruses 2023, 15(2), 389; https://doi.org/10.3390/v15020389

Variability in the Clinical Course of COVID-19 in a Retrospective Analysis of a Large Real-World Database
by Robert Flisiak, Piotr Rzymski, Dorota Zarębska-Michaluk, Przemysław Ciechanowski, Krystyna Dobrowolska, Magdalena Rogalska, Jerzy Jaroszewicz, Anna Szymanek-Pasternak, Marta Rorat, Dorota Kozielewicz et al.
Viruses 2023, 15(1), 149; https://doi.org/10.3390/v15010149

Omicron Waves in Argentina: Dynamics of SARS-CoV-2 Lineages BA.1, BA.2 and the Emerging BA.2.12.1 and BA.4/BA.5
by Carolina Torres, Mercedes Nabaes Jodar, Dolores Acuña, Romina Micaela Zambrana Montaño, Andrés Carlos Alberto Culasso, Ariel Fernando Amadio, Paula Aulicino, Santiago Ceballos, Marco Cacciabue, Humberto Debat et al.
Viruses 2023, 15(2), 312; https://doi.org/10.3390/v15020312

Hyperinflammatory Response in COVID-19: A Systematic Review
by Marcos Jessé Abrahão Silva, Layana Rufino Ribeiro, Maria Isabel Montoril Gouveia, Beatriz dos Reis Marcelino, Carolynne Silva dos Santos, Karla Valéria Batista Lima and Luana Nepomuceno Gondim Costa Lima
Viruses 2023, 15(2), 553; https://doi.org/10.3390/v15020553

The Role of Viral Infections in the Onset of Autoimmune Diseases
by Bhargavi Sundaresan, Fatemeh Shirafkan, Kevin Ripperger and Kristin Rattay
Viruses 2023, 15(3), 782; https://doi.org/10.3390/v15030782

Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID
by Aristo Vojdani, Elroy Vojdani, Evan Saidara and Michael Maes
Viruses 2023, 15(2), 400; https://doi.org/10.3390/v15020400

A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies
by Srijan Chatterjee, Manojit Bhattacharya, Sagnik Nag, Kuldeep Dhama and Chiranjib Chakraborty
Viruses 2023, 15(1), 167; https://doi.org/10.3390/v15010167

Epizootic Haemorrhagic Disease Virus Serotype 8 in Tunisia, 2021
by Soufien Sghaier, Corinne Sailleau, Maurilia Marcacci, Sarah Thabet, Valentina Curini, Thameur Ben Hassine, Liana Teodori, Ottavio Portanti, Salah Hammami, Lucija Jurisic et al.
Viruses 2023, 15(1), 16; https://doi.org/10.3390/v15010016

Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
by Levente Zsichla and Viktor Müller
Viruses 2023, 15(1), 175; https://doi.org/10.3390/v15010175

Pediatric Systemic Lupus Erythematous in COVID-19 Era
by Ancuta Lupu, Ingrith Crenguta Miron, Cristina Gavrilovici, Anca Adam Raileanu, Iuliana Magdalena Starcea, Ileana Ioniuc, Alice Azoicai, Adriana Mocanu, Lacramioara Ionela Butnariu, Felicia Dragan et al.
Viruses 2023, 15(2), 272; https://doi.org/10.3390/v15020272

Fragment-Based Approaches Identified Tecovirimat-Competitive Novel Drug Candidate for Targeting the F13 Protein of the Monkeypox Virus
by Yasir Ali, Hina Imtiaz, Muhammad Mutaal Tahir, Fouzia Gul, Umair Ali Khan Saddozai, Ashfaq ur Rehman, Zhi-Guang Ren, Saadullah Khattak and Xin-Ying Ji
Viruses 2023, 15(2), 570; https://doi.org/10.3390/v15020570

2 January 2024
MDPI Insights: The CEO’s Letter #7 - Nobel Laureates Entrust MDPI with Their Research

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Nobel Prize Laureates Entrust MDPI with Their Research

The Nobel Prize stands as a hallmark of distinction, honouring ground-breaking research across disciplines. Annually, the Nobel Prizes are awarded in six categories: Physics, Chemistry, Medicine or Physiology, Literature, Peace, and Economic Sciences.

Through the years, renowned scholars have entrusted MDPI with their work. As at December 2023, 26 Nobel laureates have contributed to more than 75 articles across 25 MDPI journals, including: Antibiotics, Applied Sciences, Biology, Biomedicines, Cancers, Catalysts, Cells, Crystals, Entropy, Games, IJMS, Life, Materials, Micromachines, Molecules, Pharmaceuticals, PharmaceuticsPhotonics, Quantum Beam Science, Remote Sensing, Sensors, Solids, Universe, Vaccines, and Viruses.

The best of the best trust us with their work.

Nobel Prize Laureates Who Have Published with MDPI

We are proud to list the names of Pierre Agostini, Hiroshi Amano, Werner Arber, Aaron Ciechanover, Robert H. Grubbs, Oliver Hart, Gerard ‘t Hooft, Michael Houghton, Harald zur Hausen, Katalin Karikó, Jean-Marie Lehn, Gérard Mourou, Ferid Murad, Shuji Nakamura, William Nordhaus, Kostya S. Novoselov, Giorgio Parisi, Charles M. Rice, Alvin E. Roth, Donna Strickland, K. Barry Sharpless, George F. Smoot, Anne L’Huillier, Drew Weissman, Kurt Wüthrich, Ada Yonath.

The privilege of hosting such contributors resonates deeply with our editorial teams. For instance, in this interview, the Editor-in-Chief (EiC) of Universe speaks on the significance of publishing a paper by Nobel laureate Gerard ’t Hooft within the journal.

2023 Nobel Prize Winners Published by MDPI

Nobel Prize Winners, 2023: Katalin Karikó, Drew Weissman, Anne L’Huillier (Ill. Niklas Elmehed © Nobel Prize Outreach)

Three laureates from the 2023 Nobel Prize cohort have trusted MDPI as their publishing platform. Notably, in a 2022 Pharmaceutics paper, molecular biologist Katalin Karikó and her team presented a methodology for evaluating mRNA capping efficiency, pivotal for therapeutic applications. Pharmaceutics had previously dedicated a Special Issue to “mRNA Therapeutics: A Themed Issue in Honor of Professor Katalin Karikó”, spotlighting ten articles from August 2021 to February 2022.

In the journal Vaccines, Professor Drew Weissman, collaborating with scholars from Pennsylvania University and George Mason University, contributed an influential review titled “Nanomaterial Delivery Systems for mRNA Vaccines”. His collaborative efforts spanned five papers across MDPI journals between 2021 and 2023.

Furthermore, Anne L'Huillier of Lund University, only the fifth female recipient of the Physics Prize, co-authored an article in Applied Sciences focusing on "Advanced EUV and X-Ray Optics". Similarly, Pierre Agostini, an Emeritus Professor from Ohio State University, co-authored an article featured in the special issue "Attosecond Science and Technology: Principles and Applications".

We extend heartfelt congratulations to all Nobel Prize laureates and express sincere gratitude for their confidence in MDPI as a platform for their scholarly contributions.

Read more:

Impactful Research

MDPI Journals Newly Indexed in 2023

The aim of indexing is to enhance the quality and credibility of published research, ensuring that researchers access the most credible resources available. While the principle behind citation indexing is straightforward, it remains one of the most dependable methods for tracking an idea's evolution across various scientific disciplines.

Throughout the year, MDPI works to expand the reach of our publications across premier multidisciplinary databases like Web of Science, Scopus, EBSCO, and ProQuest. This initiative is spearheaded by MDPI's Indexing team, under the leadership of Dr. Constanze Schelhorn.

In 2023, MDPI achieved 54 new acceptances in Scopus, 29 in Web of Science, 52 in EBSCO, and 83 in DOAJ: Directory of Open Access Journals.

The team prioritizes ensuring that our journals feature in numerous specialized databases, including PMC, PubMed, MEDLINE, Inspec, CAS, and FSTA, among others. Currently, MDPI collaborates with over 65 renowned international databases, consistently enhancing our database affiliations annually.

MDPI’s journals are indexed in all major global databases.

Furthermore, we collaborate with universities and government organizations to list our journals in country-specific ranking lists and relevant institutional repositories. This ensures compliance with requirements often set by funders or institutions for authors to publish in specific journals.

Web of Science Adds 24 MDPI Journals to Emerging Sources Citation Index (ESCI)

Clarivate recently analysed MDPI’s new journals, resulting in 24 journals, mainly established in 2020, being added to the ESCI in November and December 2023. Additionally, five journals passed this assessment earlier in the year. For a complete list of our journals in Web of Science, refer here. Journals in the ESCI meet 24 quality criteria, ensuring editorial rigor. They may be considered for inclusion in broader indices like the Science Citation Index Expanded (SCIE), the Social Sciences Citation Index (SSCI), or the Arts and Humanities Citation Index (AHCI), based on four impact criteria.

Read more:

Inside MDPI

MDPI Appoints New Chief Operating Officer (COO)

Alistair Freeland returned to MDPI and assumed the role of Chief Operating Officer in November 2023, a position he previously held from 2013 to 2019. He succeeds Dr. Yu Lin, who will remain a member of MDPI’s Board of Directors, overseeing significant financial decisions for the company. I would like to express my sincere thanks to Dr. Yu Lin for his service as COO.

Alistair brings extensive experience not only in scholarly publishing but also in technology and business management. Prior to rejoining MDPI, he was associated with SIX Group, the entity responsible for Switzerland's financial market infrastructure. There, he played a pivotal role in developing the blockchain-based platform SDX (SIX Digital Exchange), which has gained traction among major Swiss banks and the Swiss National Bank.

As COO, Alistair will collaborate with the MDPI management team to improve the practices and services we offer to scholarly communities. I am pleased to welcome Alistair back to MDPI and look forward to his contributions going forward.

Coming Together for Science

MDPI’s 2024 In-Person Academic Events Schedule

MDPI's Conference Team is dedicated to organizing and hosting in-person academic events across Europe, Asia-Pacific, and North America. We recognize conferences as invaluable platforms for scientific collaboration, scholarly exchange, discussions on contemporary topics, networking, and forging collaborations.

Here's a glimpse of the notable events we currently have scheduled for 2024:

14–16 February, 2024
Viruses 2024 – A World of Viruses
Location: Barcelona, Spain
We are honoured to feature Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes as keynote speakers for this 5th edition.
Event details

24–26 April, 2024
4th MMCS – Harnessing the Power of New Drug Modalities 
Location: Barcelona, Spain
Esteemed speakers include Prof. Arun K. Ghosh, the mind behind the Darunavir molecule, and Prof. Paul Brennan, CSO of Alzheimer's Research UK Oxford Drug Discovery Institute.
Event details

28–31 May, 2024
Polymers 2024 – Polymers for a Safe and Sustainable Future
Location:
Athens, Greece
We look forward to welcoming renowned experts like Prof. Damià Barceló, Prof. Minna Hakkareinen, and Prof. Armando J. D. Silvestre to this event.
Event details

1–4 August, 2024
The 1st International Conference on AI Sensors & The 10th International Symposium on Sensor Science
Location: Singapore
The AI Sensors 2024 Conference will unite innovators and experts in the realms of sensors, sensing technology, and artificial intelligence.
Event details

Upcoming events with details to be announced:

  • September 2024, Materials 2024 – Basel, Switzerland
  • 1921 September 2024, International Conference on Nanomaterials Sciences 2024 – Beijing, China
  • October 2024, ncRNA 2024 – Basel, Switzerland
  • November 2024, Pharmaceuticals 2024 – Barcelona, Spain
  • 2226 November 2024, International Conference on Science of Electronics – Wuhan, China
  • Stay tuned for more details on the Sustainable Publishing Forum 2024.

Click here for all upcoming MDPI events.

Organize Your Event with MDPI’s Sciforum

Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.

Closing Thoughts

Reflecting on 2023 and Looking Ahead to 2024

As we approach 2024, I reflect on the incredible journey we’ve had together at MDPI this year. The past 12 months have been marked by ambitious projects and initiatives to improve our internal processes, and a commitment to continue delivering top-notch services to our stakeholders. I’d like to thank each and every one of our staff members for contributing to the positive experiences our stakeholders have reported in our surveys. Your dedication to speed, efficiency, and effective communication with our stakeholders is very much recognized and appreciated.

Becoming a stronger organisation

While we have encountered challenges in 2023, it’s important to understand that these are a part of our growth process. Difficulties provide us with opportunities to reflect, address problems at their roots, and ultimately evolve into a stronger organization. Our stakeholders expect us to overcome tough times, and it’s an expectation that we have for ourselves.

I extend my sincere appreciation to every MDPI employee, from our editorial office and IT department to marketing, indexing, IOAP, societies, Scientific Office board, products, production, conferences, finance, operations, admin, and beyond. To our newest team members, a warm welcome; to our longstanding colleagues, your dedication is invaluable.

“I am committed to taking MDPI to a new level of excellence.”

Interacting with many of you during my visits to our offices and representing MDPI at external events has been a personal highlight. I am deeply grateful to Dr. Lin for entrusting me with the role of CEO of MDPI. Looking forward, I am committed to working closely with our management team to lead MDPI and take it to a new level of excellence, aiming to establish it as the most trusted publisher in open access worldwide. This is a collective endeavour, with each of us shaping MDPI’s reputation. I therefore encourage us to take pride in our work, as it represents not only our craft but also MDPI as a whole.

Accountability and communication

As we look forward to 2024, there’s a lot to be excited about. Together, we’ll navigate challenges, seize growth opportunities, and refine our practices. To solidify MDPI’s position as the premier open access publisher globally, we must bolster accountability, improve stakeholder communication, share MDPI’s best practices, champion the open access philosophy, and educate stakeholders about our mission, methodologies, and motivations.

Thank you for engaging with the CEO Letter over the past six months of 2023. I will continue to release this newsletter as a method of sharing the great work being done at MDPI. Please feel free to connect directly with any insights or questions.

Here’s to a joyous and prosperous 2024!

Stefan Tochev
Chief Executive Officer
MDPI AG

7 December 2023
Viruses | Collection of Papers by Chinese Academicians


“Role of Small Envelope Protein in Sustaining the Intracellular and Extracellular Levels of Hepatitis B Virus Large and Middle Envelope Proteins”
by Jing Zhang, Yongxiang Wang, Shuwen Fu, Quan Yuan, Qianru Wang, Ningshao Xia, Yumei Wen, Jisu Li and Shuping Tong
Viruses 2021, 13(4), 613; https://doi.org/10.3390/v13040613
Available online: https://www.mdpi.com/1999-4915/13/4/613

“Antibody Generation and Immunogenicity Analysis of EBV gp42 N-Terminal Region”
by Junping Hong, Dongmei Wei, Qian Wu, Ling Zhong, Kaiyun Chen, Yang Huang, Wanlin Zhang, Junyu Chen, Ningshao Xia, Xiao Zhang et al.
Viruses 2021, 13(12), 2380; https://doi.org/10.3390/v13122380
Available online: https://www.mdpi.com/1999-4915/13/12/2380

“A Hemagglutinin Stem Vaccine Designed Rationally by AlphaFold2 Confers Broad Protection against Influenza B Infection”
by Dian Zeng, Jiabao Xin, Kunyu Yang, Shuxin Guo, Qian Wang, Ying Gao, Huiqing Chen, Jiaqi Ge, Zhen Lu, Limin Zhang et al.
Viruses 2022, 14(6), 1305; https://doi.org/10.3390/v14061305
Avaliable online: https://www.mdpi.com/1999-4915/14/6/1305

“Baculovirus Display of Varicella–Zoster Virus Glycoprotein E Induces Robust Humoral and Cellular Immune Responses in Mice”
by Wenhui Xue, Tingting Li, Sibo Zhang, Yingbin Wang, Minqing Hong, Lingyan Cui, Hong Wang, Yuyun Zhang, Tingting Chen, Rui Zhu et al.
Viruses 2022, 14(8), 1785; https://doi.org/10.3390/v14081785
Available online: https://www.mdpi.com/1999-4915/14/8/1785

“An Optimized FI-RSV Vaccine Effectively Protects Cotton Rats and BALB/c Mice without Causing Enhanced Respiratory Disease”
by Min Lin, Wei Zhang, Yi-Fan Yin, Jun-Yu Si, Lu-Jing Zhang, Li Chen, Xue Lin, Ying-Bin Wang, Jun Zhang, Zi-Zheng Zheng et al.
Viruses 2022, 14(10), 2085; https://doi.org/10.3390/v14102085
Available online: https://www.mdpi.com/1999-4915/14/10/2085

“A Secreted Form of the Hepatitis E Virus ORF2 Protein: Design Strategy, Antigenicity and Immunogenicity”
by Zihao Chen, Shaoqi Guo, Guanghui Li, Dong Ying, Guiping Wen, Mujin Fang, Yingbin Wang, Zimin Tang, Zizheng Zheng and Ningshao Xia
Viruses 2022, 14(10), 2122; https://doi.org/10.3390/v14102122
Available online: https://www.mdpi.com/1999-4915/14/10/2122

“Hepatitis B Core Antibody Level: A Surrogate Marker for Host Antiviral Immunity in Chronic Hepatitis B Virus Infections”
by Yang Shi, Zihan Wang, Shengxiang Ge, Ningshao Xia and Quan Yuan
Viruses 2023, 15(5), 1111; https://doi.org/10.3390/v15051111
Available online: https://www.mdpi.com/1999-4915/15/5/1111

“3-Indoleacetonitrile Is Highly Effective in Treating Influenza A Virus Infection In Vitro and In Vivo”
by Xuejin Zhao, Lianzhong Zhao, Ya Zhao, Kun Huang, Wenxiao Gong, Ying Yang, Li Zhao, Xiaohan Xia, Zaiyun Li, Feng Sheng et al.
Viruses 2021, 13(8), 1433; https://doi.org/10.3390/v13081433
Available online: https://www.mdpi.com/1999-4915/13/8/1433

“Progression and Trends in Virus from Influenza A to COVID-19: An Overview of Recent Studies”
by Hakimeh Baghaei Daemi, Muhammad Fakhar-e-Alam Kulyar, Xinlin He, Chengfei Li, Morteza Karimpour, Xiaomei Sun, Zhong Zou and Meilin Jin
Viruses 2021, 13(6), 1145; https://doi.org/10.3390/v13061145
Available online: https://www.mdpi.com/1999-4915/13/6/1145

“A Palmitic Acid-Conjugated, Peptide-Based pan-CoV Fusion Inhibitor Potently Inhibits Infection of SARS-CoV-2 Omicron and Other Variants of Concern”
by Qiaoshuai Lan, Jasper Fuk-Woo Chan, Wei Xu, Lijue Wang, Fanke Jiao, Guangxu Zhang, Jing Pu, Jie Zhou, Shuai Xia, Lu Lu et al.
Viruses 2022, 14(3), 549; https://doi.org/10.3390/v14030549
Available online: https://www.mdpi.com/1999-4915/14/3/549

“Characterization of the Novel Phage vB_VpaP_FE11 and Its Potential Role in Controlling Vibrio parahaemolyticus Biofilms”
by Meiyan Yang, Hanfang Chen, Qiaolan Huang, Zhuanbei Xie, Zekun Liu, Jumei Zhang, Yu Ding, Moutong Chen, Liang Xue, Qingping Wu et al.
Viruses 2022, 14(2), 264; https://doi.org/10.3390/v14020264
Available online: https://www.mdpi.com/1999-4915/14/2/264

“The Epidemiology and Variation in Pseudorabies Virus: A Continuing Challenge to Pigs and Humans”
by Qingyun Liu, Yan Kuang, Yafei Li, Huihui Guo, Chuyue Zhou, Shibang Guo, Chen Tan, Bin Wu, Huanchun Chen and Xiangru Wang
Viruses 2022, 14(7), 1463; https://doi.org/10.3390/v14071463
Available online: https://www.mdpi.com/1999-4915/14/7/1463

 

6 December 2023
Editorial Board Members from Viruses Featured in the 2023 Highly Cited Researchers List Published by Clarivate


Recently, Clarivate™ revealed its 2023 list of Highly Cited Researchers™—individuals at universities, research institutes, and commercial organizations.

The scientists who were selected for this year’s list of Highly Cited Researchers published highly cited papers in the 11-year period from January 2012 to December 2022, with citation frequency in the top 1% of academic subjects and the same year of publication in the Web of Science™ database. This year, 7125 Highly Cited Researcher 2023 designations were issued to 6849 individuals, representing just 1 in 1000 researchers worldwide. This means that these researchers have demonstrated an incredible level of significant and broad influence in their chosen field or fields over the last decade. The list is truly global, spanning 67 countries or regions and spread across a diverse range of research sciences and social sciences.

According to our statistics, six members of the Editorial Board of Viruses (ISSN: 1999-4915) were selected for the list of Highly Cited Researchers by Clarivate™ in 2023. They are being recognized for their high-quality scientific research achievements and outstanding contributions to their professional fields. Viruses Editorial Office sincerely congratulates all elected editorial members and hopes that they continue to have an academically productive relationship with the journal.

Researcher

Category

Affiliation

Kuhn, Jens H.

Microbiology

National Institutes of Health (NIH)-USA, United States

Lan, Ke

Microbiology

Wuhan University, China

Jiang, Shibo

Microbiology

Fudan University, China

Perlman, Stanley

Immunology

University of Iowa, United States

Pöhlmann, Stefan

Molecular Biology and Genetics

Deutsches Primatenzentrum (DPZ), Germany

Chen, Yu

Microbiology

Wuhan University, China

30 November 2023
MDPI Insights: The CEO’s Letter #6 - MDPI Spain Summit and ResearchGate

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI Spain Summit


Stefan Tochev (CEO, MDPI) gives the opening speech at the MDPI Spain Summit.

On Friday 10 November 2023 I was in Barcelona, Spain, to deliver the opening presentation and participate in a panel at MDPI’s Spain Summit, a two-day event, inspired by our salon events in China.

With 16 Editors-in-Chief (EiCs) and 20 Editorial Board Members (EBMs) in attendance, the event, organized by our conference team and Barcelona office, featured presentations on open access (OA), MDPI, and publishing market trends in Spain.

The event provided a great opportunity to engage with stakeholders from various MDPI journals, including Nutrients, Vaccines, Buildings, IJMS, and others. We were able to gather feedback and have open conversations around manuscript quality, the peer-review process, and journal development, as well as accreditation agencies.

The main objective of this Summit was to bring together Editors representing MDPI journals across various disciplines within Spanish universities and research centers, primarily from the Barcelona area. The aim was to facilitate an open and fruitful discussion regarding the development of their journals, the future of OA in Spain, and to provide meaningful interactions and networking opportunities.

Connecting with Editorial Board Members


Stefan Tochev in conversation with Summit participants: "Our EBMs are passionate about the journals they serve."

Interacting with our EBMs in person provides a valuable opportunity to show how important it is to us to connect with them, hear their perspectives on their journals and learn more about their own experience collaborating with MDPI.

From my conversations, it was clear that our EBMs are passionate about the journals they serve. I know the advice they provide may sometimes involve just small tweaks, but these can lead to important improvements. As the saying goes, small hinges swing open big doors.

As at November 2023, MDPI has over 6,300 EBMs affiliated with Spanish institutions, with more than 30 of them serving as EiCs or section EiCs. Furthermore, over 68,000 Spanish scholars have contributed as reviewers in MDPI journals.

Open Access in Spain

In 2023, Spain implemented legislation mandating immediate OA for all publicly funded research, aligning with the EU’s Plan S initiative to expedite the transition to OA. The Spanish government also approved a four-year, €23.8 million annual budget for the first national OA strategy, aiming to make publicly funded research freely accessible upon publication. This strategy aims to strengthen the quality and transparency of research in Spain, and to help promote movement towards a digital, low-carbon economy.

For further details of Spain's OA policy and the history of government mandates, click here.

Spain has already seen a notable decline in subscription-only articles, decreasing by 62% over a 10-year period, while gold OA increased by 42%. Green OA slightly decreased, suggesting a shift towards publishing in gold OA journals rather than traditional subscription-based ones. Here are some statistics from Scopus. 

A big thank-you to the various MDPI teams, including our conference team and the Barcelona office, for organizing this very successful event!


MDPI colleagues from various offices gathered to host and support the first MDPI Spain Summit, in Barcelona, Spain.

I think this type of gathering has the potential to become an annual event in various locations. For example, Manchester could be an option, as we have over 30 EiCs and over 3,000 EBMs in the UK, a top market for MDPI that publishes high-quality research.

Impactful Research

769 Editorial Board Members of MDPI Journals Recognized as Highly Cited Researchers in 2023

Congratulations to our 769 Editorial Board Members from 40 countries/territories who have been awarded Highly Cited Researcher status for 2023 by Clarivate. This recognition is based on their outstanding scientific research contributions and significant influence in various fields, as evidenced by Web of Science data.

Click here to view the full list of 769 Editorial Board Members.

Clarivate's Highly Cited ResearchersTM list identifies individuals with exceptional impact in scientific and social science domains over the past decade. Their papers rank in the top 1% of citations in 21 fields analysed in ‘Essential Science Indicators,’ showcasing their substantial influence.

This year, 7,125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals from 67 countries, representing just 1 in 1,000 researchers worldwide.

These researchers demonstrate exceptional influence, representing a small fraction of contributors pushing the boundaries of knowledge, contributing to global well-being, sustainability, and security.

Congratulations to these scholars for their remarkable achievement: we are honoured to have them on board with our journals!

Inside MDPI

Corporate Marketing and Communications Strategy Session


Members of MDPI’s Corporate Marketing & Communications team.

For the past few years, I have led the Corporate Marketing & Communications department in our annual strategy session.

This typically involves 2–3 days of focused sessions covering key topics including budgeting, hiring targets, campaign reviews, and planning for the upcoming year, department strategy, and structure.

We are constantly exploring ways to optimize the Corporate Marketing & Communications department to support MDPI’s primary objectives and better convey the MDPI story while serving the scholarly community.

The strategy session also serves as a team-building activity, during which the team voted on bowling!

Strategy Session

In this strategy session, we looked at how to align our teams in order to better streamline our content with our campaigns, build a dedicated marketing team to strategically support our core MDPI products, expand our communications teams and functionalities to focus on company-critical campaigns and press releases, align our new brand design system with our marketing initiatives, set up a community and engagement team to support various teams with their outreach and communication efforts, and increase our use of data in the evaluation of campaign performance.

To grow in these areas, we will be hiring for various positions, including those of Public Relations Manager, Communications Manager, Internal Communications Manager, Campaign Manager, Marketing Associate, and Editorial Engagement Manager.

I am grateful for the way our Corporate Marketing & Communications department has grown and gelled over the years, and I look forward to supporting the department teams and their ideas for the future.

Coming Together for Science

ResearchGate and MDPI Partner to Boost the Visibility of Open Access Content through Journal Home


Stefan Tochev (CEO, MDPI) and Sören Hofmayer (Co-Founder and Chief Strategy Officer, ResearchGate) meet in Berlin, Germany to take their ongoing discussion further.

When I assumed the role of CEO at MDPI, my primary focus was to initiate the building of essential partnerships and collaborations within our industry. After all, I am a firm believer in achieving our goals by helping others achieve theirs and focusing on co-opetition wherever there is an opportunity. I first touched on the notion of co-opetition in MDPI Insights: The CEO's Letter #3, particularly when discussing collaborations with Elsevier.

In light of this, Sören Hofmayer (Co-Founder and Chief Strategy Officer at ResearchGate) and I connected recently to continue a discussion that had been ongoing for months. I was quickly brought up to speed and felt there was an opportunity for MDPI journals to pilot the Journal Home service that ResearchGate had launched. This would provide a new way for MDPI to engage with authors and readers and amplify the visibility of our journals.

While I receive many offers and opportunities for discussions with vendors, I am a firm believer that timing is everything, and in this case, the time for us is now. Sören and I met in person during my recent visit to Berlin and decided to proceed with piloting ten MDPI journals with the Journal Home service.

The press release below provides further details.

Press Release: Berlin (Germany) and Basel (Switzerland), 15 November 2023

ResearchGate, the professional network for researchers, and MDPI, the largest open access publisher in the world and a pioneer in open access publishing, today announced a partnership that will see ten of MDPI’s open access journals benefit from an enhanced presence on ResearchGate through its innovative Journal Home offering.  

This new partnership will expand the reach and visibility of MDPI’s participating flagship journals with ResearchGate’s highly relevant community of more than 25 million researchers globally.

Around 210,000 version-of-record articles from these 10 titles will be readily available on ResearchGate, including the full archive material and all new articles as they are published. These journals also benefit from enhanced brand visibility, with dedicated journal profiles, prominent representation on all associated article pages and all relevant touchpoints across the ResearchGate network – keeping the journals top-of-mind with their reader and author audiences. All articles covered by the new partnership will automatically be added to the authors’ publication records in ResearchGate. This not only reduces MDPI authors’ needs for direct management but also offers them valuable insights into the impact of their work, including data about readership and citations.

Closing Thoughts

November is Men’s Health Awareness Month


Stefan Tochev (CEO, MDPI) listening to music as he writes at a coffee shop in Basel, Switzerland.

November is dedicated to raising awareness of various men’s health issues. I have been fortunate to have positive male role models in my life, and I strive to share my experiences with others.

I used to take part in Movember, growing my moustache throughout November to raise awareness and funds and to help “change the face of men’s health.” With male family and friends impacted by physical and mental health issues, I have recently become more interested in men’s overall well-being.

Men often face stigma involving the perceived need always to be strong and have things figured out. Recently, I’ve had meaningful conversations with male friends and colleagues about issues we rarely discuss, and it was a positive experience.

Various factors impact men’s health and well-being, all too easily leading to risky health behaviours including a lack of health awareness, poor health education, and negative, culturally induced, behaviour patterns in our work and personal lives. I hope we can break down these barriers in our work environment.

Healthy men help build healthy families and a healthy society

Men are less likely than women to seek help with their physical and mental health struggles. This is a reminder to prioritize your overall well-being. I hope that as men, we will continue to open up to one another, becoming vulnerable in order to share what we are going through. By sharing and by supporting each other, we can learn and grow together. You are not alone, and when you fall, you can still get up and stand tall.

From one broski to another, you are loved and appreciated. I hope this mindset carries into December and beyond.

Mindfulness

Our content team recently released a handful of articles on mindfulness, a practice that I believe provides a good opportunity for stress release and self-reflection:

Stefan Tochev
Chief Executive Officer
MDPI AG

21 November 2023
769 Editorial Board Members of MDPI Journals Achieve Highly Cited Researcher Recognition in 2023


We extend our sincere congratulations to the 769 Editorial Board Members of our journals – from 40 different countries/territories – who have been recognized as Highly Cited Researchers for the year 2023 by Clarivate. They are being recognized for their high-quality scientific research achievements and outstanding contributions to their professional fields, as indicated by Web of Science data.

Clarivate's annual list of Highly Cited ResearchersTM identifies the most highly cited scientists for the past decade who stand out for their significant and broad influence in various scientific and social science domains. Their impactful papers are among the top 1 per cent in the citation distribution of one or more of 21 fields analyzed in the "Essential Science Indicators", distinguishing them as hugely influential among their peers.

This year, 7,125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals from 67 countries, representing just 1 in 1,000 researchers worldwide.

This means that these researchers have demonstrated an incredible level of significant and broad influence in their chosen field or fields over the last decade. They represent a small fraction of the researcher population whose contributions disproportionately push the boundaries of knowledge, enhancing global well-being, sustainability, and security.

Congratulations to the scholars for their noteworthy achievement – we are honored to have them on board with our journals!


Abate, Antonio
Aguilera, Ruth V.
Ahmed, Warish
Ahn, Myung-Ju
An, Qiaoshi
Anasori, Babak
Andersson, Dan I.
Angeletti, Silvia
Annabi, Nasim
Antinori, Spinello
Ariga, Katsuhiko
Asa, Sylvia L.
Astruc, Didier
Atala, Anthony
Atanasov, Atanas G.
Balsamo, Gianpaolo
Bandodkar, Amay J.
Banks, William A.
Bao, Yan-Ping
Barba, Francisco J.
Barnes, Peter J.
Barnholtz-Sloan, Jill S.
Barrow, Colin J.
Bashir, Ali Kashif
Basit, Abdul W.
Bassetti, Matteo
Batley, Jacqueline
Battino, Maurizio
Behnood, Ali
Benediktsson, Jon Atli
Biondi, Antonio
Bjarnsholt, Thomas
Blaschke, Thomas
Blay, Jean-Yves
Blumwald, Eduardo
Blunt, John W.
Boczkaj, Grzegorz
Bogers, Marcel
Bonomo, Robert A.
Boyd, Robert W.
Boyer, Cyrille
Braeckmans, Kevin
Bragazzi, Nicola Luigi
Bu, Wenbo
Bursać Kovačević, Danijela
Bush, Ashley I.
Byrd, John C.
Cabeza, Luisa F.
Cai, Xingjuan
Cambria, Erik
Cao, Guozhong
Cao, Xingzhong
Capasso, Raffaele
Carvalho, Andre F.
Casper, Jonathan
Castellanos-Gomez, Andres
Cavalli, Giacomo
Chai, Siang-Piao
Chan, Jasper Fuk-Woo
Chan, Timothy A.
Chang, Chih-Hao
Chang, Guoqing
Chao, Dongliang
Chen, Bo
Chen, Chaoji
Chen, Fahu
Chen, Gang
Chen, Jianmin
Chen, Jun
Chen, Jun
Chen, Jun
Chen, Lidong
Chen, Lingxin
Chen, Min
Chen, Mou
Chen, Peng
Chen, Qian
Chen, Qianwang
Chen, Shaowei
Chen, Shuangming
Chen, Wei
Chen, Xiaobo
Chen, Yimin
Chen, Yu
Chen, Yulin
Chen, Zhong
Chen, Zonghai
Cheng, Gong
Cheng, Huanyu
Cheng, Laifei
Cheng, Qiang
Chew, Kit Wayne
Chiclana, Francisco
Choi, Wonyong
Choi, Young Hae
Chowdhary, Anuradha
Cichocki, Andrzej
Clevers, Hans
Coops, Nicholas C.
Cortes, Javier
Cortes, Jorge
Costanza, Robert
Creutzig, Felix
Crommie, Michael F.
Cuadrado, Antonio
Cui, Haiying
Cui, Yi
Curigliano, Giuseppe
Dai, Sheng
Dai, Shifeng
Daiber, Andreas
Davies, Michael J.
Davis, Thomas P.
Dawson, Ted M.
de la Fuente-Nunez, Cesar
Delord, Jean-Pierre
Demaria, Marco
Deng, Xiangzheng
Desneux, Nicolas
Dikic, Ivan
Dimopoulos, Meletios-Athanasios
Ding, Aijun
Ding, Jianxun
Dokmeci, Mehmet Remzi
Dolgui, Alexandre
Dong, Chung-Li
Dou, Shi Xue
Dragicevic, Tomislav
Du, Bo
Du, Qian
Du, Yonghua
Duan, Xidong
Dufresne, Alain
Dummer, Reinhard
Edwards, David
Elaissari, Abdelhamid
ElMasry, Gamal
Enjuanes, Luis
Fabbro, Doriano
Facchetti, Antonio
Fan, Junliang
Fan, Kelong
Fan, Xiulin
Fan, Zhanxi
Fang, Baizeng
Fang, Chuanglin
Fang, Yongjin
Fasano, Alessio
Feng, Liangzhu
Feng, Xuning
Fensholt, Rasmus
Ferdinandy, Péter
Fernandez-Lafuente, Roberto
Filippi, Massimo
Flavian, Carlos
Fortino, Giancarlo
Fowler, Michael
Franceschi, Claudio
Frattini, Federico
Friston, Karl J.
Fu, Gengtao
Gai, Francesco
Gaisford, Simon
Galanakis, Charis M.
Galluzzi, Lorenzo
Galvano, Fabio
Gan, Ren-You
Gao, Feng
Gao, Huijun
Gao, Huile
Gao, Peng
Gao, Wei
Garbe, Claus
Garg, Abhishek D.
Gasbarrini, Antonio
Gastaldelli, Amalia
Gautier, Emmanuel L.
Genevet, Patrice
Geng, Yong
Gerdts, Gunnar
Geschwind, Daniel H.
Ghaffari, Roozbeh
Ghamisi, Pedram
Giacobbe, Daniele Roberto
Giampieri, Francesca
Gillies, Robert J.
Godos, Justyna
Gogotsi, Yury
Golding, Nick
Gong, Jinlong
Gong, Peng
Gong, Yongji
Govindan, Kannan
Gozal, David
Grancini, Giulia
Grant, William B.
Graus, Francesc
Green, Douglas R.
Grosso, Giuseppe
Gu, Meng
Gu, Zhanjun
Guan, Cao
Gueimonde, Miguel
Gui, Guan
Guigo, Roderic
Guo, Hengyu
Guo, Jianping
Guo, Lin
Guo, Song
Guo, Yan
Guo, Zaiping
Gupta, Rangan
Gutzmer, Ralf
Haase, Dagmar
Hagger, Martin S.
Hall, C. Michael
Han, Fudong
Han, Heesup
Hanes, Justin
Hartung, Hans-Peter
He, Bao-Jie  
He, Debiao
He, Hongwen
He, Jiaqing
He, Jie
He, Jr-Hau
He, Qiong
He, Xiangming
He, Xijun
He, Zhili
Heneka, Michael T.
Herrera, Francisco
Herrera-Estrella, Luis
Herrera-Viedma, Enrique
Hetz, Claudio
Holick, Michael F.
Hong, Danfeng
Hong, Xuechuan
Hsueh, Po-Ren
Hu, Bin
Hu, Enyuan
Hu, Jin-Song
Hu, Weida
Hu, Wenbin
Hu, Xiaosong
Huang, Baibiao
Huang, Hongwei
Huang, Jianliang
Huang, Jianping
Huang, Peng
Huang, Xin
Hubacek, Klaus
Hussain, Saddam
Italiano, Antoine
Iwata, Hiroji
Jaeschke, Hartmut
Jain, Atul

Jaiswal, Amit K.
Jankovic, Joseph
Janssens, Ivan A.
Jelezko, Fedor
Jeon, Byong-Hun
Ji, Guangbin
Ji, Qiang
Ji, Wei
Ji, Xiaobo
Ji, Xiaoyuan
Jiang, Bin
Jiang, Hong
Jiang, Junjun
Jiang, Lianzhou
Jiang, Qing
Jiang, Shibo
Jiang, Yuyan
Jiang, Zhongyi
Jiao, Licheng
Jin, Shi
Jin, Zhong
Kalantar-zadeh, Kourosh
Kamal, Mohammad Amjad
Kaner, Richard B.
Kaneti, Yusuf Valentino
Kang, Zhenhui
Karagiannidis, George K.
Karniadakis, George Em
Karp, Peter D.
Kataoka, Kazunori
Katritch, Vsevolod
Kawi, Sibudjing
Kepp, Oliver
Khademhosseini, Ali
Khan, Nafees A.
Kiessling, Fabian
Kildishev, Alexander V.
Kim, Haegyeom
Kim, Jeonghun
Kim, Jin-Hoi
Kim, Jong Seung
Kim, Ki-Hyun
Kirkwood, John M.
Kivshar, Yuri
Klenk, Hans-Peter
Ko, Wen-Chien
Kong, Baohua
Kontoyiannis, Dimitrios P.
Koonin, Eugene V.
Kroemer, Guido
Kuang, Dai-Bin
Kudo, Masatoshi
Kuhn, Jens H.
Kumar, Prashant
Kumar, Sudhir
Kurths, Juergen
Kurzrock, Razelle
Kuzyakov, Yakov
Kyrpides, Nikos C.
La Vecchia, Carlo
Lai, Yuekun
Lan, Ke
Lancellotti, Patrizio
Landi, Francesco
Lavie, Carl J.
Laxminarayan, Ramanan
Lee, Chengkuo
Lee, Jechan
Lee, Jin-Wook
Lee, Pooi See
Lee, Sang Soo
Lehmann, Johannes
Lei, Yaguo
Li, Bin
Li, Chunzhong
Li, Dongsheng
Li, Feng
Li, Hai
Li, Heng
Li, Hongyi
Li, Hui
Li, Jinghong
Li, Jun
Li, Li
Li, Linlin
Li, Neng
Li, Ning
Li, Shuai
Li, Shutao
Li, Wei
Li, Wentao
Li, Xiang
Li, Xuecao
Li, Xuelong
Li, Yat
Li, Yurui
Li, Zhijun
Liang, Chao
Liang, Shuquan
Liaw, Peter K.
Lin, Jun
Lin, Yuehe
Lippi, Giuseppe
Lister, Ryan
Liu, Chengmei
Liu, Gang
Liu, Hong
Liu, Hui
Liu, Jian
Liu, Jinyan
Liu, Jun
Liu, Meilin
Liu, Pan
Liu, Wei
Liu, Xianhu
Liu, Xiaoping
Liu, Xuejun
Liu, Yang
Liu, Yu
Liu, Yuan
Lonardo, Amedeo
Long, Hualou
Long, Ying
Lu, Bingan
Lu, Junling
Lu, Lu
Lu, Nanshu
Lu, Rongxing
Lucey, Brian
Lucieer, Arko
Lugato, Emanuele
Lund, Henrik
Luo, Yangchao
Luo, Yi
Luo, Zisheng
Lv, Wei
Lyons, Timothy W.
Ma, Haile
Ma, Jianmin
Ma, Jun
Ma, Tianyi
Ma, Wei
Ma, Yanming
Madabhushi, Anant
Mahmoudi, Morteza
Mai, Liqiang
Mai, Wenjie
Makridakis, Spyros
Mandala, Mario
Mantovani, Alberto
Mao, Jianfeng
Mao, Like
Mardani, Abbas
Mathivanan, Suresh
Matyjaszewski, Krzysztof
McCabe, Matthew F.
McCauley, Darren
McClements, David Julian
Mei, Lin
Melenhorst, Jan Joseph
Melero, Ignacio
Meyerholz, David K.
Van Mierlo, Joeri
Miroshnichenko, Andrey E.
Mittler, Ron
Mu, Shichun
Mubarak, Mohammad S.
Mueller, Lukas A.
Muhammad, Khan
Mumtaz, Shahid
Munekata, Paulo Eduardo Sichetti
Nakagawa, Shinichi
Nauen, Ralf
Newman, David J.
Niaura, Raymond S.
Nidheesh, P. V.
Niu, Ben
Nussinov, Ruth
O'Connor, David
Odintsov, Sergei D.
Omri, Anis
Orsini, Nicola
Ostrikov, Kostya (Ken)
Oswald, Isabelle P.
Oudard, Stephane
Ouyang, Minggao
Ozcan, Aydogan
Pan, Anlian
Pan, Anqiang
Pan, Caofeng
Pan, Genxing
Pan, Likun
Pan, Quan-Ke
Pan, Xiaoqing
Pandolfi, Pier Paolo
Parati, Gianfranco
Pateiro, Mirian
Peng, Qiang
Peng, Qing
Peng, Shushi
Perc, Matjaz
Perlin, David S.
Perlman, Stanley
Petruzzelli, Antonio Messeni
Pitt, Bertram
Pöhlmann, Stefan
Polasky, Stephen
Pommier, Yves
Poor, H. Vincent
Potenza, Marc N.
Preat, Veronique
Prinsep, Michele R.
Pu, Kanyi
Putnik, Predrag
Qin, Yuanwei
Qiu, Jieshan
Qu, Xiaogang
Ragauskas, Arthur J.
Ramakrishna, Seeram
Ramkissoon, Haywantee
Ran, Jingrun
Rao, Zhonghao
Recio, Isidra
Ren, Jinsong
Rengel, Zed
Rho, Junsuk
Riahi, Keywan
Ribeiro-Soriano, Domingo
Richardson, Paul G.
Robert, Caroline
Rocca, Maria A.
Rodriguez-Manas, Leocadio
Rojas, Orlando J.
Rojo, Teofilo
Roubaud, David
Saad, Fred
Saad, Walid
Sadorsky, Perry
Saliba, Michael
Sander, Chris
Sangaiah, Arun Kumar
Santamouris, Mattheos
Santoro, Gabriele
Scaldaferri, Franco
Schatzberg, Alan F.
Schwab, Matthias
Schweizer, Frank
Scolyer, Richard A.
Scott, Daniel
Serruys, Patrick W.
Setzer, William N.
Shahzad, Babar
Shao, Shuai
Shao, Zongping
Shen, Guozhen
Shen, Liyin

Shen, Zexiang
Shi, Peng
Shi, Yi
Siano, Pierluigi
Simões, Manuel
Sing, Swee Leong
Singh, Vijay P.
Smagghe, Guy
Smith, Lee
Soffietti, Riccardo
Song, Houbing
Song, Jibin
Song, Yu
Sood, Anil K.
Souto, Eliana B.
Stadler, Marc
Stanley, H. Eugene
Stephanopoulos, Gregory
Sternberg, Cora N.
Stoumpos, Constantinos C.
Stunnenberg, Hendrik G.
Su, Shiliang
Sun, Baoguo
Sun, Cuixia
Sun, Fengchun
Sun, Hongqi
Sun, Jie
Sun, Lijun
Sun, Litao
Sun, Runcang
Sun, Yanjuan
Sun, Zaicheng
Sun, Zhipei
Sureda, Antoni
Svenning, Jens-Christian
Tan, Chaoliang
Tan, Weihong
Tang, Chuan-He
Tang, Chuyang
Tang, Dianping
Tang, Yongbing
Tanzi, Rudolph E.
Terpos, Evangelos
Teschendorff, Andrew E.
Tian, He
Timsit, Jean-Francois
Tiwari, Aviral Kumar
Tohge, Takayuki
Tousoulis, Dimitris
Tran, Lam-Son Phan
Tress, Wolfgang
Trivedi, Pankaj
Tsao, Rong
Tully, Mark A.
Tung, Chen-Ho
Van der Bruggen, Bart
Vandenbroucke, Roosmarijn E.
Vangronsveld, Jaco
Varsani, Arvind
Vatanen, Tommi
Verbeke, Kristin
Vermote, Eric
Verpoorte, Robert
Vieta, Eduard
Vincent, Jean-Louis
Vita, Antonio
Wan, Jiafu
Wan, Shaohua
Wanek, Wolfgang
Wang, Bin
Wang, Bo
Wang, Chao
Wang, Chuanyi
Wang, Chunsheng
Wang, Dan
Wang, Feng
Wang, Gongming
Wang, Guoxiu
Wang, Haihui
Wang, Hao
Wang, Huanqing
Wang, Huanting
Wang, Hui
Wang, Jian
Wang, Jie
Wang, Jing
Wang, John
Wang, Joseph
Wang, Lianzhou
Wang, Lihui
Wang, Meng
Wang, Peng
Wang, Pengfei
Wang, Qi
Wang, Qi
Wang, Qiang
Wang, Qilin
Wang, Qin
Wang, Qing
Wang, Shaojian
Wang, Sibo
Wang, Tao
Wang, Ying
Wang, Yong
Wang, Zhen
Wang, Zhong Lin
Wang, Zhongrui
Wang, Zifa
Wang, Zuankai
Wei, Haotong
Wei, Leyi
Wei, Zhixiang
Wei, Zhongbao
Weissleder, Ralph
Weitschies, Werner
Wen, Guanghui
Wesemael, Bas van
Willerslev, Eske
Witlox, Frank
Wu, Haijun
Wu, Hao Bin
Wu, Hui
Wu, Jun
Wu, Qinglin
Wu, Shuilin
Wu, Xiaojun
Wu, Yongzhen
Wu, Yuping
Wu, Zheng-Guang
Wu, Zhong-Shuai
Xia, Jianguo (Jeff)
Xia, Meimei
Xia, Xinhui
Xia, Yongyao
Xia, Zhiguo
Xiang, Quanjun
Xiao, Fuyuan
Xiao, Jie
Xin, Sen
Xing, Baoshan
Xing, Wei
Xiong, Rui
Xu, Hui
Xu, Li Da
Xu, Ping
Xu, Yi-Jun
Xu, Zhenjiang Zech
Yan, Chong
Yan, He
Yan, Huaicheng
Yan, Kai
Yan, Ruqiang
Yang, Bing
Yang, Chenguang
Yang, Hongshun
Yang, Hui
Yang, Jian
Yang, Jianping
Yang, Jie
Yang, Jun
Yang, Kai
Yang, Shihe
Yang, Xiaofeng
Yang, Xinsong
Yang, Yun-Gui
Yao, Yonggang
Yigitcanlar, Tan
Yin, Shen
Yin, Shou-Wei
Yin, Yulong
Yin, Zongyou
Yokoya, Naoto
Young, Allan H.
Yu, Guihua
Yu, Jun
Yu, Le
Yu, Minghao
Yu, Shu-Hong
Yu, Wei
Yu, Wenwu
Yuan, Qiangqiang
Yuan, Yifei
Yuan, Yuan
Yuen, Chau
Zeadally, Sherali
Zhai, Tianyou
Zhang, Bing
Zhang, Dengsong
Zhang, Fan
Zhang, Fusuo
Zhang, Guangyu
Zhang, Guowen
Zhang, Hengjie
Zhang, Hongjie
Zhang, Hui
Zhang, Lai-Chang
Zhang, Lefei
Zhang, Lei
Zhang, Liangpei
Zhang, Lijun
Zhang, Min
Zhang, Peng
Zhang, Qiang
Zhang, Qiaobao
Zhang, Qichun
Zhang, Shicheng
Zhang, Shujun
Zhang, Tierui
Zhang, Wei
Zhang, Weili
Zhang, Xian-Ming
Zhang, Xiaodong
Zhang, Xiaogang
Zhang, Xiaoling
Zhang, Yang
Zhang, Yaobin
Zhang, Yi
Zhang, Yi-Zhou
Zhang, Yong
Zhang, Yu Shrike
Zhang, Yue-Jun
Zhang, Yuelin
Zhang, Zheng
Zhang, Zhicheng
Zhang, Zhien
Zhao, Guochun
Zhao, Jie
Zhao, Li-Dong
Zhao, Qing
Zhao, Yi
Zheng, Hao
Zheng, Weitao
Zheng, Yufeng
Zhong, Cheng
Zhou, Jie
Zhou, Jizhong
Zhou, Kun
Zhou, Liang
Zhou, Peng
Zhou, Qi
Zhou, Wei
Zhou, Weiqi
Zhu, Chengzhou
Zhu, Hongwei
Zhu, Junfa
Zhu, Jun-Jie
Zhu, Lei
Zhu, Mingshan
Zhu, Quanxin
Zhu, Yi
Zhu, Yongfa
Zhu, Zhe
Zhuang, Xiaodong
Zou, Quan
Zou, Ruqiang
Zuo, Chao

16 November 2023
Advancing Our Understanding of Viruses: Essential High-Impact Articles by Leading Experts


We are thrilled to showcase a collection of high-impact articles recently published in Viruses (ISSN: 1999-4915). These articles, authored by renowned experts in the field, offer profound insights into various aspects of virology, contributing significantly to our understanding of viruses and their implications. Explore these groundbreaking contributions below:

“Comparative Sensitivity of Rapid Antigen Tests for the Delta Variant (B.1.617.2) of SARS-CoV-2”
by Yuko Sakai-Tagawa, Seiya Yamayoshi, Peter J. Halfmann and Yoshihiro Kawaoka
Viruses 2021, 13(11), 2183; https://doi.org/10.3390/v13112183
Available online: https://www.mdpi.com/1999-4915/13/11/2183

“Jumbo Phages: A Comparative Genomic Overview of Core Functions and Adaptions for Biological Conflicts”
by Lakshminarayan M. Iyer, Vivek Anantharaman, Arunkumar Krishnan, A. Maxwell Burroughs and L. Aravind
Viruses 2021, 13(1), 63; https://doi.org/10.3390/v13010063
Available online: https://www.mdpi.com/1999-4915/13/1/63

“The Advantages and Challenges of Using Endolysins in a Clinical Setting”
by Ellen Murray, Lorraine A. Draper, R. Paul Ross and Colin Hill
Viruses 2021, 13(4), 680; https://doi.org/10.3390/v13040680
Available online: https://www.mdpi.com/1999-4915/13/4/680

“Integrase Strand Transfer Inhibitors Are Effective Anti-HIV Drugs”
by Steven J. Smith, Xue Zhi Zhao, Dario Oliveira Passos, Dmitry Lyumkis, Terrence R. Burke and Stephen H. Hughes
Viruses 2021, 13(2), 205; https://doi.org/10.3390/v13020205
Available online: https://www.mdpi.com/1999-4915/13/2/205

“The Combination of Bromelain and Acetylcysteine (BromAc) Synergistically Inactivates SARS-CoV-2”
by Javed Akhter, Grégory Quéromès, Krishna Pillai, Vahan Kepenekian, Samina Badar, Ahmed H. Mekkawy, Emilie Frobert, Sarah J. Valle and David L. Morris
Viruses 2021, 13(3), 425; https://doi.org/10.3390/v13030425
Available online: https://www.mdpi.com/1999-4915/13/3/425

“HIV Capsid and Integration Targeting”
by Alan N. Engelman
Viruses 2021, 13(1), 125; https://doi.org/10.3390/v13010125
Available online: https://www.mdpi.com/1999-4915/13/1/125

“HIV-1: To Splice or Not to Splice, That Is the Question”
by Ann Emery and Ronald Swanstrom
Viruses 2021, 13(2), 181; https://doi.org/10.3390/v13020181
Available online: https://www.mdpi.com/1999-4915/13/2/181

“Safety and Outcomes Associated with the Pharmacological Inhibition of the Kinin–Kallikrein System in Severe COVID-19”
by Eli Mansour, Andre C. Palma, Raisa G. Ulaf, Luciana C. Ribeiro, Ana Flavia Bernardes, Thyago A. Nunes, Marcus V. Agrela, Bruna Bombassaro, Milena Monfort-Pires, Rafael L. Camargo et al.
Viruses 2021, 13(2), 309; https://doi.org/10.3390/v13020309
Available online: https://www.mdpi.com/1999-4915/13/2/309

“Target Product Profile Analysis of COVID-19 Vaccines in Phase III Clinical Trials and Beyond: An Early 2021 Perspective”
by Colin D. Funk, Craig Laferrière and Ali Ardakani
Viruses 2021, 13(3), 418; https://doi.org/10.3390/v13030418
Available online: https://www.mdpi.com/1999-4915/13/3/418

These articles represent significant contributions to the field of virology, providing valuable insights for researchers and enthusiasts alike. Stay updated with the latest developments in virology by exploring these publications.

Thank you for your continued support of Viruses. We anticipate sharing more groundbreaking research with you in the future.

1 November 2023
MDPI Insights: The CEO’s Letter #5 - OA Week, UK, and Strategy

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Open Access Week 2023 – the Global Drive to Open Continues

As the world's largest open-access (OA) publisher, we believe that unrestricted access to research findings is the cornerstone of transparency, efficiency, and quality control across scientific disciplines. At MDPI, we provide free, immediate access to scientific papers, empowering scientists to examine, validate, replicate, and build upon existing results. This minimizes redundancy, optimizes resources, and fosters innovative approaches.

International OA Week, held from 23 to 29 October 2023, provided a unique opportunity to link the global movement toward open sharing and open science with the progress of policy changes at the local level. Our mission, during OA Week and all the year round, is to offer educational resources highlighting the benefits of open-access publishing. The MDPI Blog is a valuable resource for information on open access and open science.

Core principles of OA publishing

Accessibility, transparency, and collaboration are core principles of OA publishing. OA aims to break down barriers that have traditionally restricted research access, ensuring that knowledge is available to all, regardless of financial situation or institutional affiliations. Our commitment to diverse pathways for OA publishing worldwide includes discounts for researchers. You can learn more about how MDPI supports scientific communities here.

One of the key strengths of OA publishing is its ability to facilitate interdisciplinary research. By removing paywalls and promoting knowledge-sharing across disciplines, OA encourages collaboration and innovation. Researchers from various fields can access and build upon each others’ work, fostering a holistic approach to addressing complex global challenges.

OA holds the potential to democratize knowledge, advance science, and drive positive societal change.

Policy driving change

Governments, institutions, and funding agencies have recognized the transformative potential of OA and have implemented policies to promote it. These policies often require publicly funded research to be made openly accessible, accelerating the growth of OA repositories and journals. Check out our spotlights on OA policies in the USEU and China

OA publishing is continuously evolving, with community-driven models and technologies shaping its future. Initiatives such as “Plan S” and “cOAlition S” promote OA publishing from the perspective of national funders, requiring grantees to publish their research openly. A new policy announced by the US administration last year mandates that, with effect from January 2026, all US federally funded research should be freely and immediately available after publication.

Additionally, preprint servers such as MDPI's Preprints.org, which allow researchers to share their findings before formal peer review, have gained popularity, enhancing the speed at which new knowledge is disseminated. The rise of blockchain technology is also being explored to ensure transparency and authenticity in scholarly publishing.

For more than two decades, OA publishing has been revolutionizing academic publishing by promoting accessibility, transparency, and collaboration. Its support for interdisciplinary research, evolving policies, and innovative practices all contribute to its growing influence in the global research community. As OA continues to expand, it holds the potential to democratize knowledge, advance science, and drive positive societal change.

MDPI is proud to lead the transition to open access.

Read more:

Impactful Research

Spotlight on Smart Cities

Smart cities will serve as a cornerstone for future human development. Their implementation will help us tackle many of the significant challenges we are facing – climate change, ageing populations, waste management, public safety, travel, and so on. Recognising the importance of this multifaceted field, MDPI launched the inaugural issue of Smart Cities in 2018 to provide an advanced forum for research into smart technology and society. Here we take a look at how this journal has developed, and its impact in this exciting field.

As at 30 October, 2023, Smart Cities has published 421 papers and has an Impact Factor of 6.4. It also has a CiteScore of 8.5, and more than one quarter of its published papers – 124 – have been cited 10 times or more.

Highly cited papers in Smart Cities

Below are several highly cited papers recently published in Smart Cities. Citation metrics are current as at 31 October 2023.

1. “Introducing the “15-Minute City”: Sustainability, Resilience and Place Identity in Future Post-Pandemic Cities
Authors: Carlos Moreno, Zaheer Allam, Didier Chabaud, Catherine Gall and Florent Pratlong
Smart Cities 2021, 4(1), 93-111; https://doi.org/10.3390/smartcities4010006
Citations: Crossref (338), Scopus (366), Web of Science (270), Google Scholar (710)
The paper discusses the socio-economic impacts of the COVID-19 on cities, including increasing inequalities and rising unemployment. It introduces the concept of the "15-Minute City," a form of "chrono-urbanism," as a response to the challenges posed by the pandemic.

2. “A Review on Electric Vehicles: Technologies and Challenges
Authors: Julio A. Sanguesa, Vicente Torres-Sanz, Piedad Garrido, Francisco J. Martinez and Johann M. Marquez-Barja
Smart Cities 2021, 4(1), 372-404; https://doi.org/10.3390/smartcities4010022
Citations: Crossref (359), Scopus (363), Web of Science (268), Google Scholar (558)
This paper provides an overview of the progress in Electric Vehicles (EVs), focusing on battery technology, charging methods, and emerging research challenges. It also analyzes the global EV market and its future outlook.

3. “IoT in Smart Cities: A Survey of Technologies, Practices and Challenges
Authors: Abbas Shah Syed, Daniel Sierra-Sosa, Anup Kumar and Adel Elmaghraby
Smart Cities 2021, 4(2), 429-475; https://doi.org/10.3390/smartcities4020024
Citations: Crossref (121), Scopus (151), Web of Science (91), Google Scholar (215)
This paper gives an overview of the Internet of Things (IoT) in the context of Smart Cities, discussing the fundamental components, technologies, architectures, networking technologies, and artificial algorithms that underpin IoT-based Smart City systems.

4. “Artificial Intelligence Techniques in Smart Grid: A Survey
Authors: Olufemi A. Omitaomu and Haoran Niu
Smart Cities 2021, 4(2), 548-568; https://doi.org/10.3390/smartcities4020029
Citations: Crossref (76), Scopus (94), Web of Science (57), Google Scholar (120)
This survey paper reviews the utilization of artificial intelligence (AI) techniques in the context of the smart grid. It covers various applications of AI in load forecasting, power grid stability assessment, fault detection, and security issues in the smart grid and power systems.

5. “The Metaverse as a Virtual Form of Smart Cities: Opportunities and Challenges for Environmental, Economic, and Social Sustainability in Urban Futures
Authors: Zaheer Allam, Ayyoob Sharifi, Simon Elias Bibri, David Sydney Jones and John Krogstie
Smart Cities 2022, 5(3), 771-801; https://doi.org/10.3390/smartcities5030040
Citations: Crossref (72), Scopus (75), Web of Science (43), Google Scholar (176)
This paper discusses the concept of the Metaverse, a virtual world introduced by Meta (formerly Facebook), and its potential impact on urban life. It explores how emerging technologies such as AI, Big Data, IoT, and Digital Twins could reshape urban design and services in the context of the Metaverse.

Testimonial

“It was indeed a great and pleasant experience with MDPI regarding our recent publication. The submission process was very straightforward and less time-consuming than the norm. The review process was very fast compared to many other open access journals, which is praiseworthy. The support from the Editorial Office during the revision process was highly useful as well. We look forward to publishing with MDPI in the future, and I will most definitely recommend MDPI to my colleagues and collaborators. – Dr. Luís Rosa, University of Minho

Article in Smart Cities: Mobile Networks and Internet of Things Infrastructures to Characterize Smart Human Mobility

Inside MDPI

MDPI Manchester office, UK Visit


Allie Shi (Editorial Director, MDPI), Stefan Tochev (CEO, MDPI), Jamie Anderson (Manchester Office Manager, MDPI), Michael O’Sullivan (Senior Scientific Officer, MDPI), Hushneara Akhtar, and Becky Castellon (IOAP Team Lead, MDPI), dining out in Manchester, UK.

In October, I visited MDPI’s new office in Manchester. During the visit, I connected with our English Editing (EE) managers, Scientific Officer, members of the Editorial team, the Marketing team, and IOAP Team Lead.

Our Manchester office focuses primarily on EE services and provides local support for the UK market. Additionally, we regularly visit Editorial Board members and participate in local conferences.

I would like to thank Jamie Anderson, Manchester Office Manager, and her team, for their deep commitment to our Manchester staff and to MDPI’s impact on the UK market.

The UK by numbers

The UK is a hub for the world’s top universities, making it a key market for MDPI and the publishing world in general. It is home to two of the top-five-ranked universities globally, 11 in the top 100, and 15 in the top 200.

As a result, the UK plays a key role in MDPI’s global market. As at October 2023, it ranks as the seventh-largest contributor to the total number of papers published by MDPI. We have 3,500 Editorial Board members affiliated with UK institutions, including 34 serving as Editors-in-Chief (EiCs). Our commitment to collaboration with institutions is evident in the UK, where we have successfully established some 60 Institutional Open Access Program (IOAP) agreements with esteemed institutions, such as the University of Oxford, the University of Cambridge, Imperial College London, the University of Edinburgh, and more.

According to InCites Dataset + ESCI for the period 2018–2022, as at October 2023, nearly 65% of UK papers are now published as OA. Just over 10% of total OA publications are by UK authors. UK papers are known for their high quality, with an average of 11 citations per paper. Furthermore, 2.16% of UK papers are in the top 1% of cited papers, and 14.61% are in the top 10% of cited papers, showcasing their impact.

We are currently hiring EEs in various locations worldwide.

English Editing at MDPI

Our English Editing (EE) department consists of two main branches, Quality Control and Learning and Development, reflecting our priorities. We are continuously enhancing the quality of our English Editing services and have raised the relevant standards, which now extend to company-wide communications. English editors participate in international interviews, conduct English assessments, and provide colleagues with presentations on ways to improve their use of written and spoken English.

While expanding, the EE department has proactively refocused its efforts on the quality of our work and how the English Editing department can benefit the company more broadly. We currently have approximately 140 full-time English Editors based across five offices worldwide, supplemented by over 700 freelance English editors.

Our Manchester office serves as the hub for the EE Department, with EE Managers situated there, except for Kurtis Jackson, who serves as the Head of EE and is located in our Basel office. Manchester EEs play a critical role in establishing and developing EE teams in our other offices, overseeing management and recruitment. The EE department plays a vital role in MDPI’s operations, as it is the department that touches every published paper. If this work interests you, I encourage you to explore our available EE positions, whether you are seeking full-time or freelance opportunities.

Testimonials

“MDPI provides an excellent service compared to any other previously used services. It delivers fast and high-quality results but at an affordable price.” – Ardha Apriyanto, University of Potsdam

“In my role as a professor, I consider that MDPI Author Services offer an excellent quality in the editing of Western academic writing while maintaining the required standards of clarity, precision and rigor. Additionally, delivery times are fast compared to other available services.” – Jesus Insuasti, University of Nariño

Read more:

Coming Together for Science

STM and Frankfurt Book Fair

Attending STM

MDPI has been a proud sponsor of the STM Conference for several years. The STM Conference is a dynamic event featuring interactive sessions, expert panellists, idea-sharing, and ample networking opportunities. On 16 October, the event kicked off with arrival drinks, sponsored by MDPI, followed by a welcoming dinner, providing a great chance to connect and network with industry professionals. The following day was filled with speakers, sessions, and further opportunities to connect. STM exemplifies the collaborative spirit of the scientific community, with session topics including achieving open, visible, and impactful research at scale; maintaining research integrity in a rapidly changing world; and exploring the impact of ever-evolving technology in the scholarly community.

Meeting with Web of Science

On a personal note, one of the highlights of STM was a candid and productive conversation with Nandita Quaderi, Editor-in-Chief and SVP at Web of Science. During our discussion, we talked about MDPI, Web of Science, the IJERPH delisting, and ways of moving forward. This open conversation aimed at fostering better collaboration for the future.

“We discussed ways to improve our communication and collaboration.”

I appreciated our frank discussion and felt that Nandita wholeheartedly supports open access. She also expressed her appreciation for the monthly CEO Letter, which she sees as a way to add personality to the MDPI brand and provide insight into the great work we do at MDPI. While we highlighted the positives, we also discussed ways to improve our communication and collaboration moving forward. This meeting alone made the trip worthwhile, and I hope Nandita doesn’t mind my sharing that she found our chat to be “the most honest and constructive discussion” she’s had with someone from MDPI in recent years.

75th Frankfurt Book Fair


Jelena Milojevic (Book Editor, MDPI), Jovana Dubajic (Book Editor, MDPI), Evan Escamilla (Project Manager, MDPI), Laura Wagner (Head of Books, MDPI), and Jenny Knowles (Commissioning Editor, MDPI), at the Frankfurt Book Fair in Frankfurt am Main, Germany.

For the 75th time, the Frankfurter Buchmesse opened its doors in October to celebrate exciting stories and their authors. If you haven’t yet had the chance to visit the Frankfurt Book Fair, I highly recommend it. It’s the largest book fair in the world, attracting thousands of visitors from around the globe. This is the place to gain valuable industry insights from top-class publishing professionals, connect with publishers directly, and learn about the latest trends in publishing.

MDPI Books

Our Books team was also present at the Frankfurt Book Fair, networking and learning from various panels. Did you know that our MDPI Books department publishes OA Books?

The book publishing program includes monographs, book series, edited books and reprints of special issues and topical collections, among other book types.

If you have a book proposal you would like to discuss, please feel free to contact our Books team to understand the benefits and methods of publishing your next book with the OA model.

Closing Thoughts

MDPI Strategy Meeting

As the newly appointed CEO, this is my first year leading the MDPI Senior Management Strategy session. I saw it as an opportunity to explore what MDPI has the potential to become in the next five years. Guided by the vision of its founder and President, Dr. Shu-kun Lin, the company has accomplished remarkable feats over the past 27 years and currently holds the position as the world’s third-largest academic publisher, following Springer Nature and Elsevier.

Our primary objective is to build upon the milestones of the past decades and consolidate MDPI’s position as well-established publishing brand. The two-day meeting emphasized the importance of communicating MDPI’s values more actively via its brand and adopting a straightforward yet impactful approach to managing MDPI as a mature academic publisher.

“Our primary objective is to consolidate MDPI’s position as well-established publishing brand”

As the world’s number one open-access publisher, MDPI has long been a game-changer in the scholarly community, serving millions of authors. The challenge in being a trailblazer is the need to continuously improve and at the same time explore the next blue-ocean strategy, while also maintaining the smooth operation of the business. Our collection model, featuring guest-curated thematic topics in the form of Special Issues, has disrupted the industry. Other publishers closely study us and attempt to replicate our models. The future of this collection model is something we are actively addressing – while, of course, looking ahead to what comes next!

Stefan Tochev
Chief Executive Officer
MDPI AG

19 October 2023
Open Access Week 2023 – the Global Drive to Open Continues


MDPI has been a strong proponent of the open access publishing model right from the beginning. As one of the pioneering fully open access publishers, we firmly believe that unrestricted access to research findings forms the foundation for better transparency, efficiency, and quality control across all scientific disciplines.

In December 2022, we reached a significant milestone by surpassing one million articles published. That is one million articles freely available to all, to circulate and build upon!

Offering free and immediate access to scientific papers empowers scientists to examine, validate, replicate, and expand upon existing results. This not only helps prevent redundancy and optimizes how resources are used but also paves the way for innovative new approaches.

The International Open Access Week takes place from 23 to 29 October 2023, providing a unique opportunity to connect the global movement towards open sharing and open science with the progress of policy transformations at the local level.

Our goal, during Open Access Week as well as throughout the year, is to offer resources for educating people about the benefits of open access publishing. The MDPI Blog offers a wealth of information around open access and open science.

Promoting the values of accessibility, transparency, and collaboration

Open access publishing embodies the fundamental values of democratizing knowledge and fostering global accessibility. It aims to break down barriers that have traditionally limited access to scholarly work, ensuring that knowledge is available to all, regardless of their financial or institutional affiliations. 

Discounts are part of our commitment to ensuring there are diverse pathways to Open Access publishing for researchers worldwide. MDPI supports scientific communities in several different ways. 

One of the key strengths of open access publishing lies in its ability to facilitate interdisciplinary research. By removing paywalls and promoting the sharing of knowledge across disciplines, OA encourages collaboration and innovation. Researchers from diverse fields can access and build upon each other's work, fostering a holistic approach to addressing complex global challenges. 

Funders' policies are getting aligned with open science

Governments, institutions, and funding agencies have recognized the transformative potential of open access and have implemented policies to promote it. These policies often mandate that publicly funded research should be made openly accessible. Such initiatives have accelerated the growth of open access repositories and journals, reinforcing the commitment to open access principles. Check our spotlights on OA policies in the USEU and China

Open access publishing is continually evolving, with innovative and community-driven models and technologies shaping its future. Initiatives like "Plan S" and "cOAlition S" promote the adoption of OA publishing from the national funders’ perspective by requiring grantees to publish their research openly. A new policy announced by the US administration last year requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication. 

Additionally, preprint servers such as MDPI's Preprints.org, which allow researchers to share their findings before formal peer review, have gained popularity, enhancing the speed at which new knowledge is disseminated. The rise of blockchain technology is also being explored to ensure transparency and authenticity in scholarly publishing. 

For more than twenty years, open access scholarly publishing has been revolutionizing academia by promoting the values of accessibility, transparency, and collaboration. Its support for interdisciplinary research, evolving policies, and innovative practices all contribute to its growing influence in the global research community. As open access continues to expand, it holds the potential to democratize knowledge, advance science, and drive positive societal change. 

MDPI is proud to be a leader in the transition to open access.

18 October 2023
Viruses | Spotlight on the “Human Virology and Viral Diseases” Section


“Noroviruses—The State of the Art, Nearly Fifty Years after Their Initial Discovery”
by Louisa F. Ludwig-Begall, Axel Mauroy and Etienne Thiry
Viruses 2021, 13(8), 1541; https://doi.org/10.3390/v13081541
Available online: https://www.mdpi.com/1999-4915/13/8/1541

 

“Porcine Endogenous Retroviruses and Xenotransplantation, 2021”
by Joachim Denner
Viruses 2021, 13(11), 2156; https://doi.org/10.3390/v13112156
Available online: https://www.mdpi.com/1999-4915/13/11/2156

 

“Pandemics of the 21st Century: The Risk Factor for Obese People”
by Miriam Hancková and Tatiana Betáková
Viruses 2022, 14(1), 25; https://doi.org/10.3390/v14010025
Available online: https://www.mdpi.com/1999-4915/14/1/25

 

“Norovirus: Facts and Reflections from Past, Present, and Future”
by Yalda Lucero, David O. Matson, Shai Ashkenazi, Sergio George and Miguel O’Ryan
Viruses 2021, 13(12), 2399; https://doi.org/10.3390/v13122399
Available online: https://www.mdpi.com/1999-4915/13/12/2399

 

“Therapeutic DNA Vaccines against HPV-Related Malignancies: Promising Leads from Clinical Trials”
by Jianming Tang, Mingzhu Li, Chao Zhao, Danhua Shen, Lei Liu, Xiujun Zhang and Lihui Wei
Viruses 2022, 14(2), 239; https://doi.org/10.3390/v14020239
Available online: https://www.mdpi.com/1999-4915/14/2/239

 

“Viruses in the Heart: Direct and Indirect Routes to Myocarditis and Heart Failure”
by Colton R. Martens and Federica Accornero
Viruses 2021, 13(10), 1924; https://doi.org/10.3390/v13101924
Available online: https://www.mdpi.com/1999-4915/13/10/1924

 

“Tumors and Cytomegalovirus: An Intimate Interplay”
by Georges Herbein
Viruses 2022, 14(4), 812; https://doi.org/10.3390/v14040812
Available online: https://www.mdpi.com/1999-4915/14/4/812

 

“Hepatitis E Outbreak in the Central Part of Italy Sustained by Multiple HEV Genotype 3 Strains, June–December 2019”
by Anna Rosa Garbuglia, Roberto Bruni, Umbertina Villano, Francesco Vairo, Daniele Lapa, Elisabetta Madonna, Giovanna Picchi, Barbara Binda, Rinalda Mariani, Francesca De Paulis et al.
Viruses 2021, 13(6), 1159; https://doi.org/10.3390/v13061159
Available online: https://www.mdpi.com/1999-4915/13/6/1159

 

“Host Non-Coding RNA Regulates Influenza A Virus Replication”
by Yuejiao Liao, Shouqing Guo, Geng Liu, Zhenyu Qiu, Jiamin Wang, Di Yang, Xiaojing Tian, Ziling Qiao, Zhongren Ma and Zhenbin Liu
Viruses 2022, 14(1), 51; https://doi.org/10.3390/v14010051
Available online: https://www.mdpi.com/1999-4915/14/1/51

 

“Immunosuppressive Tumor Microenvironment and Immunotherapy of Epstein–Barr Virus-Associated Malignancies”
by Xueyi Zheng, Yuhua Huang, Kai Li, Rongzhen Luo, Muyan Cai and Jingping Yun
Viruses 2022, 14(5), 1017; https://doi.org/10.3390/v14051017
Available online: https://www.mdpi.com/1999-4915/14/5/1017

2 October 2023
MDPI Insights: The CEO’s Letter #4 - MDPI Presence in China

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Open Access in China

It is Saturday, 23 September, and I have just returned from an unforgettable 12-day trip to China, visiting our main offices in Beijing and Wuhan. In the wake of a packed and very enjoyable agenda of internal and external meetings, I would like to use this edition of the CEO Letter to showcase how MDPI supports the scholarly community in China.

Coincidentally, Jack McKenna, Communications Associate from MDPI’s corporate content team, has just released a blog article discussing China’s open access (OA) policy. It is a timely read, providing a concise overview of the development of the OA movement in China and reflecting on its future. I shall draw some content from Jack’s piece and use this edition of the CEO Letter to highlight the various ways in which MDPI is involved in this market. And it would be remiss of me not to include some pictures and highlights from my travels!

Open Access Policy in China

As per Jack’s post, in 2020, China became the world’s leading producer of research articles. Today, China is experiencing a “substantial growth rate in OA [Open Access] publication”. This growth is supported by the State’s commitment to research & development and its policy “requiring the promotion of open science”.

Over the past two decades, there have been gradual developments in China’s OA framework, with repositories and platforms being developed in a consistent manner. Currently, key institutions across China – including the National Science Library, the National Science and Technology Library, and the Natural Science Foundation of China – support OA. The State aims to establish consistent policies across government agencies – a framework for a more encompassing embrace of OA across institutions.

In China, the number of subscription-only articles decreased by nearly 30% over the 10-year period of 2011–2021, while gold OA increased by 22%. Between 2017 and 2020 alone, China published 800,921 academic papers in an OA format.

In 2023, as the leading publisher of academic research, China is pursuing “self-reliance”. Therefore, the State will be establishing consistent policies across government agencies, including those related to OA. Additionally, it will want to ensure that Chinese people can access the research that is supported by Chinese funding and produced by Chinese academics. For this reason, “Open Access is a matter of priority in China”.

MDPI Offices in China

 While the history of MDPI begins in Basel, Switzerland, the story of MDPI’s founder is very much rooted in China. Dr. Shu-kun Lin, Founder and President of MDPI, graduated with a BSc from Wuhan University in 1982. He also studied physical chemistry at the Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences (1982–1986; MSc in 1985), and at the University of Louisville, USA (1987–1989). Dr. Lin completed his doctorate in organic chemistry at the Swiss Federal Institute of Technology (ETH-Zürich) in 1992.


Stefan Tochev (CEO, MDPI) at MDPI’s Wuhan office.

In 2002, MDPI’s Basel headquarters moved to Matthäusstrasse 11, 4052 Basel, and Dr. Lin opened an editorial office in Qingdao, China, which launched the journal Marine Drugs in the following year. Below is a list of MDPI’s current offices in China and their respective dates of inauguration:

  • 2008: Beijing (Tongzhou, Haidian)
  • 2013: Wuhan (Hankou, Guanggu)
  • 2019: Tianjin
  • 2021: Dalian
  • 2021: Nanjing

Our Strength is in Our People

With over 6,000 MDPI staff, across 20 offices in 11 countries, MDPI is able to offer authors responsive and efficient round-the-clock support, enabling a rapid publication process.

In my experience, stakeholders are genuinely surprised when they realize the extent of our global operations. My response is to reiterate that our people are our strength. This is why we have fast and efficient processes and top-notch responsiveness. Our global presence ensures that your manuscript is constantly attended to, rather than sitting on someone’s desk. We prioritize our authors’ needs and act quickly to move things through the various stages of publication. MDPI is built on speed, convenience, and competence, which I believe are core pillars for success in any industry. We continually strive to improve our systems and processes on the basis of these core strengths. We literally have over 6,000 staff worldwide dedicated to serving your needs. It’s not magic: it’s people; it’s real.

Impactful Research

MDPI Awards

To support the academic community, and especially young researchers, and also to enhance communication among scientists, MDPI journals offer various awards in specific fields. We serve the scientific community by funding research to facilitate the development of sustainable global solutions through our annual World Sustainability Award and Emerging Sustainability Leader Award.

In 2022, MDPI made awards totalling over US$1 million in recognition and support of researchers worldwide.

Across our journal catalogue, we have granted over 2,000 awards to recognize and support researchers from all disciplines. Since 2016, these awards have served as a source of recognition, acknowledging the impact of research by heightening the influence of talented individuals. The award types mainly include the Young Investigator Award, the Best PhD Thesis Award, the Best Paper Award, and the Outstanding Reviewer Award.

To learn more about MDPI Awards and to find out which are currently available, please click here.

MDPI Awards to Scholars from China

Since 2021, there have been 23 Best Paper Awards granted to authors affiliated with Chinese institutions, identifying their papers as having high-quality scientific impact. A total of 45 Chinese scholars have received awards such as the Young Investigator Award, the Best PhD Thesis Award, the Outstanding Reviewer Award, and the Tu Youyou Award, among others. Prizes for these awards include MDPI grants for paid publications, totalling over CHF 70,000 for scholars affiliated with Chinese institutions.

MDPI’s Tu Youyou Award


Prof. Tu Youyou (left), Dr. Shu-Kun Lin (President, MDPI).

In 2015, Professor Tu Youyou was awarded the Nobel Prize in Physiology or Medicine “for her discoveries concerning a novel therapy against Malaria.” In order to commemorate Professor Tu’s contributions to human health and to promote the passion and spirit conveyed by her experiences, MDPI in 2016 established the ‘Tu Youyou Award’, which runs biennially to recognize outstanding scholars dedicated to the research of natural products and medicinal chemistry.

The 2022 Tu Youyou Award was granted to Prof. Dr. Xiaoguang Lei of Peking University. Click here to access the interview with the winner.

2015 Nobel Prize for Medicine Awarded to Professor Youyou Tu

Professor Tu’s work was celebrated in a Special Issue from Molecules on the occasion of her 80th birthday. The Special Issue: 'Artemisinin (Qinghaosu): Commemorative Issue in Honor of Professor Youyou Tu on the Occasion of her 80th Anniversary” was created five years before she won the Nobel Prize, highlighting the visibility MDPI provides researchers and their work.

Highly Cited Articles by Chinese Scholars Published in MDPI

Click here to access the most cited MDPI papers published by scholars affiliated with Chinese institutions. This list presents the most influential research from the more than 287,000 MDPI papers published by Chinese scholars. With over 9 million total citations, I encourage you to maximize your visibility and impact by publishing with MDPI, the number one most cited open access publisher.

Read more:

Inside MDPI

Stefan Tochev (CEO, MDPI) with the Beijing Marketing team.

Marketing Department in China

During my visit to our offices in Beijing and Wuhan, I had the opportunity to meet with, and to present to, our local marketing teams. These teams are responsible for various journal-related and corporate promotional activities, including newsletters, conferences, seminars, author training, journal awards, content creation, digital marketing, and social media.

I was pleased by the ambition and curiosity of our marketing colleagues. They showed a strong desire to collaborate and acquire knowledge and tactics to effectively market and promote MDPI-journal-related activities. I presented some of the principles and objectives that we apply in the Corporate Marketing and Communications department, and used the opportunity to strengthen our collaborative communications across offices.

Stefan Tochev (CEO, MDPI) with the Wuhan Marketing team.

Coming Together for Science

Collaborations, Scholarships and Meetings

MDPI maintains partnerships with nearly 190 learned societies and over 800 institutions and consortia, helping to facilitate the transition to OA publishing. Our commitment to working with institutions is evident in China, where we have successfully established over 35 Institutional Open Access Programs (IOAP) with esteemed institutions such as the Tsinghua University, Huazhong University of Science and Technology, and Shanghai Jiao Tong University.

Our institutional partnerships, waiver programs, and article processing cost discounts create diverse pathways to OA publishing for researchers worldwide.

Scholarships in China

Since 2021, several MDPI journals (Sensors, Photonics, Coatings, Materials, Energies, and Journal of Fungi) have funded full scholarships for four Master’s and five Ph.D. projects in China. These scholarships align with Tianjin University, Wuhan University of Technology, Central South University, the Chinese Academy of Sciences, and the China University of Petroleum (Beijing).

Meeting with the Society of Chinese University Journals (CUJS)


Prof. Tieming Zhang (President of CUJS, centre) and MDPI colleagues at CUJS office.

I am pleased to have participated in some highly productive meetings during my visit to China, including one with the Society of Chinese University Journals (CUJS). The meeting involved Prof. Tieming Zhang (President of CUJS), Assoc. Prof. Xin Zhang (Vice President and Secretary General), and Dr. Fei Gao (Executive Member of CUJS). Alongside my colleagues Dr. Guoshi Liu, Dr. Giulia Stefenelli, and Anita Sun, I represented MDPI and held an open discussion to address any questions regarding OA and MDPI.

We discussed several methods for collaboration, including a workshop on the future of peer review, MDPI sponsoring a funding grant for early-career researchers, and transitioning journals from diamond to gold OA. I am thankful for the opportunity to have met our colleagues at CUJS in person and feel very confident about our future collaborations in support of OA publishing in China.

MDPI hosts free academic seminars, author training sessions, and academic conferences as part of its commitment to enrich and support the scholarly community. CUJS often stages academic events (e.g., conferences, editor training, and editor competitions), and I believe there are great opportunities for CUJS and MDPI to collaborate accordingly.

Meeting with National Science Library, Chinese Academy of Sciences (NSLC)


Stefan Tochev (CEO, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Officers, MDPI), Anita Sun (PR Manager, MDPI) and Dr. Guoshi Liu (Managing Director, MDPI) at the National Science Library, Chinese Academy of Sciences.

We also visited the NSLC Director, Xiwen Liu, and colleagues Ying Jin, Zhesi Shen, and Sichao Tong. Following our introductions, we gave a presentation on the history and editorial process at MDPI, discussing specific details related to MDPI’s business and data. We highlighted the status of our  IOAP collaborations in China and the makeup of our author base, specifically in China, and drew attention to the fact that MDPI has published research by authors from every country in the world. We then discussed the design indicators, calculation methods and implementation purposes of the ‘Early Warning Journal List’ and how we can have open communication to provide any data regarding MDPI journals. I am pleased to report that we reached a consensus on future communications, and am grateful to NSLC for hosting us in their offices.

In-person meetings with stakeholders provide an invaluable opportunity to communicate what MDPI is about and the various ways in which we serve the scholarly community. While digital marketing and online communication are essential, they are no replacement for the understanding and trust that come about through in-person interactions.

The Numbers

As at September 2023, China holds the largest position in MDPI’s global market, ranking as the largest contributor to the total number of papers published by MDPI.

At this point in time, there were more than 847,000 China mainland scholars who have published with MDPI, 51 of whom are Section-Editors-in-Chief (SEiC) of MDPI journals, with seven serving as Editors-in-Chief (EiCs) for journals such as Air, Big Data and Cognitive Computing, Blockchains, Future, Nanoenergy Advances, and Targets.

Our growth and presence in China are a true testament to the service we provide to the scholarly community, and to the relationships we foster through collaborative activities. We look forward to continuing to support the growth of the scholarly community in China, providing a valuable and trusted experience with MDPI.

Closing Thoughts

Final Reflections on our MDPI Offices in Beijing and Wuhan


Stefan Tochev (CEO, MDPI), Dr. Constanze Schelhorn (Indexing Manager, MDPI), Jiale Shang (Admin, Tongzhou, MDPI) at Beijing Capital International Airport, Beijing.

I spent approximately two weeks visiting some of our offices in China, and the first word that comes to mind when describing my experience is ‘hospitality.’ My colleagues and I were met with enthusiasm and delight at the airport by the Tongzhou Admin team (thank you, Jiale Shang, and thank you, Eric Wang, for keeping us organized on this trip!) and were taken care of with great attention. From hotels to transportation, dinners, and meetings, our stay was catered for perfectly.

Perhaps this is where MDPI’s focus on customers and service originates. At our core, we are a service company that provides a publishing platform for its authors. It’s therefore no surprise that authors consistently rate their experience with MDPI very highly.

95% of submitting authors rate their overall experience with the MDPI publication process as Excellent or Good (Springer Nature report 90%).

91% of submitting authors rate their overall experience with the MDPI peer review process as Excellent or Good.

Speed/Efficiency and Editorial Relationship are two key reasons underlying this high satisfaction score. ‘Editorial Relationship’ can be further explored, but in the past month, the most commonly noted aspects were the professionalism, kindness, availability, communicativeness, and personalized assistance provided by our editorial staff throughout the process. These attributes are at the core of our work across all our offices and continents.

Hospitality and Service

Just as our Chinese colleagues strove to keep us engaged by showing us the city sights (thank you, Thea Pan, and Jason Wu from the Wuhan Marketing team!) and sharing a variety of wonderful meals, our editorial staff are committed to serving our authors throughout their publishing journey. Our aim is to place the author at the centre of everything we do, eager to welcome our ‘guests’ and provide them with a pleasant publishing experience.

I asked my colleague Francis Wu (Senior Publisher, Wuhan office) where this hospitality originates. He responded that it is part of Chinese culture. I reflected long and deep on this answer. China is a vast country, and when visitors arrive, hosts want to ensure they feel welcomed and taken care of in order to maximize their time and visit. I can’t think of a better analogy for how I would want our authors to feel when they visit MDPI for their publishing needs. A company culture that prioritizes service, something that goes beyond products and productivity, and focuses on the overall experience. Over 6,000 people, across all MDPI offices, are ready, willing and able to go the extra mile for their colleagues and their customers. This is something I am truly proud of.

Stefan Tochev
Chief Executive Officer
MDPI AG

26 September 2023
Viruses | Spotlight on the “Animal Viruses” Section


”Molecular Insights into the Flavivirus Replication Complex”
by Kaïn van den Elsen, Jun Ping Quek and Dahai Luo
Viruses 2021, 13(6), 956; https://doi.org/10.3390/v13060956
Available online: https://www.mdpi.com/1999-4915/13/6/956

“Identification of RSV Fusion Protein Interaction Domains on the Virus Receptor, Nucleolin”
by Peter Mastrangelo, Allysia A. Chin, Stephanie Tan, Amy H. Jeon, Cameron A. Ackerley, Karen K. Siu, Jeffrey E. Lee and Richard G. Hegele
Viruses 2021, 13(2), 261; https://doi.org/10.3390/v13020261
Available online: https://www.mdpi.com/1999-4915/13/2/261

“Spillover of West Caucasian Bat Lyssavirus (WCBV) in a Domestic Cat and Westward Expansion in the Palearctic Region”
by Stefania Leopardi, Ettore Barneschi, Giuseppe Manna, Barbara Zecchin, Pamela Priori, Petra Drzewnioková, Francesca Festa, Andrea Lombardo, Fabio Parca, Dino Scaravelli et al.
Viruses 2021, 13(10), 2064; https://doi.org/10.3390/v13102064
Available online: https://www.mdpi.com/1999-4915/13/10/2064

“Seroprevalence of Hepatitis E Virus in Moose (Alces alces), Reindeer (Rangifer tarandus), Red Deer (Cervus elaphus), Roe Deer (Capreolus capreolus), and Muskoxen (Ovibos moschatus) from Norway”
by Carlos Sacristán, Knut Madslien, Irene Sacristán, Siv Klevar and Carlos G. das Neves
Viruses 2021, 13(2), 224; https://doi.org/10.3390/v13020224
Available online: https://www.mdpi.com/1999-4915/13/2/224

“Vector Competence of Florida Culicoides insignis (Diptera: Ceratopogonidae) for Epizootic Hemorrhagic Disease Virus Serotype-2”
by Bethany L. McGregor, Dinesh Erram, Barry W. Alto, John A. Lednicky, Samantha M. Wisely and Nathan D. Burkett-Cadena
Viruses 2021, 13(3), 410; https://doi.org/10.3390/v13030410
Available online: https://www.mdpi.com/1999-4915/13/3/410

“Structural 3D Domain Reconstruction of the RNA Genome from Viruses with Secondary Structure Models”
by Simón Poblete and Horacio V. Guzman
Viruses 2021, 13(8), 1555; https://doi.org/10.3390/v13081555
Available online: https://www.mdpi.com/1999-4915/13/8/1555

“HIV-1 Tat Protein Promotes Neuroendocrine Dysfunction Concurrent with the Potentiation of Oxycodone’s Psychomotor Effects in Female Mice”
by Mohammed F. Salahuddin, Fakhri Mahdi, Suresh P. Sulochana and Jason J. Paris
Viruses 2021, 13(5), 813; https://doi.org/10.3390/v13050813
Available online: https://www.mdpi.com/1999-4915/13/5/813

“Differential Transcriptomic Response of Rainbow Trout to Infection with Two Strains of IPNV”
by David Tapia, Juan Kuznar, Rodolfo Farlora and José M. Yáñez
Viruses 2022, 14(1), 21; https://doi.org/10.3390/v14010021
Available online: https://www.mdpi.com/1999-4915/14/1/21

“The Pathobiology of H7N3 Low and High Pathogenicity Avian Influenza Viruses from the United States Outbreak in 2020 Differs between Turkeys and Chickens”
by Miriã F. Criado, Christina M. Leyson, Sungsu Youk, Suzanne DeBlois, Tim Olivier, Mary Lea Killian, Mia L. Torchetti, Darren J. Parris, Erica Spackman, Darrell R. Kapczynski et al.
Viruses 2021, 13(9), 1851; https://doi.org/10.3390/v13091851
Available online: https://www.mdpi.com/1999-4915/13/9/1851

“West Nile Virus and Tick-Borne Encephalitis Virus Are Endemic in Equids in Eastern Austria”
by Phebe de Heus, Jolanta Kolodziejek, Zdenĕk Hubálek, Katharina Dimmel, Victoria Racher, Norbert Nowotny and Jessika-M. V. Cavalleri
Viruses 2021, 13(9), 1873; https://doi.org/10.3390/v13091873
Available online: https://www.mdpi.com/1999-4915/13/9/1873

18 September 2023
Meet Us at the 10th Wuhan International Symposium on Modern Virology, 27–29 October 2023, Wuhan, China


Conference: The 10th Wuhan International Symposium on Modern Virology
Date: 27–29 October 2023
Location: Wuhan, China

MDPI will be attending the 10th Wuhan International Symposium on Modern Virology as an exhibitor, and we welcome researchers from different backgrounds to visit and share their latest ideas with us.

The 10th Wuhan International Symposium on Modern Virology, organized by the State Key Laboratory of Virology (Wuhan University and Wuhan Institute of Virology, Chinese Academy of Sciences), is scheduled to be held from 27 to 29 October 2023, in Wuhan, China. The aim of the meeting is to discuss the main scientific problems and research hotspots of virology, exchange the latest research results and research ideas, display new methods, technologies, and products for diagnosis and prevention of viral diseases, promote communication and cooperation among scholars in China as well as with international counterparts, and promote the development of virology research in China.

Since 2004, the Wuhan International Symposium on Modern Virology has been successfully held nine times every two years, and it has become a forward-looking, innovative, and influential academic activity in the field of virology in China and an important platform for academic exchange.

The conference will invite well-known experts and scholars in the field of virology to attend and provide reports. The setting of the conference includes communication forms such as congress reports, session reports, and poster presentations, and the working language of the conference is Chinese or English.

The following MDPI journals will be represented:

If you are planning to attend this conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit the following website: https://mm.sciconf.cn/cn/web/index/18668.

12 September 2023
Viruses | Spotlights in the “General Virology” Section


“Molecular Basis of Epstein–Barr Virus Latency Establishment and Lytic Reactivation”
by Takayuki Murata, Atsuko Sugimoto, Tomoki Inagaki, Yusuke Yanagi, Takahiro Watanabe, Yoshitaka Sato and Hiroshi Kimura
Viruses 2021, 13(12), 2344; https://doi.org/10.3390/v13122344
Available online: https://www.mdpi.com/1999-4915/13/12/2344

“Site-Specific O-Glycosylation Analysis of SARS-CoV-2 Spike Protein Produced in Insect and Human Cells”
by Ieva Bagdonaite, Andrew J. Thompson, Xiaoning Wang, Max Søgaard, Cyrielle Fougeroux, Martin Frank, Jolene K. Diedrich, John R. Yates III, Ali Salanti, Sergey Y. Vakhrushev et al.
Viruses 2021, 13(4), 551; https://doi.org/10.3390/v13040551
Available online: https://www.mdpi.com/1999-4915/13/4/551

“HIV-1 Entry and Membrane Fusion Inhibitors”
by Tianshu Xiao, Yongfei Cai and Bing Chen
Viruses 2021, 13(5), 735; https://doi.org/10.3390/v13050735
Available online: https://www.mdpi.com/1999-4915/13/5/735

“Plant Viruses: From Targets to Tools for CRISPR”
by Carla M. R. Varanda, Maria do Rosário Félix, Maria Doroteia Campos, Mariana Patanita and Patrick Materatski
Viruses 2021, 13(1), 141; https://doi.org/10.3390/v13010141
Available online: https://www.mdpi.com/1999-4915/13/1/141

“Recent Advances in Bunyavirus Glycoprotein Research: Precursor Processing, Receptor Binding and Structure”
by Ruben J. G. Hulswit, Guido C. Paesen, Thomas A. Bowden and Xiaohong Shi
Viruses 2021, 13(2), 353; https://doi.org/10.3390/v13020353
Available online: https://www.mdpi.com/1999-4915/13/2/353

“Influenza A Virus Hemagglutinin and Other Pathogen Glycoprotein Interactions with NK Cell Natural Cytotoxicity Receptors NKp46, NKp44, and NKp30”
by Jasmina M. Luczo, Sydney L. Ronzulli and Stephen M. Tompkins
Viruses 2021, 13(2), 156; https://doi.org/10.3390/v13020156
Available online: https://www.mdpi.com/1999-4915/13/2/156

6 September 2023
Recap of Awards Granted to Scholars in 2022


MDPI is committed to supporting the academic community, nurturing talent and advancing science. Awards are an important part of the research landscape and play a vital role in helping academics gain recognition, especially young researchers as they embark on new research avenues.

In 2022, our journals presented a total number of 394 Awards, including Travel Awards, Young Investigator Awards, Best PhD Thesis Awards, Best Paper Awards, and Outstanding Reviewer Awards, with several winners announced for some of the awards. The total prize sum amounted to just under 580,000 Swiss francs (CHF), or approximately 650,000 US dollars. Overall, more than 720 scholars were awarded.

The majority of the awards were dedicated to young researchers in relatively early stages of their careers. This encompassed 66 of the afore-mentioned Travel Awards, 60 Young Investigator Awards, supporting research projects and conference attendance, as well as 51 Best PhD Thesis Awards. Additionally, 113 Best Paper Awards were given by our journals. The selection committees were entrusted with identifying the most impactful and novel research and review articles published in their journal within a given year.

MDPI will continue its support and recognition for the academic community moving forward, sponsoring new awards across disciplines. To learn more about all the awardees and their research projects in your field of study, please visit the following pages:

To explore more MDPI awards, please click here.

4 September 2023
Viruses | Top Cited Papers in 2021 in the Section “Viruses of Plants, Fungi and Protozoa”


“Illuminating the Plant Rhabdovirus Landscape through Metatranscriptomics Data”
by Nicolás Bejerman, Ralf G. Dietzgen and Humberto Debat
Viruses 2021, 13(7), 1304; https://doi.org/10.3390/v13071304
Available online: https://www.mdpi.com/1999-4915/13/7/1304

“ViralRecall—A Flexible Command-Line Tool for the Detection of Giant Virus Signatures in ‘Omic Data”
by Frank O. Aylward and Mohammad Moniruzzaman
Viruses 2021, 13(2), 150; https://doi.org/10.3390/v13020150
Available online: https://www.mdpi.com/1999-4915/13/2/150

“Probing into the Effects of Grapevine Leafroll-Associated Viruses on the Physiology, Fruit Quality and Gene Expression of Grapes”
by Yashu Song, Robert H. Hanner and Baozhong Meng
Viruses 2021, 13(4), 593; https://doi.org/10.3390/v13040593
Available online: https://www.mdpi.com/1999-4915/13/4/593

“Metagenomic Studies of Viruses in Weeds and Wild Plants: A Powerful Approach to Characterise Variable Virus Communities”
by Beata Hasiów-Jaroszewska, Dieke Boezen and Mark P. Zwart
Viruses 2021, 13(10), 1939; https://doi.org/10.3390/v13101939
Available online: https://www.mdpi.com/1999-4915/13/10/1939

“High-Throughput Sequencing Indicates Novel Varicosavirus, Emaravirus, and Deltapartitivirus Infections in Vitis coignetiae
by Tomoyuki Nabeshima and Junya Abe
Viruses 2021, 13(5), 827; https://doi.org/10.3390/v13050827
Available online: https://www.mdpi.com/1999-4915/13/5/827

“Quality Assessment and Validation of High-Throughput Sequencing for Grapevine Virus Diagnostics”
by Nourolah Soltani, Kristian A. Stevens, Vicki Klaassen, Min-Sook Hwang, Deborah A. Golino and Maher Al Rwahnih
Viruses 2021, 13(6), 1130; https://doi.org/10.3390/v13061130
Available online: https://www.mdpi.com/1999-4915/13/6/1130

“Metagenomics Analysis of the Wheat Virome Identifies Novel Plant and Fungal-Associated Viral Sequences”
by Carla Dizon Redila, Ved Prakash and Shahideh Nouri
Viruses 2021, 13(12), 2457; https://doi.org/10.3390/v13122457
Available online: https://www.mdpi.com/1999-4915/13/12/2457

“Factors Determining Transmission of Persistent Viruses by Bemisia tabaci and Emergence of New Virus–Vector Relationships”
by Saptarshi Ghosh and Murad Ghanim
Viruses 2021, 13(9), 1808; https://doi.org/10.3390/v13091808
Available online: https://www.mdpi.com/1999-4915/13/9/1808

“Integrating High throughput Sequencing into Survey Design Reveals Turnip Yellows Virus and Soybean Dwarf Virus in Pea (Pisum Sativum) in the United Kingdom”
by Aimee R. Fowkes, Sam McGreig, Hollie Pufal, Shona Duffy, Becky Howard, Ian P. Adams, Roy Macarthur, Rebecca Weekes and Adrian Fox
Viruses 2021, 13(12), 2530; https://doi.org/10.3390/v13122530
Available online: https://www.mdpi.com/1999-4915/13/12/2530

“Multiple Viral Infections Detected in Phytophthora condilina by Total and Small RNA Sequencing”
by Leticia Botella and Thomas Jung
Viruses 2021, 13(4), 620; https://doi.org/10.3390/v13040620
Available online: https://www.mdpi.com/1999-4915/13/4/620

30 August 2023
MDPI Insights: The CEO’s Letter #3 - Sustainability and Co-opetition

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Our Commitment to Sustainability

As a pioneer in academic open access publishing since 1996, MDPI has always been dedicated to facilitating scientific exchange across all disciplines. Our approach to open science is guided by principles such as Open Access (OA), Timeliness and Efficiency, Simplicity, High-Quality Service, Flexibility, and a commitment to Sustainability. This commitment involves preserving published papers for the long term and supporting the future of science through partnerships, sponsorships, and awards.

In this edition of the CEO Letter, I will delve into MDPI’s various sustainability initiatives. As a leader in OA publishing, we are able to provide the public with a significant amount of environment-related content at no cost.

MDPI and the Sustainable Development Goals (SDGs)

In 2020, the SDG Publishers Compact was launched to accelerate implementation of the SDGs by promoting content that informs, develops, and inspires action. MDPI joined this initiative in 2021 and subsequently launched the MDPI SDG Hub in 2022, offering free access to recent research within the scope of each of the 17 SDGs. We also support authors from underrepresented communities by waiving publication charges for selected SDG-related papers. Detailed sustainability practices and supported publications are available in the report under each Goal page.

“More than 80% of MDPI articles and reviews published in 2022 relate to the Sustainable Development Goals.” [source: InCites, Accessed on 21.08.2023]

As at August 2023, MDPI boasts 14 journals dedicated to sustainability-related topics. Our first journal in this area, Sustainability, has published over 29,000 articles on the SDGs, accumulating over 240,000 citations (source: InCites, as at 1 January 2023). These journals serve as vital platforms for researchers to share insights and address environmental challenges. In addition:

MDPI journals specializing in sustainability-related topics:

  • 2009: Sustainability
  • 2012: Resources
  • 2013: Climate
  • 2014: Environments
  • 2016: Recycling
  • 2019: Clean Technologies
  • 2020: Sustainable Chemistry
  • 2021: Wind, Biomass, Conservation, Pollutants, Solar
  • 2022: Waste, Microplastics

Read more:

Impactful Research

Highly Cited Articles in Sustainability

In 2022, content published in Sustainability and indexed in Journal Citation Reports (JCR) received nearly 190,000 citations. This highlights the fact that Sustainability publishes highly cited research articles related to environmental sciences and SDG-related topics such as climate action.

We are pleased to share that Sustainability received a 2022 CiteScore of 5.8, marking a 16% increase from the 2021 metric. Specifically, the CiteScore positions Sustainability as follows: Q1 (27 out of 163) in the “Environmental Science (miscellaneous)” category, and Q1 (101 out of 779) in the “Geography Planning and Development” category. For additional journal statistics, please visit here.

“Sustainability received a 2022 CiteScore of 5.8”

While MDPI journals such as Climate and Atmosphere have a distinct focus on atmosphere pollution and its impact on climate processes, journals like Sustainability, Environments, Water, Remote Sensing, and IJERPH publish content related to climate change. These journals have published over 32,300 articles related to SDG 13: Climate Action.

Highly Cited Papers in Sustainability

Below are several highly cited papers published in Sustainability over the past three years. Citation metrics are current as at 15 August 2023.

1. “A Global Assessment: Can Renewable Energy Replace Fossil Fuels by 2050?
Authors: Jerry L. Holechek, Hatim M. E. Geli, Mohammed N. Sawalhah, and Raul Valdez
Sustainability 2022, 14(8), 4792; https://doi.org/10.3390/su14084792
Citations: Crossref (97), Scopus (91), Web of Science (82), Google Scholar (125)

This paper addresses one of the most significant challenges of climate change – achieving Net Zero Carbon by 2050. The meta-analysis suggests that while difficult, this transition is possible through the concerted application of pathways, lifestyle changes, and global cooperation.

2. “Anxiety and the Ecological Crisis: An Analysis of Eco-Anxiety and Climate Anxiety
Author: Panu Pihkala
Sustainability 2020, 12(19), 7836; https://doi.org/10.3390/su12197836
Citations: Crossref (144), Scopus (121), Web of Science (159), Google Scholar (382)

This paper has received substantial media attention, including coverage by The Guardian, BBC, Vice, and CNBC. An interview with Dr. Panu Pihkala, a leading interdisciplinary researcher on the topic, can be found on MDPI’s podcast: Insight Faster, Episode 1.

3. “Impact of Climate Change on Agriculture and Its Mitigation Strategies: A Review
Authors: Gurdeep Singh Malhi, Manpreet Kaur, and Prashant Kaushik
Sustainability 2021, 13(3), 1318; https://doi.org/10.3390/su13031318
Citations: Crossref (207), Scopus (221), Web of Science (186), Google Scholar (355)

This paper reviews literature on climate change, addressing its causes, future projections, impact on agriculture, including plant physiology, growth, productivity, pest infestation, and the economic implications of mitigation strategies.

4. Impacts of Plastic Pollution on Ecosystem Services, Sustainable Development Goals, and Need to Focus on Circular Economy and Policy Interventions
Authors: Rakesh Kumar, Anurag Verma, Arkajyoti Shome, Rama Sinha, Srishti Sinha, Prakash Kumar Jha, Ritesh Kumar, Pawan Kumar, Shubham, Shreyas Das, Prabhakar Sharma, and P. V. Vara Prasad
Sustainability 2021, 13(17), 9963; https://doi.org/10.3390/su13179963
Citations: Crossref (134), Scopus (136), Web of Science (113), Google Scholar (184)

This review aims to assess the adverse effects of plastic pollution on ecosystems, link the management of plastic with the SDGs, and propose policy measures using transdisciplinary approaches. Empowering communities to reduce plastic use is crucial. Addressing global plastic pollution is a priority.

Sustainability is an international, cross-disciplinary, open access journal that explores environmental, cultural, economic, and social sustainability of human beings. It provides a forward-looking platform for research on sustainability and sustainable development, and is published semi-monthly online by MDPI. Sustainability is affiliated with The Canadian Urban Transit Research & Innovation Consortium (CUTRIC) and The International Council for Research and Innovation in Building and Construction (CIB).

Read more:

Inside MDPI

President of Ireland Authors Editorial in MDPI Journal Sustainability

It’s a very special occasion when the president of a country takes the initiative to write an editorial for a journal. Michael D. Higgins, President of the Republic of Ireland, has contributed his insights to a forthcoming Special Issue in Sustainability:

This Special Issue, focusing on “making sustainable development happen” at grassroots levels, allows for perspectives from, and on, the major world faiths, exploring how challenges have been conceptualised and addressed, in addition to case studies of faith-based sustainability initiatives in practice.

The experience of faith institutions and communities in translating theological and moral commitments to sustainable development into action is now a topic we must examine with urgency; one on which I am so glad this Special Issue focuses.

As President of Ireland, I very much support this Special Issue of Sustainability. It is my great hope that the contents of the papers contained herein will assist in making sustainable development happen at grassroots levels across the world so that we can cooperate together, people of faith and of none, to ensure a just, inclusive and sustainable future for all on our fragile planet.

Read the completed editorial here:

Special Issue “Faith and Sustainable Development: Exploring Practice, Progress and Challenges among Faith Communities and Institutions”: Foreword by the President of Ireland
Author: Michael D. Higgins
Sustainability 2023, 15(12), 9683; https://doi.org/10.3390/su15129683

Coming Together for Science

The World Sustainability Forum 2023

The World Sustainability Forum (WSF) is a biennial MDPI event focused on sustainability. WSF 2023 marks the tenth anniversary of the conference series, taking place on 14 September. For the first time, the event will be hosted as a 24-hour conference across three locations – Singapore, Basel in Switzerland, and Toronto in Canada – alongside virtual streaming.

This unique format allows us to span three time zones, providing live coverage of critical sustainability-related topics throughout the day:

  • The Singapore Hub, chaired by Professor Horn Mun Cheah and Associate Professor Renee Tan, will explore “Sustainability for Social and Community Impact”.
  • The Basel Hub, chaired by Prof. Dr. Anet Režek Jambrak and Dr. Lela Mélon, will delve into “Sustainability in the industry, and at university and corporate settings”.
  • The Toronto Hub, led by Dr. Umberto Berardi, will discuss “The Sustainable Built Environment”.

MDPI Sustainability Foundation: Recognizing Excellence in Sustainability Research

The MDPI Sustainability Foundation supports researchers through two sustainability-focused awards:

  1. The World Sustainability Award, amounting to USD 100,000, is given to senior researchers.
  2. The Emerging Sustainability Leader Award, valued at USD 20,000, sponsored by the journal Sustainability, is presented to early-career researchers.

The winners of the Sustainability Foundation will be formally awarded during the WSF2023 on 14 September. Interviews with the award winners and finalists are available below.

2023 World Sustainability Award Winners

  1. Professor Michael R. Templeton
  2. Professor Tom Lyon
  3. Dr Krithi K. Karanth

Interviews with 2023 Emerging Sustainability Leader Award Finalists

  • Dr. Bahareh Kamranzad
  • Dr. Youjin Kim
  • Dr. Julia Lohmann

As a hybrid event, WSF23 provides scholars with the option to attend in person at one of the conference sites or, for a more sustainable approach, virtually. All sessions will be recorded and archived for future access. Registration is open until 3 September 2023, with in-person and virtual tickets available here.

Read more:

Closing Thoughts

“Co-opetition”: Collaboration Plus Healthy Competition – A Visit to Elsevier

I firmly believe in fostering collaboration and at the same time promoting healthy competition within the academic publishing industry. The market offers ample room for publishers and related companies to provide valuable services and products that enrich the academic community. While MDPI is recognized for its efficient and streamlined processes –thanks to our over 6,000 colleagues, in-house tools, and initiatives that support the author journey – our ethos has always involved learning from and collaborating with other organizations.

MDPI’s Interaction with Elsevier

In January 2023, I had a brief conversation with Judy Verses, President of Global Academic and Government Markets at Elsevier, following her participation in a panel discussion at the Academic Publishers Europe event in Berlin. One of the highlights for me was Judy’s insight into the impact of research, particularly her emphasis on the role of collaboration, including policy and showing the impact of research to influence on funding decisions.

“Such collaborations drive forward-looking strategies to elevate our support for the scholarly community”

Judy and I resumed our discussion in August, when I visited Elsevier's office to review current projects, such as our recent agreement with Science Direct and the continued indexing of MDPI journals in Scopus (indexing database owned by Elsevier). We also explored possible opportunities for the future, including a potential collaboration to expand MDPI’s Scilit data infrastructure. This endeavour aims to aggregate and provide access to scholarly metadata encompassing journal articles, conference papers, books, preprints, and more. While these discussions are ongoing, the underlying principle remains that such collaborations drive forward-looking strategies to elevate our services and support for the scholarly community.

It was great that Judy and I acknowledged the merits of 'co-opetition,' a concept based of the belief that fostering cooperation alongside healthy competition can lead to shared advancements for both individual companies and the industry at large.

‘Fully OA’ Organizations Dedicated to Open Access

MDPI proudly aligns with the ‘Fully OA’ group, a collaborative initiative comprising nine organizations dedicated to Open Access. Our monthly meetings, including an OASPA representative, serve as platforms to share non-confidential information, resources, and projects. These gatherings also facilitate discussions on topics relevant to fully OA organizations. Occasionally, joint actions spring from these interactions, such as collaborative blog posts on pertinent subjects and joint statements, such as a recent response to the House Appropriations Committee.

This display of cooperation among competing entities forms a strategic alliance focused on nurturing the best interests of the OA publishing model.

As I wrap up this third edition of the CEO Letter, I encourage you to seize opportunities for collaboration and contribute to advancing our shared academic culture. As the African proverb has it, “If you want to go fast, go alone; if you want to go far, go together.”

Stefan Tochev
Chief Executive Officer
MDPI AG

28 August 2023
Viruses | Top Cited Papers in 2021–2022 Related to African Swine Fever Virus


“African Swine Fever in Wild Boar in Europe—A Review”
by Carola Sauter-Louis, Franz J. Conraths, Carolina Probst, Ulrike Blohm, Katja Schulz, Julia Sehl, Melina Fischer, Jan Hendrik Forth, Laura Zani, Klaus Depner et al.
Viruses 2021, 13(9), 1717; https://doi.org/10.3390/v13091717
Available online: https://www.mdpi.com/1999-4915/13/9/1717

“ASFV-G-∆I177L as an Effective Oral Nasal Vaccine against the Eurasia Strain of Africa Swine Fever”
by Manuel V. Borca, Elizabeth Ramirez-Medina, Ediane Silva, Elizabeth Vuono, Ayushi Rai, Sarah Pruitt, Nallely Espinoza, Lauro Velazquez-Salinas, Cyril G. Gay and Douglas P. Gladue
Viruses 2021, 13(5), 765; https://doi.org/10.3390/v13050765
Available online: https://www.mdpi.com/1999-4915/13/5/765

“Evaluation of the Safety Profile of the ASFV Vaccine Candidate ASFV-G-ΔI177L”
by Xuan Hanh Tran, Le Thi Thu Phuong, Nguyen Quang Huy, Do Thanh Thuy, Van Dung Nguyen, Pham Hào Quang, Quách Võ Ngôn, Ayushi Rai, Cyril G. Gay, Douglas Paul Gladue et al.
Viruses 2022, 14(5), 896; https://doi.org/10.3390/v14050896
Available online: https://www.mdpi.com/1999-4915/14/5/896

“Deletion of the L7L-L11L Genes Attenuates ASFV and Induces Protection against Homologous Challenge”
by Jingyuan Zhang, Yanyan Zhang, Teng Chen, Jinjin Yang, Huixian Yue, Lidong Wang, Xintao Zhou, Yu Qi, Xun Han, Junnan Ke et al.
Viruses 2021, 13(2), 255; https://doi.org/10.3390/v13020255
Available online: https://www.mdpi.com/1999-4915/13/2/255

“African Swine Fever Virus CD2v Protein Induces β-Interferon Expression and Apoptosis in Swine Peripheral Blood Mononuclear Cells”
by Sabal Chaulagain, Gustavo A. Delhon, Sushil Khatiwada and Daniel L. Rock
Viruses 2021, 13(8), 1480; https://doi.org/10.3390/v13081480
Available online: https://www.mdpi.com/1999-4915/13/8/1480

“Structures and Functional Diversities of ASFV Proteins”
by Guoguo Wang, Mengjia Xie, Wei Wu and Zhongzhou Chen
Viruses 2021, 13(11), 2124; https://doi.org/10.3390/v13112124
Available online: https://www.mdpi.com/1999-4915/13/11/2124

“African Swine Fever Virus Ubiquitin-Conjugating Enzyme Is an Immunomodulator Targeting NF-κB Activation”
by Lucía Barrado-Gil, Ana del Puerto, Inmaculada Galindo, Miguel Ángel Cuesta-Geijo, Isabel García-Dorival, Carlos Maluquer de Motes and Covadonga Alonso
Viruses 2021, 13(6), 1160; https://doi.org/10.3390/v13061160
Available online: https://www.mdpi.com/1999-4915/13/6/1160

“Prevention and Control Strategies of African Swine Fever and Progress on Pig Farm Repopulation in China”
by Yuanjia Liu, Xinheng Zhang, Wenbao Qi, Yaozhi Yang, Zexin Liu, Tongqing An, Xiuhong Wu and Jianxin Chen
Viruses 2021, 13(12), 2552; https://doi.org/10.3390/v13122552
Available online: https://www.mdpi.com/1999-4915/13/12/2552

“African Swine Fever Virus as a Difficult Opponent in the Fight for a Vaccine—Current Data”
by Hanna Turlewicz-Podbielska, Anna Kuriga, Rafał Niemyjski, Grzegorz Tarasiuk and Małgorzata Pomorska-Mól
Viruses 2021, 13(7), 1212; https://doi.org/10.3390/v13071212
Available online: https://www.mdpi.com/1999-4915/13/7/1212

“African Swine Fever and Its Epidemiological Course in Lithuanian Wild Boar”
by Katja Schulz, Marius Masiulis, Christoph Staubach, Alvydas Malakauskas, Gediminas Pridotkas, Franz J. Conraths and Carola Sauter-Louis
Viruses 2021, 13(7), 1276; https://doi.org/10.3390/v13071276
Available online: https://www.mdpi.com/1999-4915/13/7/1276

21 August 2023
Viruses | Top Cited Papers in 2021–2022 Related to Hepatitis


“HBV-Integration Studies in the Clinic: Role in the Natural History of Infection”
by Teresa Pollicino and Giuseppe Caminiti
Viruses 2021, 13(3), 368; https://doi.org/10.3390/v13030368
Available online: https://www.mdpi.com/1999-4915/13/3/368

“Mechanism of Hepatitis B Virus cccDNA Formation”
by Lei Wei and Alexander Ploss
Viruses 2021, 13(8), 1463; https://doi.org/10.3390/v13081463
Available online: https://www.mdpi.com/1999-4915/13/8/1463

“Hepatitis A: Epidemiology, High-Risk Groups, Prevention and Research on Antiviral Treatment”
by Marion Migueres, Sébastien Lhomme and Jacques Izopet
Viruses 2021, 13(10), 1900; https://doi.org/10.3390/v13101900
Available online: https://www.mdpi.com/1999-4915/13/10/1900

“Current Trend in Antiviral Therapy for Chronic Hepatitis B”
by Rong-Nan Chien and Yun-Fan Liaw
Viruses 2022, 14(2), 434; https://doi.org/10.3390/v14020434
Available online: https://www.mdpi.com/1999-4915/14/2/434

“Hepatitis B Virus DNA Integration: In Vitro Models for Investigating Viral Pathogenesis and Persistence”
by Thomas Tu, Henrik Zhang and Stephan Urban
Viruses 2021, 13(2), 180; https://doi.org/10.3390/v13020180
Available online: https://www.mdpi.com/1999-4915/13/2/180

“Animal Models of Hepatitis B Virus Infection–Success, Challenges, and Future Directions”
by Yongzhen Liu, Stephanie Maya and Alexander Ploss
Viruses 2021, 13(5), 777; https://doi.org/10.3390/v13050777
Available online: https://www.mdpi.com/1999-4915/13/5/777

“Novel Biomarkers of Hepatitis B Virus and Their Use in Chronic Hepatitis B Patient Management”
by Alicia Vachon and Carla Osiowy
Viruses 2021, 13(6), 951; https://doi.org/10.3390/v13060951
Available online: https://www.mdpi.com/1999-4915/13/6/951

“Ectopic Expression of Genotype 1 Hepatitis E Virus ORF4 Increases Genotype 3 HEV Viral Replication in Cell Culture”
by Kush K. Yadav, Patricia A. Boley, Zachary Fritts and Scott P. Kenney
Viruses 2021, 13(1), 75; https://doi.org/10.3390/v13010075
Available online: https://www.mdpi.com/1999-4915/13/1/75

“A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy”
by Cesare Mazzaro, Luca Quartuccio, Luigi Elio Adinolfi, Dario Roccatello, Gabriele Pozzato, Riccardo Nevola, Maurizio Tonizzo, Stefano Gitto, Pietro Andreone and Valter Gattei
Viruses 2021, 13(11), 2249; https://doi.org/10.3390/v13112249
Available online: https://www.mdpi.com/1999-4915/13/11/2249

“Hepatitis B Virus-Associated Hepatocellular Carcinoma”
by Giacomo Emanuele Maria Rizzo, Giuseppe Cabibbo and Antonio Craxì
Viruses 2022, 14(5), 986; https://doi.org/10.3390/v14050986
Available online: https://www.mdpi.com/1999-4915/14/5/986

14 August 2023
MDPI’s 2022 Young Investigator Awards in Biology and Life Sciences—Winners Announced


MDPI’s Young Investigator Awards recognize promising junior researchers, acknowledge their contributions, and enhance communication among scientists. We are proud to present the winners for the year 2022 in biology and life sciences. The winners were selected by the journals’ Award Evaluation Committee.

We warmly congratulate the awarded young investigators for their outstanding contributions. MDPI will continue to provide support and recognition to the academic community.

Agriculture:

  • Thomas Hartinger, University of Veterinary Medicine Vienna, Austria

Agronomy:

  • Leontina Lipan, Universidad Miguel Hernández, Spain

Animals:

  • Daniel Stec, Polish Academy of Sciences, Poland

Brain Sciences:

  • Dibyadeep Datta, Yale Medical School, USA
  • Giacomo Valle, ETH Zurich, Switzerland
  • Morgan H. James, Rutgers University, USA

Foods:

  • Xiaonan Lu, McGill University, Canada

Genes:

  • Alfredo Iacoangeli, King's College London, UK
  • Elisa De Franco, University of Exeter, UK
  • Riccardo Pecori, German Cancer Research Center, Germany
  • Vanessa Silva, University of Trás-os-Montes and Alto Douro, Portugal

Horticulturae:

  • Massimiliano Renna, University of Bari Aldo Moro at Bari, Italy

Insects:

  • Adam G. Dolezal, University of Illinois Urbana-Champaign, United States

Microorganisms:

  • Carla Rodrigues, Institut Pasteur, France
  • Lorena Rodriguez-Rubio, University of Barcelona, Spain
  • Kevin Solomon, University of Delaware, USA

Nutrients:

  • Colleen Deane, University of Southampton, UK

Toxins:

  • Paz Otero Fuertes, University of Vigo, Spain

Pathogens:

  • Marta Giovanetti, National Reference Laboratory of Flavivirus in the Oswaldo Cruz Foundation, Brazil
  • Carrie M. Long, National Institute of Allergy and Infectious Diseases (NIAID), USA

Vaccines:

  • Carina Joe, University of Oxford, UK

About MDPI Awards:

In order to reward the academic community, especially young researchers and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.

To explore more MDPI awards, please click here.

14 August 2023
MDPI’s 2022 Travel Awards in Biology and Life Sciences—Winners Announced


We are proud to recognize the winners of MDPI’s 2022 Travel Awards in biology and life sciences for their outstanding presentations.

MDPI journals regularly offer travel awards to encourage junior scientists to present their latest research at academic conferences in specific fields, which helps to increase their influence.

The winners mentioned below were carefully selected by the journal editors based on an outline of their research and the work to be presented at an academic conference.

We would like to warmly congratulate the winners of the 2022 Travel Awards and wish them the greatest success in their future research endeavors. MDPI will continue to enhance communication among scientists.

Brain Sciences:

  • Liloia Donato, University of Turin, Italy
  • Roberta Bettoni, University of Milano Bicocca, Italy

Diversity:

  • Vanessa Silva, University of Trás-os-Montes and Alto Douro, Portugal

IJMS:

  • Carlo Matera, University of Milan, Italy
  • Elisabetta Coppi, University of Florence, Italy
  • Ilaria Tonazzini, Nanoscience Institute—National Research Council (CNR) @ NEST in Pisa, Italy

MPs:

  • Pere Catala, University Eye Clinic Maastricht, Maastricht University Medical Center, the Netherlands

Sports:

  • Angela Blasimann, University of Antwerp, Belgium
  • Angelo Sabag, Western Sydney University, Australia

About MDPI Awards:

In order to reward the academic community, especially young researchers and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.

To explore more MDPI awards, please click here.

14 August 2023
MDPI’s 2022 Outstanding Reviewer Awards in Biology and Life Sciences—Winners Announced


In order to acknowledge our reviewers, who demonstrate diligence, professionalism, and timeliness when generously dedicating their time to reviewing manuscripts, MDPI journals regularly offer outstanding reviewer awards to scholars who participate in the peer review process.

We are proud to recognize the winners for the year 2022 in biology and life sciences for their outstanding contributions, among extensive competition, by presenting them with an Outstanding Reviewer Award.

We would like to take this opportunity to congratulate all of the winners on their achievements. MDPI will continue to provide support and recognition to the academic community.

Agronomy:

  • Ewa Ropelewska, The National Institute of Horticultural Research, Poland
  • Marek Rašovský, Slovak University of Agriculture in Nitra, Slovakia
  • Prakash Jha, Kansas State University, USA
  • Vasileios Greveniotis, Institute of Industrial and Forage Crops, Greece

Biology:

  • Alberto Collareta, University of Pisa, Italy
  • Francisco Curate, University of Coimbra, Portugal
  • Gianpiero Greco, University of Study of Bari, Italy
  • Luca Poli, University of Study of Bari, Italy
  • Shaohua Chen, South China Agricultural University, China

Brain Sciences:

  • Chong Chen, Yamaguchi University Graduate School of Medicine, Japan

Children:

  • Marco Sapienza, University of Catania, Italy
  • Sabina Barrios-Fernández, University of Extremadura, Spain

Diversity:

  • Corrado Battisti, Torre Flavia LTER (Long Term Ecological Research) Station, Italy
  • Daniel Stec, Institute of Systematics and Evolution of Animals of the Polish Academy of Sciences, Poland
  • Emilia Grzędzicka, Institute of Systematics and Evolution of Animals of the Polish Academy of Sciences, Poland
  • Igor Zelnik, University of Ljubljana, Slovenia

Endocrines:

  • Eva S. Liu, 1Harvard Medical School, USA 2Brigham and Women’s Hospital, USA

Fermentation:

  • Aleksandra Szydlowska, Warsaw University of Life Sciences (WULS), Poland
  • Mohamed Ali Abdel-Rahman, Al-Azhar University, Egypt

Fishes:

  • Andrew G. Jeffs, University of Auckland, New Zealand
  • Mohamed Samy-Kamal, Universitat d'Alacant, Spain

Foods:

  • Baskaran Stephen Inbaraj, Fu Jen Catholic University, Taiwan
  • Marzena Włodarczyk-Stasiak, University of Life Sciences in Lublin, Poland
  • Minaxi Sharma, Haute Ecole Provinciale de Hainaut-Condorcet, Belgium
  • Viviani Ruffo de Oliveira, Federal University of Rio Grande do Sul (UFRGS), Brazil

Genes:

  • Federico Manuel Giorgi, University of Bologna, Italy
  • Jan Bocianowski, Poznań University of Life Sciences, Poland
  • Magdalena Mroczek, Center for Cardiovascular Genetics and Gene Diagnostics, Switzerland

IJMS:

  • Keigi Fujiwara, University of Texas MD Anderson Cancer Center, USA
  • Tomasz W. Kaminski, University of Pittsburgh, USA
  • Takujiro Homma, Yamagata University, Japan
  • William Bryan Terzaghi, Wilkes University, United States
  • Zong-jie Cui, Beijing Normal University, China

Insects:

  • Abraão Almeida Santos, University of Florida, USA
  • Agata Kaczmarek, Polish Academy of Sciences, Poland
  • Miguel A. García-Martínez, Universidad Veracruzana, Mexico

Life:

  • Andrei S. Rodin, Diabetes and Metabolism Research Institute, USA
  • Kazuhiko Kotani, Jichi Medical University, Japan

Metabolites:

  • Jianing Mi, King Abdullah University of Science and Technology, Saudi Arabia
  • Nguyen Phuoc Long, Inje University College of Medicine, Republic of Korea
  • Xian Luo, University of Alberta, Canada

Pathogens:

  • Guillaume Fiches, Ohio State University, USA
  • Jianxuan Wu, Gilead Sciences, USA
  • Tomasz M. Karpiński, Poznań University of Medical Sciences, Poland

Plants:

  • Alicia Ayerdi Gotor, Institut Polytechnique UniLaSalle, France
  • Andrea Mastinu, University of Brescia, Italy
  • Edyta Paczos-Grzeda, University of Life Sciences in Lublin, Poland
  • Narayan Bhusal, Seoul National University, Republic of Korea
  • Mohsen Hesami, University of Guelph, Canada

Toxins:

  • Christian Müller, University of Greifswald, Germany
  • Margarita Fernández-Tejedor, IRTA, Spain

Vaccines:

  • Christian Napoli, “Sapienza” University of Rome, Italy
  • Federico Marchesi, University of Parma, Italy
  • Roger E. Thomas, University of Calgary, Canada

Veterinary Sciences:

  • Fun-In Wang, National Taiwan University, Taiwan
  • Valeria Grieco, University of Milan, Italy

About MDPI Awards:

In order to reward the academic community, especially young researchers and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.

To explore more MDPI awards, please click here.

14 August 2023
MDPI’s 2022 Best PhD Thesis Awards in Biology and Life Sciences—Winners Announced


MDPI’s Best PhD Thesis Awards are presented to recognize the young scholars who are judged to have completed the most outstanding PhD thesis in their field of research and to encourage them to continue their outstanding work and further contributions to their field.

We would like to warmly congratulate the winners of the 2022 Best PhD Thesis Awards and wish them success in their future research endeavors. MDPI will continue to enhance communication among scientists.

Brain Sciences:

  • “CYP2D in the Brain Alters Response to Drugs and Neurotoxins”
    by Marlaina R. Stocco, University of California, USA
  • “Neural Encoding of Prior Experience in Sensorimotor Behavior”
    by Nicolas Meirhaeghe, Institut de Neurosciences de la Timone, France
  • “Perinatal Stem Cell: Epigenetic, Biological and Differentiative Characteristics”
    by Giulia Gaggi, University "G.D'Annunzio" of Chieti-Pescara, Italy

Genes:

  • “Uncovering the Genetic Variation Involved in Asthma Exacerbations through Multiple Genomic Approaches”
    by Esther Herrera Luis, Universidad de La Laguna, Spain

Veterinary Sciences:

  • “Development of Novel Tools for Monitoring Antimicrobial Resistance in Complex Microbial Communities and Their Application to Improving Our Stewardship of Antimicrobials in Livestock”
    by Ashenafi Feyisa Beyi, Iowa State University, United States

About MDPI Awards:

In order to reward the academic community, especially young researchers and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.

To explore more MDPI awards, please click here.

14 August 2023
MDPI’s Best Paper Awards in Biology and Life Sciences—Winners Announced in 2022


The purpose of our Best Paper Awards is to promote and recognize the most impactful contributions published within MDPI journals.

The editors of each journal carefully selected reviews and research papers through a rigorous judging process based on criteria such as scientific merit, overall impact, and the quality of presentation.

We are honored to present the winners for the year 2022 in biology and life sciences, who were selected amongst extensive competition, and congratulate the authors for their outstanding scientific publications. MDPI will continue to provide support and recognition to the academic community.

Agronomy:

Biology:

Brain Sciences:

Diversity:

Genes:    

IJMS:     

Insects:  

Life:

Metabolites:          

MPs:

Pathogens:

Plants:

Toxins:

Vaccines:               

Veterinary Sciences:

About MDPI Awards:

In order to reward the academic community, especially young researchers and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.

To explore more MDPI awards, please click here.

9 August 2023
MDPI World Hepatitis Day Webinar 2023, Held on 28 July 2023

To commemorate the World Hepatitis Day 2023, MDPI organized a webinar on 28 July 2023 to encourage researchers to come together, take action, and highlight how the exchange of findings facilitates efforts to raise awareness of hepatitis. The low coverage of testing and treatment is the most important gap to be addressed to achieve the global elimination goals of hepatitis B virus (HBV) by 2030.

Session 1:

Speaker/Presentation
Introduction
Prof. Dr. Chia-Yen Dai
Achieving Elimination of Hepatitis C in Taiwan
Dr. Tan Yee Joo
Understanding the Functions of Hepatitis B Viral Proteins and Targeting Them in Antiviral Drug Development
Dr. Sheikh Mohammad Fazle Akbar
Standing at the Half-Way: An Analysis of “Elimination of Hepatitis by 2030” in Developed and Developing Countries
Q&A Session

 You can watch the recorded webinar below:

Session 2:

Speaker/Presentation
Introduction
Prof. Dr. John Tavis
The International Coalition to Eliminate HBV (ICE-HBV): Promoting Global Scientific Collaboration in HBV Cure Research
Prof. Dr. Mark A. Feitelson
Microbial Metabolites that Attenuate the Pathogenesis of Cancer and Autoimmunity
Prof. Dr. Natalia Osna
Hepatitis in HIV Infection
Q&A Session

 You can watch the recorded webinar below:

 Relevant Special Issues:

Pathogens
Research on Hepatitis B Virus: Past, Present, and Future
Edited by: Hyung Joon Yim
Submission deadline: 31 August 2023 

JPM
Novel Challenges and Therapeutic Options for Liver Diseases
Edited by: Guido Gerken
Submission deadline: 30 September 2023 

Medicina
Viral Hepatitis Research: Updates and Challenges
Edited by: Endrit Shahini, Antonio Giovanni Solimando and Antonella Argentiero
Submission deadline: 15 October 2023 

Cells
Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis: Molecular and Multicellular Control of Evolving Diseased States
Edited by: Jérôme Eeckhoute
Submission deadline: 15 February 2024 

Diagnostics
Diagnosis and Management of Liver Diseases—2nd Edition
Edited by: Jeong-Ju Yoo
Submission deadline: 30 September 2023 

Vaccines
Vaccination and Treatments against Viral Hepatitis: Achievements, Challenges and Perspectives
Edited by: Bárbara Vieira Do Lago and Vinicius M. Mello
Submission deadline: 15 October 2023

3 August 2023
Viruses | Invitation to Read Selected Papers from Editor’s Choice Articles


We are excited to present the latest edition of the Editor’s Choice Articles, where we shine a spotlight on exceptional research published in Viruses (ISSN: 1999-4915). As passionate advocates of scientific excellence, our team of scientific editors has carefully curated a selection of high-quality articles covering diverse topics in the virology community.

In this edition, you will find an array of fascinating studies exploring Baculovirus, HIV, Flavivirus, Rodent-Borne Viruses, Avian Influenza Viruses, Phage, Lyssavirus, Coronaviruses, SARS-CoV, Papillomavirus, and much more. To provide you with a glimpse into the essence of each research endeavor, every article is accompanied by a graphical abstract and a succinct summary.

Our Editor's Choice Articles not only celebrate groundbreaking discoveries, but also foster engagement within the scientific community. We look forward to your insights and feedback, as they are paramount to advancing our collective understanding of virology.

Dive into the latest advancements in virology research and join us in exploring the frontiers of science.

Global Metabolic Profiling of Baculovirus Infection in Silkworm Hemolymph Shows the Importance of Amino-Acid Metabolism
by Min Feng, Shigang Fei, Junming Xia, Mengmeng Zhang, Hongyun Wu, Luc Swevers and Jingchen Sun
Viruses 2021, 13(5), 841; https://doi.org/10.3390/v13050841
Available online: https://www.mdpi.com/1999-4915/13/5/841

Message from the Editor:

In this study, global metabolic changes associated with BmNPV infection in silkworm hemolymphs were analyzed to understand the interaction between the host metabolic responses and BmNPV infection. The results revealed a unique amino acid utilization process that was implemented during BmNPV infection, in which amino acid consumption was increased at 24 hours post infection, but its abundance recovered at 72 hours post infection. Furthermore, it was found that glycolysis and glutaminolysis are not essential during BmNPV infection.


Microglial HIV-1 Expression: Role in HIV-1 Associated Neurocognitive Disorders
by Hailong Li, Kristen A. McLaurin, Jessica M. Illenberger, Charles F. Mactutus and Rosemarie M. Booze
Viruses 2021, 13(5), 924; https://doi.org/10.3390/v13050924
Available online: https://www.mdpi.com/1999-4915/13/5/924

Message from the Editor:

In this study, two complementary studies were conducted to (1) evaluate the HIV-1 mRNA distribution pattern and major cell type expressing HIV-1 mRNA in HIV-1 transgenic (Tg) rats, and (2) validate our findings by developing and critically testing a novel biological system to model active HIV-1 infection in rats. The results showed that microglia were the predominant cell type expressing HIV-1 mRNA in the HIV-1 Tg rats. Within eight weeks of infection, EcoHIV rats exhibited neurocognitive impairments and synaptic dysfunction, which may have resulted from the activation of the NogoA-NgR3/PirB-RhoA signaling pathway and/or neuroinflammation.


An Absolutely Conserved Tryptophan in the Stem of the Envelope Protein E of Flaviviruses Is Essential for the Formation of Stable Particles
by Iris Medits, Franz X. Heinz and Karin Stiasny
Viruses 2021, 13(9), 1727; https://doi.org/10.3390/v13091727
Available online: https://www.mdpi.com/1999-4915/13/9/1727

Message from the Editor

Medits, Heinz, and Stiasny (2021) investigated the importance of tryptophan in different stages of the viral life cycle via a mutagenesis-based approach using tick-borne encephalitis virus (TBEV). The study shows that W421 does not play an important role in viral fusion-related processes, but is essential for virus assembly by establishing interactions that confer stability to infectious mature particles. As revealed by a resuscitating mutation in passaged virus mutants, these stabilizing interactions could also be provided by another large hydrophobic amino acid (leucine) at the same position.


Phylogenomic Characterization of Lopma Virus and Praja Virus, Two Novel Rodent-Borne Arteriviruses
by Bert Vanmechelen, Zafeiro Zisi, Sophie Gryseels, Joëlle Goüy de Bellocq, Bram Vrancken, Philippe Lemey, Piet Maes and Magda Bletsa
Viruses 2021, 13(9), 1842; https://doi.org/10.3390/v13091842
Available online: https://www.mdpi.com/1999-4915/13/9/1842

Message from the Editor:

The complete genome sequences of four new arterivirus variants belonging to two putative novel species were reported in this study. These new arteriviruses were discovered in African rodents and were given the names Lopma virus and Praja virus. Phylogenetic analysis shows that Lopma virus clusters in the subfamily Variarterivirinae, while Praja virus clusters near members of the subfamily Heroarterivirinae: the yet undescribed forest pouched giant rat arterivirus and hedgehog arterivirus 1.


The Pathobiology of H7N3 Low and High Pathogenicity Avian Influenza Viruses from the United States Outbreak in 2020 Differs between Turkeys and Chickens
by Miriã F. Criado, Christina M. Leyson, Sungsu Youk, Suzanne DeBlois, Tim Olivier, Mary Lea Killian, Mia L. Torchetti, Darren J. Parris, Erica Spackman, Darrell R. Kapczynski et al.
Viruses 2021, 13(9), 1851; https://doi.org/10.3390/v13091851
Available online: https://www.mdpi.com/1999-4915/13/9/1851

Message from the Editor:

In this study, Criado et al. (2021) reported clear differences in the pathobiology of avian influenza viruses (AIVs) in turkeys and chickens. Results showed that the H7N3 2020 low-pathogenicity avian influenza viruses (LPAIVs) and the high-pathogenicity avian influenza virus (HPAIV) were more infectious in turkeys than in chickens and were efficiently transmitted to contact turkeys but not chickens, corroborating the high susceptibility of turkeys to AIV infections. Other than that, the LPAIV with the NA stalk deletion was found to be more infectious in turkeys, but did not have enhanced infectivity in chickens.


Reduced Infection Efficiency of Phage NCTC 12673 on Non-Motile Campylobacter jejuni Strains Is Related to Oxidative Stress
by Jessica C. Sacher, Muhammad Afzal Javed, Clay S. Crippen, James Butcher, Annika Flint, Alain Stintzi and Christine M. Szymanski
Viruses 2021, 13(10), 1955; https://doi.org/10.3390/v13101955
Available online: https://www.mdpi.com/1999-4915/13/10/1955

Message from the Editor:

This investigation revealed a complex interplay between phage infectivity, oxidative stress, and flagellar motility in C. jejuni. The results indicated that the apparent dependence of phage NCTC 12673 on C. jejuni motility is not related to adsorption to the flagella, but instead can be explained by the phage’s reduced infection efficiency under conditions of oxidative stress. Moreover, evidence has demonstrated that the phage-encoded FlaGrab is phase-variable, and that variable expression of this protein may be linked to a mechanism by which the phage can tune its infectivity according to the oxidative-stress state of the cell.


Spillover of West Caucasian Bat Lyssavirus (WCBV) in a Domestic Cat and Westward Expansion in the Palearctic Region
by Stefania Leopardi, Ettore Barneschi, Giuseppe Manna, Barbara Zecchin, Pamela Priori, Petra Drzewnioková, Francesca Festa, Andrea Lombardo, Fabio Parca, Dino Scaravelli et al.
Viruses 2021, 13(10), 2064; https://doi.org/10.3390/v13102064
Available online: https://www.mdpi.com/1999-4915/13/10/2064

Message from the Editor:

In June 2020, a cat from Arezzo (Italy) that died from a neurological disease was diagnosed with West Caucasian Bat Lyssavirus (WCBV). People that were exposed to the cat received full post-exposure prophylaxis, while animals underwent six months of quarantine. In a tunnel located near the cat’s house, a group of bent-winged bats that had shown virus-neutralizing antibodies to WCVB across four sampling occasions was identified, but no virus was found in salivary swabs.


Evolution of Anti-RBD IgG Avidity following SARS-CoV-2 Infection
by Alexandra Tauzin, Gabrielle Gendron-Lepage, Manon Nayrac, Sai Priya Anand, Catherine Bourassa, Halima Medjahed, Guillaume Goyette, Mathieu Dubé, Renée Bazin, Daniel E. Kaufmann et al.
Viruses 2022, 14(3), 532; https://doi.org/10.3390/v14030532
Available online: https://www.mdpi.com/1999-4915/14/3/532

Message from the Editor:

Tauzin et al. (2022) developed a simple assay to measure the avidity of anti-receptor-binding domain (RBD) IgG elicited by SARS-CoV-2 infection. It was observed that, while the level of antibodies declined over time, the anti-RBD avidity progressively increased and correlated with the B cell class switch. Additionally, it was observed that anti-RBD avidity increased similarly after SARS-CoV-2 mRNA vaccination and after SARS-CoV-2 infection.


Depo Medroxyprogesterone (DMPA) Promotes Papillomavirus Infections but Does Not Accelerate Disease Progression in the Anogenital Tract of a Mouse Model
by Jiafen Hu, Sarah A. Brendle, Jingwei J. Li, Vonn Walter, Nancy M. Cladel, Timothy Cooper, Debra A. Shearer, Karla K. Balogh and Neil D. Christensen
Viruses 2022, 14(5), 980; https://doi.org/10.3390/v14050980
Available online: https://www.mdpi.com/1999-4915/14/5/980

Message from the Editor:

In this study, a mouse papillomavirus (MmuPV1) anogenital infection model was used to test two hypotheses: (1) contraceptives such as DMPA increase the susceptibility of the anogenital tract to viral infection and (2) long-term contraceptive administration induces more advanced disease at the anogenital tract. From the experiment’s results, DMPA promoted initial papillomavirus infections in the lower genital tract, and the chronic administration of DMPA did not promote cancer development in the infected tissues in our mouse model.


SARS CoV-2 (Delta Variant) Infection Kinetics and Immunopathogenesis in Domestic Cats
by Miruthula Tamil Selvan, Sachithra Gunasekara, Ping Xiao, Kristen Griffin, Shannon R. Cowan, Sai Narayanan, Akhilesh Ramachandran, Darren E. Hagen, Jerry W. Ritchey, Jennifer M. Rudd et al.
Viruses 2022, 14(6), 1207; https://doi.org/10.3390/v14061207
Available online: https://www.mdpi.com/1999-4915/14/6/1207

Message from the Editor:

A feline model was established to study COVID-19 disease progression, and this model was utilized to evaluate infection kinetics and immunopathology of the rapidly circulating Delta variant (B.1.617.2) of SARS-CoV-2. From the results, RNA sequencing of infected feline lung tissues identified upregulation of multiple gene pathways associated with cytokine–receptor interactions, chemokine signaling, and viral protein–cytokine interactions during acute infection with SARS-CoV-2. Weighted correlation network analysis (WGCNA) of differentially expressed genes identified several distinct clusters of dysregulated hub genes that are significantly correlated with both clinical signs and lesions during acute infection.


Origins and Evolution of Seasonal Human Coronaviruses
by James R. Otieno, Joshua L. Cherry, David J. Spiro, Martha I. Nelson and Nídia S. Trovão
Viruses 2022, 14(7), 1551; https://doi.org/10.3390/v14071551
Available online: https://www.mdpi.com/1999-4915/14/7/1551

Message from the Editor:

In this study, the evolutionary histories of seasonal human coronaviruses (sHCoVs) were found to be highly complex, owing to the frequent recombination of CoVs, including within and between sHCoVs, and uncertain, due to the under sampling of non-human viruses. The recombination rate was highest for 229E and OC43, whereas substitutions per recombination event were highest in NL63 and HKU1. Additionally, OC43 may have ungulate, canine, or rabbit CoV ancestors, while 229E may have origins in bat, camel, or unsampled intermediate hosts, depending on the gene studied.


Increased Polymerase Activity of Zoonotic H7N9 Allows Partial Escape from MxA
by Philipp P. Petric, Jacqueline King, Laura Graf, Anne Pohlmann, Martin Beer and Martin Schwemmle
Viruses 2022, 14(11), 2331; https://doi.org/10.3390/v14112331
Available online: https://www.mdpi.com/1999-4915/14/11/2331

Message from the Editor:

The objective of this study was to determine whether the H7N9 can adapt to escape MxA-mediated restriction. From the results, it showed that viral polymerase activity-enhancing mutations can partially overcome the antiviral activity of MxA against zoonotic H7N9. However, in patients and in an experimental infection model, no true MxA escape mutations were detected, suggesting that, fortunately, MxA still seems to pose a high human species barrier for H7N9.


SIV Infection Regulates Compartmentalization of Circulating Blood Plasma miRNAs within Extracellular Vesicles (EVs) and Extracellular Condensates (ECs) and Decreases EV-Associated miRNA-128
by Steven Kopcho, Marina McDew‑White, Wasifa Naushad, Mahesh Mohan and Chioma M. Okeoma
Viruses 2023, 15(3), 622; https://doi.org/10.3390/v15030622
Available online: https://www.mdpi.com/1999-4915/15/3/622

Message from the Editor:

This study aimed to (i) investigate the abundance and compartmentalization of exmiRNAs in EVs versus ECs in the healthy uninfected state and (ii) evaluate how SIV infection may affect exmiRNA abundance and compartmentalization in these particles. The data showed that SIV infection altered the profile of the miRNAome of EVs and revealed that miR-128-3p may be a potential target of HIV/SIV. The significant decrease in miR-128-3p in HIV-infected humans and in SIV-infected RMs may indicate disease progression.

29 July 2023
Viruses | Top Cited Papers in 2021–2022 Related to SARS-CoV-2 Host Cell Interactions

“TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein”
by Mai Kishimoto, Kentaro Uemura, Takao Sanaki, Akihiko Sato, William W. Hall, Hiroaki Kariwa, Yasuko Orba, Hirofumi Sawa and Michihito Sasaki
Viruses 2021, 13(3), 384; https://doi.org/10.3390/v13030384
Available online: https://www.mdpi.com/1999-4915/13/3/384

“Quinine Inhibits Infection of Human Cell Lines with SARS-CoV-2”
by Maximilian Große, Natalia Ruetalo, Mirjam Layer, Dan Hu, Ramona Businger, Sascha Rheber, Christian Setz, Pia Rauch, Janina Auth, Maria Fröba et al.
Viruses 2021, 13(4), 647; https://doi.org/10.3390/v13040647
Available online: https://www.mdpi.com/1999-4915/13/4/647

“mRNA-lncRNA Co-Expression Network Analysis Reveals the Role of lncRNAs in Immune Dysfunction during Severe SARS-CoV-2 Infection”
by Sumit Mukherjee, Bodhisattwa Banerjee, David Karasik and Milana Frenkel-Morgenstern
Viruses 2021, 13(3), 402; https://doi.org/10.3390/v13030402
Available online: https://www.mdpi.com/1999-4915/13/3/402

“The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner”
by Victoria Callahan, Seth Hawks, Matthew A. Crawford, Caitlin W. Lehman, Holly A. Morrison, Hannah M. Ivester, Ivan Akhrymuk, Niloufar Boghdeh, Rafaela Flor, Carla V. Finkielstein et al.
Viruses 2021, 13(6), 1062; https://doi.org/10.3390/v13061062
Available online: https://www.mdpi.com/1999-4915/13/6/1062

“Modeling within-Host SARS-CoV-2 Infection Dynamics and Potential Treatments”
by Mehrshad Sadria and Anita T. Layton
Viruses 2021, 13(6), 1141; https://doi.org/10.3390/v13061141
Available online: https://www.mdpi.com/1999-4915/13/6/1141

“Resveratrol and Pterostilbene Inhibit SARS-CoV-2 Replication in Air–Liquid Interface Cultured Human Primary Bronchial Epithelial Cells”
by Bram M. ter Ellen, Nilima Dinesh Kumar, Ellen M. Bouma, Berit Troost, Denise P. I. van de Pol, Heidi H. van der Ende-Metselaar, Leonie Apperloo, Djoke van Gosliga, Maarten van den Berge, Martijn C. Nawijn et al.
Viruses 2021, 13(7), 1335; https://doi.org/10.3390/v13071335
Available online: https://www.mdpi.com/1999-4915/13/7/1335

“SARS-CoV-2 N Protein Targets TRIM25-Mediated RIG-I Activation to Suppress Innate Immunity”
by Gianni Gori Savellini, Gabriele Anichini, Claudia Gandolfo and Maria Grazia Cusi
Viruses 2021, 13(8), 1439; https://doi.org/10.3390/v13081439
Available online: https://www.mdpi.com/1999-4915/13/8/1439

“Robust Neutralizing Antibody Levels Detected after Either SARS-CoV-2 Vaccination or One Year after Infection”
by Stefan Glöckner, Franziska Hornung, Michael Baier, Sebastian Weis, Mathias W. Pletz, Stefanie Deinhardt-Emmer, Bettina Löffler and the CoNAN Study Group
Viruses 2021, 13(10), 2003; https://doi.org/10.3390/v13102003
Available online: https://www.mdpi.com/1999-4915/13/10/2003

“Macrophages and Monocytes: “Trojan Horses” in COVID-19”
by Elena Percivalle, Josè Camilla Sammartino, Irene Cassaniti, Eloisa Arbustini, Mario Urtis, Alexandra Smirnova, Monica Concardi, Cristina Belgiovine, Alessandro Ferrari, Daniele Lilleri et al.
Viruses 2021, 13(11), 2178; https://doi.org/10.3390/v13112178
Available online: https://www.mdpi.com/1999-4915/13/11/2178

“SARS-CoV-2 Infects Human ACE2-Negative Endothelial Cells through an αvβ3 Integrin-Mediated Endocytosis Even in the Presence of Vaccine-Elicited Neutralizing Antibodies”
by Antonella Bugatti, Federica Filippini, Marta Bardelli, Alberto Zani, Paola Chiodelli, Serena Messali, Arnaldo Caruso and Francesca Caccuri
Viruses 2022, 14(4), 705; https://doi.org/10.3390/v14040705
Available online: https://www.mdpi.com/1999-4915/14/4/705

27 July 2023
MDPI Insights: The CEO’s Letter #2 - Open Peer-Review and IJERPH

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Open Peer Review Reports

Continuing the topic of openness from my inaugural monthly CEO letter, in these Opening Thoughts, I highlight the growth and importance of open peer-review reports at MDPI. Open peer reports align with the principles of open science, making the publishing process more transparent and facilitating rigorous peer review.

MDPI journals operate an open peer-review option by default, allowing authors to publish review reports and author responses (often referred to as open reports) together with the published paper. Publishing the reviewer reports and author responses together with the article provides greater transparency and trust for readers, as this allows them to track the editorial decision-making process. Open peer-review also encourages reviewers and editors to provide high-quality comments, as these will be made public if the article is accepted for publication.

Start and Growth of Open Peer Review at MDPI

The MDPI journal Life was a pioneer in offering this opportunity to its authors in 2014. The first MDPI article with peer-review reports openly published was a review by the Nobel Laureate Werner Arber, in which the review reports were published as supplementary material. By 2018, open peer-review was available across all MDPI journals. As such, MDPI authors have embraced the open peer-review model, providing a steady increase in the number of MDPI articles. As of 2023, approximately one-third (34.0%) of MDPI articles were published with open review reports.

As at July 2023, the percentage of MDPI articles published with open peer review has increased to 36.2% of the total papers published in 2023 so far, indicating ongoing growth in adoption.

Open peer review continues to play a critical role in the assessment of the peer-review process in Life. For further insights, please see the recent editorial by Dr. Pabulo Henrique Rampelotto, the former Editor-in-Chief of Life, who spearheaded the implementation of the open peer-review process.

Benefits of Open Peer Review

The benefits of open peer review include increased transparency, trust and constructive feedback. To promote open communication further and increase the robustness of the peer-review process, we encourage reviewers to sign their reports so that their name appears on the review report (this process is referred to as open identity). The default option is for reviewers to remain anonymous; however, by signing the reports, reviewers receive direct credit for their contribution to the peer-review process and show their commitment towards open science.

As the leading open access publisher, MDPI remains committed to promoting open peer-review and encourages authors to choose this approach. Our goal is to provide a rigorous and transparent peer-review process that benefits the scientific community, and we believe that open peer-review is a vital step in fostering openness and collaboration in scientific communication.

Impactful Research

MDPI Papers Cited in the News – IJERPH edition

Every month, our corporate marketing team compiles data from Altmetrics to create a list of MDPI papers that have been cited in the news. This list continues to grow as renowned news outlets regularly reference research published by MDPI in their articles.

During 2022, a total of 111,965 MDPI research papers were mentioned in prominent news outlets such as National Geographic, The Washington Post, Forbes, The Guardian, the BBC, CNN, Time, and Harvard Business Review.

Highly Cited Journal Publications

IJERPH, known for publishing impactful research, received the most news mentions among all MDPI journals in 2022, based on Altmetrics data:

  • International Journal of Environmental Research and Public Health: 3509 mentions
  • Nutrients: 2698 mentions
  • International Journal of Molecular Sciences: 1701 mentions
  • Journal of Clinical Medicine: 1131 mentions
  • Viruses: 1111 mentions

These numbers show the recognition and impact of the articles published in IJERPH. For a more detailed view of the journal’s most cited and viewed papers, you can visit here. In total, IJERPH has garnered over 28,000 mentions in prominent news outlets, and as at July 2023, an impressive count of over 17,000 papers cited 10 times or more. These figures highlight the impactful contribution of IJERPH publications to the scientific community.

Example of Recent Mentions

During May and June 2023, a noteworthy selection of articles from IJERPH was cited in news articles, including:

The Washington Post: “Bringing nature inside can improve your health. Here’s how to do it.”
IJERPH paper:Physiological Benefits of Viewing Nature: A Systematic Review of Indoor Experiments

Harvard Business Review: “How to Take Better Breaks at Work, According to Research
IJERPH paper:Canine-Assisted Therapy Improves Well-Being in Nurses

National Geographic: “Lyme disease is spreading fast—but a vaccine may be on the way
IJERPH paper:Range Expansion of Tick Disease Vectors in North America: Implications for Spread of Tick-Borne Disease

Inside MDPI

MDPI Develops an Artificial Intelligence Tool to Enhance the Peer-Review Process

At MDPI, we believe that rigorous peer-review is the corner-stone of high-quality academic publishing. We are grateful to the scholars who generously dedicate their time to peer-review articles submitted to MDPI journals. Their contributions are invaluable to the advancement of science.

Peer-review is a critical part of the publication process, ensuring that MDPI upholds the highest quality standards for the papers we publish. Every manuscript submitted to our journals undergoes a comprehensive peer-review process conducted by subject-matter experts.

To further enhance our peer-review process, our Data Analytics team has developed an Artificial Intelligence (AI) tool designed to support the selection of reviewers. This proprietary tool utilizes Natural Language Processing (NLP), a specially designed AI language model, to extract information from the title and abstract of submitted papers. It then searches our database for similar manuscripts and suggests potential reviewers based on this analysis. Integrated with MDPI's submission system (SuSy), the AI tool cross-references the suggested candidates with our reviewer database to verify their invitation status and availability.

The goal of this tool is to provide better targeted peer-review invitations, reducing the number of emails sent for each paper and increasing the efficiency of our editorial staff.

In the near future, our Data Analytics team plans to deploy similar AI projects to improve other critical aspects of our services, offering an enhanced experience to our authors and readers.

Click here to learn about MDPI’s review process, including procedures, responsibilities, and benefits.

Read more:

Coming Together for Science

The Future of IJERPH

On 5 July 2023, Prof. Dr. Paul B. Tchounwou, the founding Editor-in-Chief of IJERPH, along with five Section Editors in Chief (Prof. Dr. Germán Vicente-Rodríguez, Prof. Dr. Karl Goodkin, Prof. Dr. William A. Toscano, Prof. Dr. Jimmy T. Efird, and Prof. Dr. William Douglas Evans), gathered in Basel to discuss the future of the journal. The meeting provided an opportunity to address the recent decision by The Web of Science to delist IJERPH due to the journal failing the Content Relevance criterion, and propose best strategies that will ensure high scientific rigor as well as a clear scope and aim of IJERPH, going forward.

While the delisting is disappointing for IJERPH, as well as for our authors, academic editors, and the entire scientific community supporting our journal, we see it as an opportunity to reflect and prepare for the future direction of the journal.

Since its launch in 2004, IJERPH’s vision and mission have evolved to be more complete and comprehensive in engaging scientific communities. In light of this, we will refresh the journal’s aims and scope, ensuring they align with the organic expansion of IJERPH. Additionally, we will restructure the journal sections into broader categories, encouraging collaborative research and transdisciplinary approaches for authors. This is designed to foster collaboration and knowledge exchange among diverse fields, contributing to a holistic understanding of health promotion and disease prevention. We are confident that these next steps will enhance the scientific strength and societal impact of our journal.

Journal Achievements

In addition to the productive discussions, we took the time to celebrate some of the remarkable achievements of IJERPH, which I highlight below:

  • Founded by Prof. Dr. Paul B. Tchounwou in 2004
  • Indexed in PubMed in 2008
  • Received its first Impact Factor in 2012
  • Published its 5000th paper in 2017
  • Over 60,000 papers published as at June 30, 2023
  • 131,628,173 paper views in 2018–2022
  • Over 28,000 mentions in prominent news outlets
  • 17,000 papers cited 10 times or more as at June 30, 2023
  • No.1 journal in the 2022 Google Scholar Metrics in the category of Public Health
  • Awarded several editions of Young Investigator Awards, Travel Awards, and Outstanding Reviewer Awards since 2018.

These achievements showcase the journal’s significant contributions to the field and its impact on global health. We are proud of the exceptional work accomplished by the IJERPH team and look forward to building upon this success in the years to come.

Closing Thoughts

MDPI’s Impact in Spain

During the past month, I had the opportunity to visit our new office building in Barcelona, where I met with our local colleagues to discuss the ways we serve the scholarly community, particularly in Spain. The multi-functional office plays a vital role in supporting various business needs, including editorial, design, conference management, data analytics, journal relationship management, publishing partnerships, and collaborations with societies.

Spain holds a significant position in MDPI’s global market, ranking as the fourth-largest contributor to the total number of papers published by MDPI as at July 2023, ranking next to Italy, the USA, and China, with Germany completing the top five.

The Numbers

Out of the 1,680,000 total MDPI articles published as at 25 July, almost 80,000 articles are contributed by Spanish authors, representing nearly 40,000 unique authors affiliated with Spanish institutions. Remarkably, over 6,300 of these authors hold editorial board member (EBM) positions within MDPI journals, with 30 of them serving as Editors-in-Chief (EiCs).

Our commitment to working with institutions is very evident in Spain, where we have successfully established over 40 Institutional Open Access Programs (IOAP) with esteemed institutions such as the University of Barcelona, the Autonomous University of Barcelona, Pompeu Fabra University, the University of Navarre, and Complutense University of Madrid.

Over the past five years, we have successfully organized eight in-person conferences in Barcelona, attracting over 1,150 registrations, with two forthcoming events scheduled for 2024. Barcelona's excellent connectivity to international airports makes it easily accessible to participants from around the world. Its welcoming atmosphere provides us with the perfect environment for knowledge-sharing, networking, and contributing to the local economy.

Our growth and presence in Spain are a true testament to the incredible service we provide to the scholarly community and the relationships we foster through responsive and collaborative communication. We look forward to continuing to support Spanish scholars, providing them a valuable and trusted experience with MDPI, the leader in open access publishing.

Testimonials

I close this letter as I did in the first edition, by sharing testimonials from our stakeholders. Here are a few IJERPH testimonials from a Spanish guest editor and an author:

Guest Editor
“I want to thank the kindness, attention and professionalism of the MDPI team throughout the editorial process of the Special Issue. I believe that it is a very professional and quality editorial process.”
- Professor Víctor Arufe-Giráldez, University of A Coruña
Special Issue in International Journal of Environmental Research and Public Health: Physical Activity in Childhood and Adolescence
Special Issue in International Journal of Environmental Research and Public Health: Physical Education: Present and Future
__
Author
“I want to thank the rigor of the revisions made to the manuscripts to improve their quality, the support to the authors for the editor assignment system they have and the follow-up they carry out, for the speed in answering and in carrying out the entire process of the revision, and for doing all this at an affordable price.”
- Dr. María Paz García-Caro, University of Granada
Article in International Journal of Environmental Research and Public Health: Factors Associated with Suicide Attempts and Suicides in the General Population of Andalusia (Spain)

Stefan Tochev
Chief Executive Officer
MDPI AG

19 July 2023
Meet Us at the 12th International Congress of Plant Pathology, 20–25 August 2023, Lyon, France


MDPI will attend the 12th International Congress of Plant Pathology. This event will be held from 20 to 25 August 2023 in Lyon, France, and is hosted by the International Society for Plant Pathology.

Plant pathologists and plant health researchers from around the world will meet to discuss their latest research as well as the current and future issues facing plant health experts. The host, the French Phytopathological Society, has set an exciting and challenging theme for the congress: “One Health for all plants, crops and trees”. This topic promises to provide a broad platform for talks, posters, and discussions that consider the integral nature of plant health with human, animal, and environmental health. In addition to an excellent program of keynote talks, concurrent sessions, poster presentations, and networking opportunities, there will be a number of satellite events before the meeting dates to provide opportunities for deeper discussions on a number of topics.

The following MDPI journals will be represented:

If you plan on attending this conference, please feel free to stop by our booth and start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://www.icpp2023.org/.

18 July 2023
Viruses | Top Cited Papers in 2021 Related to Phage Therapy


“Phage Therapy Related Microbial Succession Associated with Successful Clinical Outcome for a Recurrent Urinary Tract Infection”
by Austen Terwilliger, Justin Clark, Maile Karris, Haroldo Hernandez-Santos, Sabrina Green, Saima Aslam and Anthony Maresso
Viruses 2021, 13(10), 2049; https://doi.org/10.3390/v13102049
Available online: https://www.mdpi.com/1999-4915/13/10/2049

“Bacteriophage Rescue Therapy of a Vancomycin-Resistant Enterococcus faecium Infection in a One-Year-Old Child following a Third Liver Transplantation”
by Kevin Paul, Maya Merabishvili, Ronen Hazan, Martin Christner, Uta Herden, Daniel Gelman, Leron Khalifa, Ortal Yerushalmy, Shunit Coppenhagen-Glazer, Theresa Harbauer et al.
Viruses 2021, 13(9), 1785; https://doi.org/10.3390/v13091785
Available online: https://www.mdpi.com/1999-4915/13/9/1785

“The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies”
by Dan Liu, Jonas D. Van Belleghem, Christiaan R. de Vries, Elizabeth Burgener, Qingquan Chen, Robert Manasherob, Jenny R. Aronson, Derek F. Amanatullah, Pranita D. Tamma and Gina A. Suh
Viruses 2021, 13(7), 1268; https://doi.org/10.3390/v13071268
Available online: https://www.mdpi.com/1999-4915/13/7/1268

“A Case of Phage Therapy against Pandrug-Resistant Achromobacter xylosoxidans in a 12-Year-Old Lung-Transplanted Cystic Fibrosis Patient”
by David Lebeaux, Maia Merabishvili, Eric Caudron, Damien Lannoy, Leen Van Simaey, Hans Duyvejonck, Romain Guillemain, Caroline Thumerelle, Isabelle Podglajen, Fabrice Compain et al.
Viruses 2021, 13(1), 60; https://doi.org/10.3390/v13010060
Available online: https://www.mdpi.com/1999-4915/13/1/60

“A Design of Experiment Approach to Optimize Spray-Dried Powders Containing Pseudomonas aeruginosaPodoviridae and Myoviridae Bacteriophages”
by Emilie Tabare, Tea Glonti, Christel Cochez, Cyrille Ngassam, Jean-Paul Pirnay, Karim Amighi and Jonathan Goole
Viruses 2021, 13(10), 1926; https://doi.org/10.3390/v13101926
Available online: https://www.mdpi.com/1999-4915/13/10/1926

“Characterization of Anti-Bacterial Effect of the Two New Phages against Uropathogenic Escherichia coli
by Lívia Slobodníková, Barbora Markusková, Michal Kajsík, Michal Andrezál, Marek Straka, Adriána Liptáková and Hana Drahovská
Viruses 2021, 13(7), 1348; https://doi.org/10.3390/v13071348
Available online: https://www.mdpi.com/1999-4915/13/7/1348

“Past and Future of Phage Therapy and Phage-Derived Proteins in Patients with Bone and Joint Infection”
by Tristan Ferry, Camille Kolenda, Thomas Briot, Aubin Souche, Sébastien Lustig, Jérôme Josse, Cécile Batailler, Fabrice Pirot, Mathieu Medina, Gilles Leboucher et al.
Viruses 2021, 13(12), 2414; https://doi.org/10.3390/v13122414
Available online: https://www.mdpi.com/1999-4915/13/12/2414

“Phage Therapy Experience at the Eliava Phage Therapy Center: Three Cases of Bacterial Persistence”
by Elisabed Zaldastanishvili, Lika Leshkasheli, Mariam Dadiani, Lia Nadareishvili, Lia Askilashvili, Nino Kvatadze, Marina Goderdzishvili, Mzia Kutateladze and Nana Balarjishvili
Viruses 2021, 13(10), 1901; https://doi.org/10.3390/v13101901
Available online: https://www.mdpi.com/1999-4915/13/10/1901

“A Case of In Situ Phage Therapy against Staphylococcus aureus in a Bone Allograft Polymicrobial Biofilm Infection: Outcomes and Phage-Antibiotic Interactions”
by Brieuc Van Nieuwenhuyse, Christine Galant, Bénédicte Brichard, Pierre-Louis Docquier, Sarah Djebara, Jean-Paul Pirnay, Dimitri Van der Linden, Maya Merabishvili and Olga Chatzis
Viruses 2021, 13(10), 1898; https://doi.org/10.3390/v13101898
Available online: https://www.mdpi.com/1999-4915/13/10/1898

“Bacteriophage Therapy for Difficult-to-Treat Infections: The Implementation of a Multidisciplinary Phage Task Force (The PHAGEFORCE Study Protocol)”
by Jolien Onsea, Saartje Uyttebroek, Baixing Chen, Jeroen Wagemans, Cédric Lood, Laura Van Gerven, Isabel Spriet, David Devolder, Yves Debaveye, Melissa Depypere et al.
Viruses 2021, 13(8), 1543; https://doi.org/10.3390/v13081543
Available online: https://www.mdpi.com/1999-4915/13/8/1543

18 July 2023
Meet Us at the MDPI World Hepatitis Day Webinar 2023, 28 July 2023

The low coverage of testing and treatment is the most important gap to be addressed to achieve the global elimination goals of hepatitis B virus (HBV) by 2030. 

To commemorate the World Hepatitis Day 2023, MDPI is launching a special webinar to encourage researchers to come together, take action, and highlight how the exchange of findings facilitates efforts to raise awareness of hepatitis.

We are looking forward to seeing you at the MDPI World Hepatitis Day Webinar 2023. 

Conference secretariat: Ms. Shun Li
Date and time: 28 July 2023, 7:00 a.m. and 3:00 p.m., CEST

This is a free webinar. After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized. 

Unable to attend? Register anyway and we will let you know when the recording is available to watch. 

Session 1:

Speaker/Presentation Time in CEST
Introduction 7:00 a.m.–7:10 a.m.
Prof. Dr. Chia-Yen Dai
Achieving Elimination of Hepatitis C in Taiwan
7:10 a.m.–7:40 a.m.
Dr. Tan Yee Joo
Understanding the Functions of Hepatitis B Viral Proteins and Targeting Them in Antiviral Drug Development
7:40 a.m.–8:10 a.m.
Dr. Sheikh Mohammad Fazle Akbar
Standing at the Half-Way: An Analysis of “Elimination of Hepatitis by 2030” in Developed and Developing Countries
8:10 a.m.–8:40 a.m.
Q&A Session 8:40 a.m.–9:00 a.m.

Register for Session 1 for free!

Session 2:

Speaker/Presentation Time in CEST
Introduction 3:00 p.m.–3:10 p.m.
Prof. Dr. John Tavis
The International Coalition to Eliminate HBV (ICE-HBV): Promoting Global Scientific Collaboration in HBV Cure Research
3.10 p.m.–3:40 p.m.
Prof. Dr. Mark A. Feitelson
Microbial Metabolites that Attenuate the Pathogenesis of Cancer and Autoimmunity
3:40 p.m.–4:10 p.m.
Prof. Dr. Natalia Osna
Hepatitis in HIV Infection
4:10 p.m.–4:40 p.m.
Q&A Session 4:40 p.m.–5:00 p.m.

Register for Session 2 for free! 

Relevant Special Issues:
Pathogens
"Research on Hepatitis B Virus: Past, Present, and Future"
Edited by: Hyung Joon Yim
Submission deadline: 31 August 2023 

JPM
"Novel Challenges and Therapeutic Options for Liver Diseases"
Edited by: Guido Gerken
Submission deadline: 30 September 2023 

Medicina
"Viral Hepatitis Research: Updates and Challenges"
Edited by: Endrit Shahini, Antonio Giovanni Solimando and Antonella Argentiero
Submission deadline: 15 October 2023 

Cells
"Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis: Molecular and Multicellular Control of Evolving Diseased States"
Edited by: Jérôme Eeckhoute
Submission deadline: 15 February 2024 

Diagnostics
"Diagnosis and Management of Liver Diseases—2nd Edition"
Edited by: Jeong-Ju Yoo
Submission deadline: 30 September 2023 

Vaccines
"Vaccination and Treatments against Viral Hepatitis: Achievements, Challenges and Perspectives"
Edited by: Bárbara Vieira Do Lago and Vinicius M. Mello
Submission deadline: 15 October 2023

11 July 2023
MDPI’s Newly Launched Journals in June 2023

With the first issue released in June 2023, five new MDPI journals disseminating multi-disciplinary science are due to launch, which will cover the subjects of medicine & pharmacology, biology and physical sciences.

The newly launched journals will be overseen by professional Editorial Board Members and Editors to ensure an accurate and rapid publication, rigorous peer review and broad visibility.

Please feel free to browse and discover more about the new journals below.

Journal Founding Editor-in-Chief Journal topics (selected)
Prof. Dr. Jun Ma, Peking University, China| Editorial | view inaugural issue growth and development;
diet and nutrients; school health promotion policies and practices; child health and care; adolescent health and wellbeing | view journal scope | submit an article
Prof. Dr. Bernd Rehm, Griffith University, Australia | Editorial | view inaugural issue DNA and gene synthesis; synthetic transcription factors; protein engineering; viral engineering; metabolic engineering | view journal scope | submit an article
Prof. Dr. Varsha Gandhi, University of Texas MD Anderson Cancer Center, USA | Editorial | view inaugural issue lymphatics; cancers associated with lymphocytes and lymphoblasts; lymphatic tissues; lymphoma; lymphoid leukemia | view journal scope | submit an article
Dr. Bradley Turner, University of Melbourne, Australia | Editorial | view inaugural issue multiple sclerosis; amyotrophic lateral sclerosis; primary lateral sclerosis; atherosclerosis; systemic sclerosis | view journal scope | submit an article
Prof. Dr. Clemens Burda, Case Western Reserve University, USA | Editorial | view inaugural issue Gamma ray, X-ray, and UV–Vis spectroscopies; NIR/mid-infrared/Raman spectroscopy; microwave and THz spectroscopy; high-resolution gas-phase atomic, molecular, and cluster spectroscopy; MS, NMR, and EPR spectroscopy | view journal scope | submit an article

We wish to thank everyone who has supported the development of open access publishing. You are welcome to submit an application to the New Journal Committee (newjournal-committee@mdpi.com) if you would like to create more new journals.

3 July 2023
Viruses Received an Updated Impact Factor of 4.7, Ranked in Q2


We are pleased to inform you that the Viruses’ 2022 Impact Factor is 4.7. Viruses (ISSN: 1999-4915) now ranks Q2 (15 among 36 titles) in the “Virology” category. Our journal continues to build momentum in the virology community.

For more journal statistics, please visit https://www.mdpi.com/journal/viruses/stats.  

The Viruses Editorial Office would like to thank all authors, reviewers, and editors who have contributed to the journal.

3 July 2023
MDPI Insights: The CEO’s Letter #1 - Open Access and Impactful Research

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

The Future is Open, and MDPI is Leading the Way

I strongly believe in a future that embraces openness, where open source, open information, and open access (OA) take center stage. This belief that led me to join MDPI in 2020, and I am honored to have recently been appointed as Chief Executive Officer (CEO). In this capacity, and operating in close liaison with Dr. Lin and MDPI’s senior management, I shall work to build on Dr. Lin’s achievements of the past quarter-century. In this role, I will focus on communication initiatives to promote MDPI's remarkable work and continue to build our company as a trusted leader in OA publishing. For over two decades, MDPI has been at the forefront of reshaping the academic publishing landscape, with OA surpassing subscription-based publishing in 2020. This trajectory is deeply rooted in our history and reflects our unwavering commitment and vision for an open future.

1 Million Published Articles

2023 began with a remarkable achievement for MDPI, as we became the first OA publisher to reach the milestone of 1 million published articles. This represents 2.7 million unique authors who have trusted us with their work, or about a third of all researchers worldwide. As the world's most cited OA publisher, we are proud in sharing these significant milestones.

Our mission remains unchanged: to make science open and accessible to all. We understand the importance of knowledge access, empowering researchers to stay at the forefront of a rapidly changing world. Our diverse range of journals covers a wide spectrum of disciplines, offering cutting-edge insights, trusted tools, and crucial knowledge to address global challenges.

Liberating Science

As the world’s leading OA publisher, MDPI is actively liberating science. We are committed to eliminating the frustrations researchers and the general public face when accessing information, ensuring it is not locked behind paywalls. We firmly believe that everyone has a right to information, and our commitment to open access publishing drives our work.

In this inaugural edition of Insights: The CEO's Letter, I draw inspiration from the upcoming 20th anniversary of the Berlin Declaration on Open Access. Its stated mission reminds us that true impact is achieved when knowledge is widely and readily available to society:

"Our mission of disseminating knowledge is only half complete if the information is not made widely and readily available to society”

Impactful Research

MDPI Publishes Impactful Research: Recognized by Leading Indexing Databases

MDPI journals are indexed in every single top database in the world.

As of June 2023, we have 214 journals indexed within Web of Science, 223 indexed within Scopus, 87 indexed within PubMed and PMC, and 17 indexed within MEDLINE, and these numbers increase every month. We constantly strive to expand the coverage of our journals within leading multi-disciplinary and scope-specific databases, resulting in an incredibly broad range of journals that are indexed within a variety of databases. MDPI has active relationships with approximately 65 well-known databases around the world, and we continue to expand our portfolio every year so that your work can be found, cited, and referenced with ease.

Continued Growth of MDPI Journals

The 2022 Scopus and Web of Science journal citation metrics were officially released in June, and I am pleased to report that 31 MDPI journals received their first CiteScore, taking the total number of journals with a CiteScore to 216. The number of MDPI journals receiving an Impact Factor (IF) also continues to grow with 111 receiving their first, by being covered in the ESCI, bringing our total number of journals with an IF to 208 of which 41 journals received an IF above 4.0. Looking at 2022 CiteScores in the Scopus database, 80% of MDPI journals have a score that ranks them in Q1 or Q2 in at least one subject category.

Publishing impactful science would not be possible without all of our authors, editors and reviewers. Thank you for your contribution and continued support! Together we share the latest scientific insights faster and ensure that your work is accessible to all.

Read more

Interview with Indexing Manager—Constanze Shelhorn

Inside MDPI

Preprints.org: Clarivate adds the Preprint Citation Index to the Web of Science

At MDPI, we are dedicated to driving the advancement of science. Through our initiative, Preprints.org, researchers can publish their work and gain valuable feedback from the broader research community, ensuring rapid progress in their respective fields. This is particularly crucial during times of health and climate challenges, where timely dissemination of findings is essential.

Increased Visibility for Preprints

I am pleased to share that Clarivate recognizes the significance of preprints and has taken a crucial step to enhance their visibility. Clarivate has added the Preprint Citation Index to the Web of Science, encompassing preprints published not only on Preprints.org but also on other reputable repositories.

Looking ahead, the future of preprints appears promising, bolstered by the recent indexing announcement from the Web of Science. As a result, preprints will receive increased visibility, serving as a valuable resource for staying informed about the latest research developments.

Read more

What are Preprints?
The Pros and Cons of Preprints
Preprints and COVID-19
Preprints—The Future of Open Access Publishing?

Coming Together for Science

The First International Conference on Antioxidants: Sources, Methods, Health Benefits and Industrial Applications

In this edition of ‘Coming Together for Science,’ I am pleased to highlight the First International Conference on Antioxidants organized by our conference team in the beautiful city of Barcelona, Spain. The conference attracted over 130 attendees, who engaged in 42 talks, and 89 poster presentations spread across several sessions.

Working Together

Under the leadership of Prof. Dr. Alessandra Napolitano (Department of Chemical Sciences, University of Naples ‘Federico II’, Naples, Italy) and Prof. Dr. Rosa M. Lamuela Raventos (Department of Nutrition, Food Sciences and Gastronomy, University of Barcelona, Spain) as chairs, and supported by the committee members, 10 invited keynote speakers, poster presenters, and all the attendees, this dedicated group of academics came together to discuss the natural sources, methodologies, health benefits, and industrial applications of antioxidants.

Especially noteworthy is the positive feedback received from attendees, with 94% rating the overall organization of the conference as good or excellent. I particularly love the picture above, capturing the gathering of some of the participants. You can browse through more photos in the event gallery located here.

Managing Events With Sciforum

If you are considering hosting your own academic event, I highly recommend checking out Sciforum, MDPI's event management platform. Sciforum simplifies the entire process, making it easy to host your own event by allowing you to focus on what really matters: Science!

Read more

Sciforum: forthcoming events
Spotlight on Antioxidants

Closing Thoughts

Stefan Tochev, Dr. Shu-Kun Lin, Dr. Eric O. Freed, Peter Roth, Wynne Wang, Allison Yang

Viruses and Editorial Quality: Acknowledging the Dedication of our Viruses Journal Team

During a June meeting with Dr. Eric O. Freed, the founding and current Editor-in-Chief of our journal Viruses, I was reminded of the exceptional dedication of our editorial board. Meeting with Eric is a pleasure, as he has a strong commitment and clear vision for the journal. Over the course of two days, we gained a deep understanding of the journal’s expectations and focus on strategic growth, editorial board representation, and engagement.

I am pleased to share that Viruses holds a CiteScore of 7.1 (an increase of 7.57% versus the 2021 metric) and an Impact Factor of 4.7. You can view the journal statistics here. Viruses publishes highly cited papers, and is indexed in renowned databases such as Scopus, SCIE (Web of Science), PubMed, and others, and maintains affiliations with prestigious societies. Moreover, the Viruses team has recently announced an exciting upcoming event titled ‘Viruses 2024 – A World of Viruses,’ scheduled to take place in Barcelona, Spain, from 14–16 February 2024.

Testimonials

If you notice my enthusiasm regarding our editorial service, it’s because the surveys and testimonials we receive speak volumes about the experiences of our authors, reviewers, and guest editors who collaborate with MDPI. The purpose of these letters is to highlight the exceptional work that we do and the experiences we create for the scholars – thus, let me end with this testimonial from an author:

“It was a great pleasure to publish in Viruses Special Issue [Emerging Viruses in Aquaculture]. The submission process was easy. Guest editors were very helpful and provided all the guidance and support as needed. The handling of the manuscript by the Editorial Team was very fast, efficient, and professional. The reviewer’s comments were insightful, and the publication processes were remarkably rapid.”
Ms. Magdalena Stachnik, Państwowy Instytut Weterynaryjny | PIWet

Article in Viruses: Emerging Viral Pathogens in Sturgeon Aquaculture in Poland: Focus on Herpesviruses and Mimivirus Detection

Stefan Tochev
Chief Executive Officer
MDPI AG

28 June 2023
2022 Impact Factors for MDPI Journals

The 2022 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:

We are thrilled to announce that 90% of our ranked MDPI journals, specifically 86 out of 96 (captured in the table below), are performing above average in Q1 or Q2. This year, Clarivate has expanded its Impact Factor (IF) awards to include journals in the Emerging Sources Citation Index (ESCI) and the Arts and Humanities Citation Index (AHCI), providing greater transparency for the full set of journals indexed in the Web of Science Core Collection. As a result, 111 of MDPI journals have received their first IF in 2023, with 37 journals surpassing an IF of 3.0. In total, 208 MDPI journals have been honored with an IF.

Clarivate explains that by "expanding the coverage but holding to highly selective standards, the [Impact Factor] is now a reliable indicator of trustworthiness, as well as a measure of scholarly impact, at the journal level."

Please visit our blog post where we discuss the release of the latest citation metrics with our Indexing Manager, Dr. Constanze Schelhorn, to find out what's different this time around and how to make use of different metrics available.

Journal Impact Factor Rank Quartile Category
Vaccines 7.8 Q1 Immunology
Medicine, Research & Experimental
Antioxidants 7.0 Q1 Food Science & Technology
Biochemistry & Molecular Biology
Chemistry, Medicinal
Cells 6.0 Q2 Cell Biology
Nutrients 5.9 Q1 Nutrition & Dietetics
International Journal of Molecular Sciences 5.6 Q1 Biochemistry & Molecular Biology
Q2 Chemistry, Multidisciplinary
Journal of Theoretical and Applied Electronic Commerce Research 5.6 Q2 Business
Biomolecules 5.5 Q1 Biochemistry & Molecular Biology
Biosensors 5.4 Q1 Chemistry, Analytical
Instruments & Instrumentation
Q2 Nanoscience & Nanotechnology
Fractal and Fractional 5.4 Q1 Mathematics, Interdisciplinary Applications
Marine Drugs 5.4 Q1 Chemistry, Medicinal
Pharmacology & Pharmacy
Pharmaceutics 5.4 Q1 Pharmacology & Pharmacy
Nanomaterials 5.3 Q1 Physics, Applied
Q2 Chemistry, Multidisciplinary
Materials Science, Multidisciplinary
Nanoscience & Nanotechnology
Cancers 5.2 Q2 Oncology
Foods 5.2 Q1 Food Science & Technology
Polymers 5.0 Q1 Polymer Science
Remote Sensing 5.0 Q1 Geosciences, Multidisciplinary
Q2 Remote Sensing
Imaging Science & Photographic Technology
Environmental Sciences
Antibiotics 4.8 Q1 Pharmacology & Pharmacy
Q2 Infectious Diseases
Drones 4.8 Q2 Remote Sensing
Journal of Functional Biomaterials 4.8 Q2 Engineering, Biomedical
Materials Science, Biomaterials
Biomedicines 4.7 Q1 Pharmacology & Pharmacy
Q2 Biochemistry & Molecular Biology
Medicine, Research & Experimental
Journal of Fungi 4.7 Q2 Mycology
Microbiology
Viruses 4.7 Q2 Virology
Bioengineering 4.6 Q2 Engineering, Biomedical
Gels 4.6 Q1 Polymer Science
Molecules 4.6 Q2 Chemistry, Multidisciplinary
Biochemistry & Molecular Biology
Pharmaceuticals 4.6 Q2 Pharmacology & Pharmacy
Chemistry, Medicinal
Toxics 4.6 Q1 Toxicology
Q2 Environmental Sciences
Biomimetics 4.5 Q1 Engineering, Multidisciplinary
Q2 Materials Science, Biomaterials
Microorganisms 4.5 Q2 Microbiology
Plants 4.5 Q1 Plant Sciences
Biology 4.2 Q2 Biology
Chemosensors 4.2 Q2 Instruments & Instrumentation
Chemistry, Analytical
Electrochemistry
Membranes 4.2 Q2 Engineering, Chemical
Materials Science, Multidisciplinary
Chemistry, Physical
Polymer Science
Toxins 4.2 Q1 Toxicology
Q2 Food Science & Technology
Metabolites 4.2 Q2 Biochemistry & Molecular Biology
Batteries 4.0 Q2 Electrochemistry
Materials Science, Multidisciplinary
Q3 Energy & Fuels
Catalysts 3.9 Q2 Chemistry, Physical
Journal of Clinical Medicine 3.9 Q2 Medicine, General & Internal
Land 3.9 Q2 Environmental Studies
Sensors 3.9 Q2 Instruments & Instrumentation
Chemistry, Analytical
Engineering, Electrical & Electronic
Sustainability 3.9 Q2 Environmental Sciences (SCIE)
Environmental Studies (SSCI)
Q3 Green & Sustainable Science & Technology (SCIE)
Green & Sustainable Science & Technology (SSCI)
Buildings 3.8 Q2 Construction & Building Technology
Engineering, Civil
Agronomy 3.7 Q1 Agronomy
Q2 Plant Sciences
Fermentation 3.7 Q2 Biotechnology & Applied Microbiology
Pathogens 3.7 Q2 Microbiology
Agriculture 3.6 Q1 Agronomy
Diagnostics 3.6 Q2 Medicine, General & Internal
Genes 3.5 Q2 Genetics & Heredity
Journal of Intelligence 3.5 Q2 Psychology, Multidisciplinary
Lubricants 3.5 Q2 Engineering, Mechanical
Processes 3.5 Q2 Engineering, Chemical
Coatings 3.4 Q2 Materials Science, Coatings & Films
Physics, Applied
Q3 Materials Science, Multidisciplinary
ISPRS International Journal of Geo-Information 3.4 Q2 Geography, Physical
Q3 Computer Science, Information Systems
Remote Sensing
Materials 3.4 Q2 Metallurgy & Metallurgical Engineering
Physics, Applied
Physics, Condensed Matter
Q3 Materials Science, Multidisciplinary
Chemistry, Physical
Micromachines 3.4 Q2 Instruments & Instrumentation
Physics, Applied
Chemistry, Analytical
Q3 Nanoscience & Nanotechnology
Water 3.4 Q2 Water Resources
Environmental Sciences
Brain Sciences 3.3 Q3 Neurosciences
Energies 3.2 Q3 Energy & Fuels
Fire 3.2 Q1 Forestry
Q2 Ecology
Life 3.2 Q2 Biology
Current Issues in Molecular Biology 3.1 Q3 Biochemistry & Molecular Biology
Horticulturae 3.1 Q1 Horticulture
Animals 3.0 Q1 Agriculture, Dairy & Animal Science
Veterinary Sciences
Insects 3.0 Q1 Entomology
Atmosphere 2.9 Q3 Meteorology & Atmospheric Sciences
Environmental Sciences
Electronics 2.9 Q2 Engineering, Electrical & Electronic
Physics, Applied
Q3 Computer Science, Information Systems
Forests 2.9 Q1 Forestry
Inorganics 2.9 Q2 Chemistry, Inorganic & Nuclear
Journal of Marine Science and Engineering 2.9 Q1 Engineering, Marine
Q2 Oceanography
Engineering, Ocean
Metals 2.9 Q2 Metallurgy & Metallurgical Engineering
Q3 Materials Science, Multidisciplinary
Tropical Medicine and Infectious Disease 2.9 Q2 Tropical Medicine
Parasitology
Q3 Infectious Diseases
Universe 2.9 Q2 Astronomy & Astrophysics
Physics, Particles & Fields
Healthcare 2.8 Q2 Health Policy & Services (SSCI)
Q3 Health Care Sciences & Services (SCIE)
Applied Sciences 2.7 Q2 Engineering, Multidisciplinary
Physics, Applied
Q3 Chemistry, Multidisciplinary
Materials Science, Multidisciplinary
Crystals 2.7 Q2 Crystallography
Q3 Materials Science, Multidisciplinary
Entropy 2.7 Q2 Physics, Multidisciplinary
Magnetochemistry 2.7 Q2 Chemistry, Inorganic & Nuclear
Q3 Chemistry, Physical
Materials Science, Multidisciplinary
Symmetry 2.7 Q2 Multidisciplinary Sciences
Actuators 2.6 Q2 Instruments & Instrumentation
Engineering, Mechanical
Aerospace 2.6 Q1 Engineering, Aerospace
Behavioral Sciences 2.6 Q2 Psychology, Multidisciplinary
Current Oncology 2.6 Q3 Oncology
Machines 2.6 Q2 Engineering, Mechanical
Q3 Engineering, Electrical & Electronic
Medicina 2.6 Q3 Medicine, General & Internal
Separations 2.6 Q3 Chemistry, Analytical
Minerals 2.5 Q2 Mining & Mineral Processing
Mineralogy
Geochemistry & Geophysics
Children 2.4 Q2 Pediatrics
Diversity 2.4 Q2 Biodiversity Conservation
Q3 Ecology
Journal of Cardiovascular Development and Disease 2.4 Q3 Cardiac & Cardiovascular Systems
Mathematics 2.4 Q1 Mathematics
Photonics 2.4 Q3 Optics
Veterinary Sciences 2.4 Q1 Veterinary Sciences
Fishes 2.3 Q2 Marine & Freshwater Biology
Fisheries
Axioms 2.0 Q2 Mathematics, Applied
Systems 1.9 Q2 Social Sciences, Interdisciplinary
Tomography 1.9 Q3 Radiology, Nuclear Medicine & Medical Imaging


Note: The Journal of Personalized Medicine's Impact Factor was omitted in the original release and will be assigned separately. Please find the data on the journal webpage in due course.

Source: 2022 Journal Impact Factors, Journal Citation Reports TM (Clarivate, 2023)

 

13 June 2023
Viruses Receives an Increased CiteScore of 7.1


We are pleased to inform you that Viruses (ISSN: 1999-4915) has received an updated CiteScore of 7.1, an increase of 7.57% compared with the 2021 metric. The 2022 CiteScore™ was released recently, making an assessment of the scientific influence of journals in the 2019 to 2022 period.

Viruses CiteScore ranks as follows:

  • Q1 (74 out of 304 journals) in the “Infectious Diseases” category;
  • Q2 (29 out of 75 journals) in the “Virology” category.

For more journal statistics, please visit https://www.mdpi.com/journal/viruses/stats.

Excellent performance is inseparable from the support and dedication of all journal editors, reviewers, authors, and readers. We would like to take this opportunity to thank all of you who have contributed to the journal.

5 June 2023
Meet Us at the 42nd Annual Meeting of the American Society for Virology, 24–28 June 2023, Athens, Georgia, USA


MDPI journals will be attending the 42nd annual meeting of the American Society for Virology as an exhibitor. This meeting will be held in Athens, Georgia, USA from 24 to 28 June 2023.

The American Society for Virology (ASV) is a wonderful community that brings together virologists from all areas of the field. As a result, the annual meetings are rich in diverse scientific offerings and they can be quite large (sometimes over 1600 attendees). This conference is hosted by the University of Georgia and held at the Classic Center; the scientific program will include symposia, concurrent workshops, poster sessions, exhibits, and special events. Professional development activities and social events will be interspersed throughout the meeting.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference and our booth, please visit: https://asv.org/asv2023/.

7 April 2023
World Health Day–Health for All

On 7 April 2023—World Health Day, the World Health Organization (WHO) will observe its 75th anniversary. In 1948, countries of the world came together and founded the WHO to promote health, keep the world safe, and serve the vulnerable, so that everyone, everywhere, can attain the highest level of health and well-being. The WHO’s 75th anniversary is an opportunity to look back at public health successes that have improved quality of life over the last seven decades. It is also an opportunity to motivate action to tackle the health challenges of today and tomorrow. In order to encourage everyone to understand health and pay attention to health, we have also curated a list of publications on topics related to universal health coverage, healthy diet, and mental health. We also want to remind everyone that all research published in MDPI journals is available in an open access format, allowing practitioners, policy makers, and people around the world to access the latest scientific knowledge to build upon and share. Although we still have a long way to go to achieve universal health, this day also provides an opportunity to celebrate the progress made and inspire further action toward a more just and equitable world. Join us on a journey at MDPI to achieve Health for All.

Journal Recommendation

Section: Nutrition and Public Health

Special Issue: Dietary Antioxidants and Cardiovascular Health

Section: School Health

Topical Collection: Poxviruses

Special Issue: Disruptive Behavior Disorders: Symptoms, Evaluation and Treatment

Special Issue: Organophosphate-Induced Neurotoxicity: Countermeasures, Mechanisms, and Physiology

31 March 2023
Meet Us at the 8th European Congress of Virology 2023, 4–7 May 2023, Gdańsk, Poland


Conference: 8th European Congress of Virology 2023
Date: 4–7 May 2023
Location: Gdańsk, Poland

MDPI will be attending the 8th European Congress of Virology 2023 (ECV 2023) as an exhibitor, and we welcome researchers from different backgrounds to visit and share their latest ideas with us.

This conference is organized by the European Society for Virology. ECV 2023 will be a great opportunity for European virologists representing various fields of research to meet, present their results, and discuss all the developments in virology that have taken place during this unusual time. It will also be a great opportunity to meet friends, renew old acquaintances, and establish new collaborations. Although coronavirus studies will undoubtedly be one of the leading subjects at ECV 2023, it is important to have all research areas represented, including basic, clinical, veterinary, and plant virology. 

The following MDPI journals will be represented:

If you are planning to attend this conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.eusv-congress.eu/.

30 March 2023
Meet Us at the 2023 American Society for Microbiology Annual Meeting (ASM Microbe 2023), 15–19 June 2023, Houston, USA


The 2023 American Society for Microbiology Annual Meeting (ASM Microbe 2023) will be held in Houston, USA, from 15 to 19 June 2023. This annual meeting is the largest gathering of microbiologists in the world, and it is expected that nearly 8,000 professionals from all over the world will attend the meeting. Founded in 1899, the American Society for Microbiology (ASM) is the oldest and largest single life science society in the world, consisting of more than 50,000 scientists and health professionals, of which more than one-third of the members are from countries and regions outside the United States. The mission of the American Society for Microbiology is to promote and advance the science of microbiology.

Topics include:

  • Disaster Microbiology;
  • Emerging Infections – What is the next pandemic? (Focus on Nipah and Marburg);
  • Natural Product Discovery and Synthesis;
  • Combating the Climate Crisis with Critters: Microbial Carbon Capture;
  • Powering the Future: Applied Microbiology in the Energy Industry;
  • Equity and Access in Laboratory Diagnostics;
  • Microbiome Management in a Changing World.

The following MDPI journals will be represented:

  • Microorganisms;
  • Journal of Fungi;
  • Viruses;
  • Applied Biosciences;
  • MPs;
  • IJMS;
  • Vaccines;
  • Fermentation;
  • Diversity;
  • Metabolites;
  • Biomolecules;
  • Antibiotics;
  • Pathogens;
  • Life.

If you are attending this conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you at booth number #2504 in person and answering any questions you may have. For more information about the conference and our virtual booth, please visit the following link: https://asm.org/Events/ASM-Microbe/Home.

27 March 2023
Prof. Dr. Juan Carlos de la Torre Appointed Associate Editor of Section “Viral Immunology, Vaccines, and Antivirals” in Viruses

We are pleased to announce that Prof. Dr. Juan Carlos de la Torre has been appointed Associate Editor of the Section “Viral Immunology, Vaccines, and Antivirals” in Viruses (ISSN 1999-4915).


Name
: Prof. Dr. Juan Carlos de la Torre  

Affiliation: Department of Immunology and Microbiology IMM-6, Scripps Research, 10466 North Torrey Pines Road, La Jolla, CA 92037, USA

Interests: molecular, cell biology and pathogenesis of mammarenaviruses; virus-host cell interactions; antivirals; live attenuated vaccines

Homepage: https://www.scripps.edu/delatorre/research.html

 

Prof. Dr. Juan Carlos de la Torre is a Professor at the Department of Immunology and Microbiology at Scripps Research, Las Jolla, CA, USA. He obtained his Ph.D. in molecular biology and virology from the Universidad Autonoma de Madrid, Spain, in 1985. After conducting a postdoctoral research training with Dr. John Holland (UCSD) on evolution of RNA viruses, and subsequently with Dr. Michael Oldstone (Scripps Research) on viral pathogenesis, he joined the Scripps Research faculty in 1996. His research focuses on the molecular, cell biology and pathogenesis of mammarenaviruses, as well as the development of strategies, antivirals, and vaccines, to combat human pathogenic mammarenaviruses. Several mammarenaviruses cause hemorrhagic fever (HF) disease in humans and pose important public health problems in their endemic regions. In addition, the worldwide-distributed prototypic mammarenavirus LCMV is a neglected human pathogen. There are no FDA-licensed mammarenavirus vaccines and current anti-mammarenaviral therapy is limited to an off-label use of ribavirin whose efficacy remains controversial. His laboratory pioneered the development of mammarenavirus reverse genetics that has provided investigators with a novel and powerful approach for the investigation of mammarenavirus replication, gene expression, assembly and budding, as well as virus-host cell factor interactions that determine the infection outcome. These advances in mammarenavirus genetics also allow investigators to identify and characterize novel antiviral drugs, as well as implement novel vaccine platforms to combat human pathogenic mammrenaviruses.

The following is a short Q&A with Prof. Dr. Juan Carlos de la Torre, who shared his vision for the journal with us, as well as his views of the research area and Open Access publishing:

1. What appealed to you about the journal that made you want to take the role as its Associate Editor?

I have been serving as a reviewer for Viruses for some time and the scope of the journal, the overall quality of the papers being submitted there, as well as their review process, fit very well with my scientific interests and views about scientific publication.

2. What is your vision for the journal?

Viruses should focus on providing a publishing space for high-quality publications covering diverse areas of virology, while ensuring reasonable publication expenses for the authors and that the review process is timely.

3. What does the future of this field of research look like?

I think the future of virology will involve multidisciplinary collaborations, including large scale collaborative efforts. The combined expertise of different laboratories coordinated into effective collaborations can address complex problems in a timely manner that are beyond the capabilities of any single laboratory. This will pose new challenges for publication in terms of the mechanisms that will be implemented to appropriately recognize the contributions of each group and individuals.

4. What do you think of the development of Open Access in the publishing field?

In short, I am 100% in favor of Open Access in the publishing field.

13 March 2023
MDPI’s Newly Launched Journals in December 2022

As a leading open access publisher, MDPI provides scholars with a high-quality and rich academic exchange platform by continuously expanding into new and exciting research areas.

In December 2022, MDPI launched five new journals, covering multiple subjects such as life sciences, biology, medicine and pharmacology, social sciences and humanities. These new journals are being edited by established scholars across the world.

Journal

Founding Editor-in-Chief

Journal Topics (Selected)

Prof. Dr. Fabio Gresta, University of Messina, Italy| Editorial | view inaugural issue

grass/forage/turf production; grassland management; pasture monitoring; grazing and livestock; grass agro-ecosystems| view journal scope | submit an article

Prof. Dr. Christos G. Athanassiou, University of Thessaly, Greece| Editorial | view inaugural issue

pesticides; fungicides; herbicides; fertilizers; soil conditioners| view journal scope | submit an article

Prof. Dr. Stephen H. Safe, Texas A&M University, USA| Editorial | view inaugural issue

receptor structure; receptor function; receptor signaling; receptor expression and regulation; receptor interactions with drugs| view journal scope | submit an article

Dr. Jean Jacques Vanden Eynde, University of Mons-UMONS, Belgium| Editorial | view inaugural issue

drug discovery; medicinal chemistry; preclinical and clinical research; marketed drugs; intellectual property and regulatory affairs| view journal scope | submit an article

Prof. Dr. Heather Kanuka, University of Alberta, Canada| Editorial | view inaugural issue

higher education; tertiary education; policy and practice in higher education; educational leadership in higher education; educational administration and management in higher education| view journal scope | submit an article

If you are interested in creating more open access journals with us to publish cutting-edge research, please send your journal proposal application to newjournal-committee@mdpi.com.

7 March 2023
Displaying Co-Authors’ Email Addresses on the Webpage of Published Papers

MDPI is pleased to announce that we now display the co-authors’ email addresses in addition to the corresponding author’s email address on the webpage of published papers, protected by Captcha. For more information about this change, please visit the journal’s instructions for authors page. 

We believe this change will facilitate academic discussions and advance our cause of open science and research. The corresponding authors are responsible for communicating with their co-authors and indicating in our system (https://susy.mdpi.com/) if co-authors would prefer for their email addresses not to be displayed.

2 March 2023
Prof. Dr. Enzo Tramontano Appointed Associate Editor of Section “Viral Immunology, Vaccines, and Antivirals” in Viruses

We are pleased to announce that Prof. Dr. Enzo Tramontano has been appointed as the Associate Editor of the Section “Viral Immunology, Vaccines, and Antivirals” in Viruses (ISSN: 1999-4915).

Name: Prof. Dr. Enzo Tramontano

Affiliation: Chair, Department of Life and Environmental Sciences, University of Cagliari, Cittadella Universitaria di Monserrato SS554, Monserrato, 09042 Cagliari, Italy

Interests: virology; antiviral drugs; drug development; endogenous retroviruses; viral escape of innate immunity

Homepage: https://unica.it/unica/page/it/enzo_tramontano

Prof. Dr. Enzo Tramontano is a Professor of microbiology and Chair of the Department of Life and Environmental Sciences at the University of Cagliari (Italy), and is currently the Vice-President of the Italian Society for Virology (SIV-ISV). His research activities focus on the i) discovery and development of antiviral agents; ii) understanding the molecular mechanism of innate immunity viral evasion; iii) study of the expression of retroviral sequences stably integrated into human genomes to explore their physiological and pathological role.

The following is a short Q&A with Prof. Dr. Enzo Tramontano, who shared his vision for the journal with us, as well as his views of the research area and Open Access publishing:

1. What appealed to you about the journal that made you want to take the role as its Associate Editor?

It is a relatively new, well-respected international scientific journal with a dynamic Editor-in-Chief and a strong and diversified Editorial Board. I believe it will be an exciting task.

2. What is your vision for the journal?

The journal should be a platform of excellence for virology research, providing cutting-edge high-quality research papers and accurate review articles focused on prominent topics. In addition, I believe it must also contribute to inspiring a new generation of virologists with a passion for questions and discoveries, as well as the scientific rigor for investigating them.

3. What does the future of this field of research look like?

Viruses are an essential component of our planet. The COVID-19 pandemic has reminded us how they may impact our daily life, but their role far exceeds their pathological effects. Virology is a rising field in which new basic knowledge may lead to many novel technological advances, as it has already been proven historically.

4. What do you think of the development of Open Access in the publishing field?

The Open Access policy addresses the need of improving the diffusion of scientific information, speeding up technological innovation and boosting the benefits of public investment in research. Open Access may also improve the impact of science outside the scientific community, reaching a wider audience on relevant topics.

We wish Prof. Dr. Enzo Tramontano every success in his new position, and we look forward to his contributions to the journal.

16 February 2023
Increasing Visibility for Preprints.org – Clarivate adds the Preprint Citation Index to the Web of Science

On 9 February 2023, Clarivate, a global leader in providing trusted insights and analytics, added the Preprint Citation Index to the Web of Science platform, streamlining the research process by allowing researchers to locate and link to preprints alongside other trusted content in the database.

The Preprint Citation Index will act as a bridge to connect cutting-edge preprints with peer-reviewed journal articles published within the Web of Science Core Collection. Alerts can be easily set to monitor new research across several repositories and authors will also be able to include preprints on their Web of Science Research Profile to more accurately display their various research outputs.

As of its launch, the Preprint Citation Index will provide nearly two million preprints from various repositories, including MDPI’s own Preprints.org.

MDPI's Preprints Platform – Preprints.org

To advance Open Science and the fast dissemination of research, MDPI offers researchers a free multidisciplinary preprint platform. Preprints.org accepts submissions from all research areas and offers authors high visibility, permanent archiving, article-level Metrics and immediately citable content by assigning a Digital Object Identifier (DOI) to all preprints.

During submission to any MDPI journal, authors have the option to share their research as a preprint. After an initial screening, the manuscript is available online in 48 hours or less. Once online, preprints can be downloaded, shared, commented on, and cited, providing authors maximum visibility.

We invite you to join the ranks of the over 100k researchers using Preprints.org and share your research.

For more information, please visit Preprints.org.

9 January 2023
Prof. Dr. Shibo Jiang Appointed Associate Editor of the “SARS-CoV-2 and COVID-19” Section in Viruses

We are pleased to announce that Prof. Dr. Shibo Jiang has been appointed Associate Editor of the “SARS-CoV-2 and COVID-19” Section in Viruses (ISSN: 1999-4915). We wish Prof. Dr. Shibo Jiang every success in his new position and we look forward to his contributions to the journal.

Name: Prof. Dr. Shibo Jiang
Affiliation: Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Fudan University, Shanghai 200032, China
Interests: HIV; coronaviruses; viral fusion; viral entry; vaccine development
Homepage: https://www.kerafast.com/cat/796/shibo-jiang-md-phd

Research on the following topics is welcome in this Section:

  • COVID-19;
  • SARS-CoV-2;
  • Immunity;
  • Diseases;
  • Epidemiology and evolution;
  • Pneumonia;
  • Bat virus;
  • Vaccine design;
  • Antiviral drug design;
  • Treatment;
  • Diagnosis;
  • Prevention, prognosis and therapeutics;
  • Clinical, medical and medicina;
  • Public health research;
  • Reverse genetics;
  • Innate immunity;
  • Adaptive immunity;
  • Virus-host interactions;
  • Animal models.

For more information about the “SARS-CoV-2 and COVID-19” Section, please visit the following link: https://www.mdpi.com/journal/viruses/sections/SARS-CoV-2_and_COVID-19.

9 January 2023
Prof. Dr. Anthony V. Nicola Appointed Associate Editor of Section “Human Virology and Viral Diseases” in Viruses

We are pleased to announce that Prof. Dr. Anthony V. Nicola has been appointed Associate Editor of the “Human Virology and Viral Diseases” Section in Viruses (ISSN: 1999-4915). We wish Prof. Dr. Anthony V. Nicola every success in his new position and we look forward to his contributions to the journal.

Name: Prof. Dr. Anthony V. Nicola
Affiliation: Department of Veterinary Microbiology and Pathology, College of Veterinary Medicine, Washington State University, Pullman, WA, USA
Interests: virology; virus–cell interactions; viral entry; herpesviruses; herpes simplex virus; membrane fusion; viral glycoproteins
Homepage: https://vetmed.wsu.edu/our-team/profile/?nid=anthony.nicola

Viruses have caused some of the most dramatic and deadly disease pandemics and epidemics the world has known. Subsequently, most of these causing agents have become common viruses with different epidemiological trends. The most recent trend has focused on emerging and re-emerging viruses and our related preparedness and responses. However, human virology goes beyond (re)-emerging viral diseases. This Section aims at addressing all aspects of human viruses, medical virology, and virus-induced clinical diseases. All types of manuscripts addressing a broad range of topics including epidemiology, prevention, diagnostics, and treatment will be considered in this Section. Manuscripts must represent original and significant contributions.

Prof. Dr. Anthony V. Nicola has led a Special Issue for Viruses, “Viral Entry Pathways”, in which more than ten feature papers have been published.

For more information about the “Human Virology and Viral Diseases” Section, please visit the following link: https://www.mdpi.com/journal/viruses/sections/Human_Virology_Viral_Diseases.

9 January 2023
Prof. Dr. Satya Parida Appointed Associate Editor of Section “Animal Viruses” in Viruses

We are pleased to announce that Prof. Dr. Satya Parida has been appointed Associate Editor of the “Animal Viruses” Section in Viruses (ISSN: 1999-4915). We wish Prof. Dr. Satya Parida every success in his new position and we look forward to his contributions to the journal.

Name: Prof. Dr. Satya Parida
Affiliation: Laboratory and Vaccine Specialist, Food and Agriculture Organization of the United Nations, Rome, Italy
Interests: peste des petits ruminants virus; PPRV; FMDV; vaccines; pathogenesis of PPRV
Homepage: https://www.jenner.ac.uk/team/satya-parida

This Section concerns viruses infecting animals and mechanistic studies of viral structure, entry, gene expression, and genome replication, assembly, and exit. Studies on virus–host interactions, innate immune responses, viral transformation, viral transmission, population dynamics, and evolution are also considered in this Section.

Prof. Dr. Satya Parida is leading two Special Issues for Viruses, “Global Foot-and-Mouth Disease Control” and “Peste des Petits Ruminants (PPR) Eradication: Improved Understanding of Epidemiology, Diagnostics and Vaccine Efficacy, Volume II”, in which more than twenty feature papers have been published.

For more information about the “Animal Viruses” Section, please visit the following link: https://www.mdpi.com/journal/viruses/sections/animal_viruses.

9 January 2023
Prof. Dr. Akira Ono Appointed Associate Editor of Section “Animal Viruses” in Viruses

We are pleased to announce that Prof. Dr. Akira Ono has been appointed Associate Editor of the “Animal Viruses” Section in Viruses (ISSN: 1999-4915). We wish Prof. Dr. Akira Ono every success in his new position and we look forward to his contributions to the journal.

Name: Prof. Dr. Akira Ono
Affiliation: Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI 48109, USA
Interests: assembly of enveloped viruses including retroviruses; lipid membrane–protein interactions; RNA–protein interactions; cell contact-mediated virus spread; virion incorporation of host proteins
Homepage: https://medicine.umich.edu/dept/microbiology-immunology/akira-ono-phd

This Section concerns viruses infecting animals and mechanistic studies of viral structure, entry, gene expression, and genome replication, assembly, and exit. Studies on virus–host interactions, innate immune responses, viral transformation, viral transmission, population dynamics, and evolution are also considered in this Section.

Prof. Dr. Akira Ono has led two Special Issues for Viruses, “Role of Lipids in Virus Replication” and “The 11th International Retroviral Nucleocapsid and Assembly Symposium”, in which more than ten feature papers have been published.

For more information about the “Animal Viruses” Section, please visit the following link: 
https://www.mdpi.com/journal/viruses/sections/animal_viruses.

22 December 2022
Special Issue Mentor Program

We are pleased to announce the launch of a new initiative—the MDPI Special Issue Mentor Program.

This program will enable early career researchers (who must hold a Ph.D. in a related field) to experience editing a Special Issue in MDPI journals, under the mentorship of our experienced Editorial Board Members or other experienced scientists. The mentor program will provide an excellent opportunity for early career scientists to gain editorial experience, and to cultivate their ability to edit scientific research.

The mentee’s responsibilities include:

  • Proposing a Special Issue title and assisting the mentor in preparing a summary (around 200–400 words) and 3–10 keywords describing the background, importance, and goal of the Issue;
  • Writing a brief promotion plan for the Special Issue;
  • Preparing a list of scholars who may be interested in the Issue and personally e-mailing invitations on behalf of Guest Editors;
  • Writing an editorial for the online Special Issue together with the mentor.

The mentor’s responsibilities include:

  • Conducting a final check before the Special Issue is published online;
  • Performing editorial control of the Special Issue and quality control of the publications, both of which must be carried out in a timely manner;
  • Providing suggestions to younger scholars if they have any doubts or concerns regarding submissions;
  • Organizing video calls with young scholars and the Editorial Office regularly to discuss problems and improvement suggestions for the Special Issue;
  • Making and submitting decisions regarding submissions with the assistance of mentees.

Certificates and awards:
After the Special Issue closes, the Editorial Office will provide official certificates for all the mentors and early career researchers.

If you are interested in this opportunity, please send your Special Issue proposal to the Editorial Office of a journal you choose, and we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail. The full list of MDPI journals is as follows: https://www.mdpi.com/about/journals.

In addition to the new Special Issue Mentor Program, we will continue to welcome all Special Issue proposals focusing on hot research topics.

14 December 2022
"Thanks a Million!" – One Million Articles Published in MDPI Journals

MDPI has just become the first open access (OA) publisher to reach the milestone of one million articles published. That is one million articles freely available to all, to circulate and build upon! We are proud to share this special moment with the global scientific community.

This landmark has been reached thanks to the immeasurable support of more than 600,000 expert reviewers, 66,000 editorial board members and 6700 hard-working colleagues across MDPI’s global offices.

Within more than 25 years of publishing, our journals received 2.1 million manuscripts and generated 4.6 million peer review reports to get to one million papers published.

1 Million Infographic

Reaching the milestone of one million articles published reinforces our mission to remove any existing barriers and to make scientific research accessible to all. Since its inception, MDPI’s goal has been to create reliable processes to make science open. This is a path towards facilitating the dissemination of novel insights in scientific communities.

Regular feedback from authors and reviewers shows that our service is greatly appreciated and needed. At the same time, the feedback helps us identify areas for further improvement.

As it stands, a significant share of published research findings remain closed access. More than half of the content published with the most well-known legacy publishers stays behind a paywall, and that is not including articles published in hybrid OA journals, or made available months or years after publication.

A new policy announced by the US administration in August 2022 requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication. While the new policy does not mandate articles be published under an open access license, it is aligned with the open access movement in removing all barriers to research. Similarly, some of the most advanced research institutions in the world intend to have all funded research articles published in open access by 2025.

MDPI is proud to be the leading agent of the transition to open access.

"Thanks a Million" to all the contributors!

8 December 2022
MDPI Sustainability Foundation: New Look and Nominations for the 2023 Sustainability Awards Now Open

We are pleased to announce that the website of the MDPI Sustainability Foundation has been revamped! For the past couple of months, our UX UI team and front-end developers have been working hard to launch the website in time for the opening of the Sustainability Awards nominations.

The website is not the only thing that has had a remodeling. Indeed, the format of the Emerging Sustainability Leader Award (ESLA) has been updated. ESLA is now a competition open to individual researchers or start-ups founded by researchers under the age of 35. Nominee applications will go through 2 rounds of selection until the final 3 are decided. The finalists will then be invited to give pitch presentations during the Award Ceremony to win either first place (10,000 USD) or runner-up (2 x 5000 USD).

The World Sustainability Award, on the other hand, remains the same: a total prize money of 100,000 USD is up for grabs by senior individual researchers or groups of researchers from the international research community.

Nominations for both the World Sustainability Award and the Emerging Sustainability Leader award are now open! Check out our new website for more information on how to nominate.

5 December 2022
Viruses | Seeking Cooperation with Academic Conferences

Viruses (ISSN: 1999-4915) is an open access journal that provides an advanced forum for studies of viruses. It publishes reviews, regular research papers, communications, conference reports, and short notes. Our aim is to publish papers that have a significant impact on the virology community. We encourage scientists to publish their experimental and theoretical results in as much detail as possible.

The full experimental details must be provided so that the results can be reproduced. There is no restriction on the length of the papers. We also encourage the publication of timely reviews and commentaries on topics of interest to the virology community. Papers are either published in the open journal or in Special Issues devoted to specific topics of interest to the field. We accept proposals for review articles that are not part of Special Issues.

In order to support the scientific community and contribute to the faster distribution of important scientific research, Viruses has cooperated with various academic conferences and is now seeking cooperation with additional academic conferences. The journal is open to a diverse range of collaborations, such as media partnerships, awards, exhibitions, and publications.

The scope of Viruses includes, but is not limited to, the following:

  • Virus, viruses, virion, virology, virological, viral, viral infections, virologist;
  • Virus classification;
  • Virus-like agents, viroids, prions;
  • Bacteriophage;
  • Vaccines, viral immunology;
  • Antiviral drugs, antiviral therapy, antiviral drug development;
  • Origin of viruses, viral evolution;
  • Virus structures, genomes;
  • Virus dynamics, mathematical and simulation models of virus infections.

We welcome consultations with any conferences related to Viruses. If you are interested in collaborating with Viruses, please contact us at viruses@mdpi.com.

1 December 2022
Editorial Board Members from Viruses Featured in the 2022 Highly Cited Researchers List Published by Clarivate


Recently, ClarivateTM revealed its 2022 list of Highly Cited Researchers™—Individuals at universities, research institutes and commercial organizations.

The scientists who were selected into this year’s list of Highly Cited Researchers have published highly cited papers in the 11-year period from January 2011 to December 2021, with citation frequency in the top 1% of academic subjects and the same year of publication in the Web of ScienceTM database. Based on Web of Science Citation data, 6,938 researchers from across the globe who have demonstrated a disproportionate level of significant and broad influence in their chosen field or fields over the last decade have been awarded Highly Cited Researcher 2022 designations. The list is truly global, spanning 69 countries or regions and spread across a diverse range of research sciences and social sciences.

According to statistics, 8 members of the Editorial Board of Viruses (ISSN: 1999-4915) have been selected into the list of Highly Cited Researchers of Clarivate in 2022. They are being recognized for their high-quality scientific research achievements and outstanding contributions to professional fields. The Viruses journal office sincerely congratulates all elected Editorial Board Members and hopes that they continue to have an academically productive relationship with the journal.

Name

Affiliation

Prof. Dr. Ke Lan

Wuhan University, China

Prof. Dr. Mark J. Mulligan

NYU Langone Vaccine Center, USA

Prof. Dr. Nikos Vasilakis

University of Texas Medical Branch, USA

Prof. Dr. Stanley Perlman

University of Iowa, USA

Prof. Dr. Yu Chen

Wuhan University, China

Prof. Dr. Shibo Jiang

Fudan University, China

Prof. Dr. Stefan Pöhlmann

German Primate Center, Germany

Prof. Dr. Guy Smagghe

Ghent University, Belgium

8 November 2022
Editorial Board Members from Viruses Featured in Stanford’s List of the World’s Top 2% Scientists

Stanford University has recently published an update of the list of the top 2% most widely cited scientists—the World’s Top 2% Scientists.

The time node of the statistical data of this list is from 1960 to 2022, and it is divided into two lists: "Lifetime Scientific Influence Ranking" and "2022 Annual Scientific Influence Ranking". The "Lifetime Scientific Influence Ranking" counts the comprehensive influence performance of scientists during their careers, and the "2022 Annual Influence Ranking" focuses on highlighting the academic influence of scientists in the previous year. This ranking, considered the most prestigious worldwide, is based on the bibliometric information contained in the Scopus database and includes more than 200,000 researchers from the more than 10 million scientists considered to be active worldwide, with 22 scientific fields and 176 subfields taken into account.

We are pleased to share that 83 Editorial Board Members from MDPI’s journal Viruses (ISSN: 1999-4915) were featured in Stanford University’s list of World’s Top 2% Scientists in 2022.

Name

Affiliation

Dr. Akira Ono

University of Michigan, USA

Prof. Dr. Alexander Bukreyev

University of Texas Medical Branch, USA

Prof. Dr. Andrew Pekosz

Johns Hopkins University, USA

Prof. Dr. Alexander Ploss

Princeton University, USA

Prof. Dr. Artur Summerfield

Institute of Virology and Immunology (IVI), Switzerland

Prof. Dr. Ayato Takada

Hokkaido University, Japan

Prof. Dr. Barbara Baker

University of California, USA

Dr. Birke Bartosch

Centre de recherche en cancérologie de Lyon, France

Dr. Krisztián Bányai

Veterinary Medical Research Institute, Hungary

Dr. Covadonga Alonso

Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria, Spain

Prof. Dr. Charles Grose

University of Iowa, USA

Prof. Dr. Hualan Chen

Chinese Academy of Agricultural Sciences, China

Prof. Dr. Yu Chen

Wuhan University, China

Prof. Dr. Christopher S. Sullivan

The University of Texas at Austin, USA

Prof. Dr. Clinton Jones

Oklahoma State University, USA

Prof. Dr. Craig Meyers

Pennsylvania State College of Medicine, USA

Prof. Dr. Craig E. Cameron

The University of North Carolina at Chapel Hill, USA

Dr. Craig McCormick

Dalhousie University, Canada

Prof. Dr. Henryk H. Czosnek

The Hebrew University of Jerusalem, Israel

Dr. Blossom Damania

University of North Carolina at Chapel Hill, USA

Dr. Daniel DiMaio

Yale University, USA

Dr. Daniel L. Rock

the University of Illinois at Urbana-Champaign, USA

Prof. Dr. Terje Dokland

University of Alabama at Birmingham, USA

Dr. Eric O. Freed

National Cancer Institute, USA

Dr. Eugene V. Ryabov

Beltsville Agricultural Research Center, USDA, USA

Prof. Dr. Giorgio Palù

University of Padova, Italy

Prof. Dr. Guangxiang Luo

University of Alabama at Birmingham School of Medicine, USA

Prof. Dr. Graciela Andrei

Rega Institute for Medical Research, Belgium

Prof. Dr. Haitao Guo

University of Pittsburgh, USA

Prof. Dr. Guy Smagghe

Ghent University, Belgium

Dr. Helle Bielefeldt-Ohmann

The University of Queensland, Australia

Dr. Hernan Garcia-Ruiz

University of Nebraska-Lincoln, Lincoln, USA

Dr. Jason Kindrachuk

University of Manitoba, Canada

Prof. Dr. Jianming Hu

Pennsylvania State University College of Medicine, USA

Prof. Dr. K. Andrew White

York University, Canada

Prof. Dr. Ke Lan

Wuhan University, China

Dr. Koichi Watashi

National Institute of Infectious Diseases, Japan

Prof. Dr. Lennart Svensson

Linköping University, Sweden

Prof. Dr. Shuwen Liu

Southern Medical University, China

Dr. Luis Martinez-Sobrido

Texas Biomedical Research Institute, San Antonio, USA

Dr. Luis Menéndez-Arias

Universidad Autónoma de Madrid, Spain

Dr. Kenneth Lundstrom

PanTherapeutics, Switzerland

Prof. Dr. Michael J. Buchmeier

University of California, USA

Prof. Dr. Marc Kvansakul

La Trobe University, Australia

Prof. Dr. Louis M. Mansky

University of Minnesota, USA

Prof. Dr. Mark J. Mulligan

NYU Grossman School of Medicine, USA

Dr. Markus Thali

University of Vermont, USA

Prof. Dr. Matthias J. Schnell

Sidney Kimmel Medical College at Thomas Jefferson University, USA

Dr. Maurizia Rossana Brunetto

University Hospital of Pisa, Italy

Prof. Dr. Mikael Skurnik

Medicum, University of Helsinki, Finland

Prof. Dr. Manuel Ramos-Casals

Department of Autoimmune Diseases, ICMID, Hospital Clinic, Spain

Prof. Dr. Niklas Arnberg

Umeå University, Sweden

Prof. Dr. Nikos Vasilakis

University of Texas Medical Branch, USA

Prof. Dr. Norbert Nowotny

University of Veterinary Medicine, Austria

Prof. Dr. Nancy Raab-Traub

University of North Carolina, USA

Prof. Dr. Nobuhiro Suzuki

Okayama University, Japan

Prof. Dr. Oliver T. Fackler

University Hospital Heidelberg, Germany

Prof. Dr. Peng Zhou

Wuhan Institute of Virology, Chinese Academy of Sciences, China

Prof. Dr. Polly Roy

London School of Hygiene, UK

Dr. Rollie J. Clem

Kansas State University, USA

Prof. Dr. Regina Hofmann-Lehmann

University of Zurich, Switzerland

Prof. Dr. Rob Lavigne

KU Leuven, Belgium

Prof. Dr. Robert Thimme

University Hospital Freiburg, Germany

Dr. Romain Paillot

Writtle University College, UK

Prof. Dr. Satya Parida

Food and Agriculture Organization of the United Nations, Italy

Prof. Dr. Shibo Jiang

Fudan University, China

Prof. Dr. Shinji Makino

The University of Texas Medical Branch, USA

Prof. Dr. Shannon C. Kenney

University of Wisconsin-Madison, USA

Prof. Dr. Mark K. Slifka

Oregon Health & Science University, USA

Prof. Dr. Stefan Pöhlmann

Infection Biology Unit, German Primate Center, Germany

Prof. Dr. Stanley Perlman

University of Iowa, USA

Prof. Dr. Akinori Takaoka

Hokkaido University, Japan

Prof. Dr. Hengli Tang

Florida State University, USA

Prof. Dr. Thomas Hohn

University of Basel, Switzerland

Prof. Dr. Tina Dalianis

Karolinska Institutet, Sweden

Prof. Dr. Toshiki Watanabe

St. Marianna University Graduate School, Japan

Prof. Dr. Enzo Tramontano

University of Cagliari, Italy

Prof. Dr. Bin He

University of Illinois, USA

Dr. Ulrich Desselberger

University of Cambridge, UK

Dr. Volker Nickeleit

The University of North Carolina School of Medicine, USA

Prof. Dr. Volker Lohmann

University of Heidelberg, Germany

Dr. Weiyong Liu

Huazhong University of Science and Technology, China

Dr. Zongdi Feng

The Ohio State University College of Medicine, USA

The latest Stanford rankings reflect the significant influence and research excellence of the scientists, who are committed to furthering their knowledge for the benefit of the world.

We would like to congratulate our Editorial Board Members on their excellent achievement and thank them for their immense contribution to the scientific progression and development of Viruses.

1 November 2022
Viruses | Editor’s Choice Articles in 2020–2021

We are pleased to invite you to read the Editor’s Choice Articles of Viruses (ISSN: 1999-4915). A list of the high-quality and interesting papers that were specifically recommended by our Editorial Board Members can be found at the following link: https://www.mdpi.com/journal/viruses/editors_choice.

The papers list is as follows:

“The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner”
by Mizuki Y., Maki K. et al.
Viruses 2020, 12(6), 629; https://doi.org/10.3390/v12060629
Available online: https://www.mdpi.com/1999-4915/12/6/629

“Semipersistently Transmitted, Phloem Limited Plant Viruses Are Inoculated during the First Subphase of Intracellular Stylet Penetrations in Phloem Cells”
by Jaime J., Aránzazu M. and Alberto F.
Viruses 2021, 13(1), 137; https://doi.org/10.3390/v13010137
Available online: https://www.mdpi.com/1999-4915/13/1/137

“Global Metabolic Profiling of Baculovirus Infection in Silkworm Hemolymph Shows the Importance of Amino-Acid Metabolism”
by Min F., Shigang F., Junming X., Mengmeng Z., Hongyun W., Luc S. and Jingchen S.
Viruses 2021, 13(5), 841; https://doi.org/10.3390/v13050841
Available online: https://www.mdpi.com/1999-4915/13/5/841

“Microglial HIV-1 Expression: Role in HIV-1 Associated Neurocognitive Disorders”
by Hailong L., Kristen A. M., Jessica M. I., Charles F. M. and Rosemarie M. B.
Viruses 2021, 13(5), 924; https://doi.org/10.3390/v13050924
Available online: https://www.mdpi.com/1999-4915/13/5/924

“Tracking HIV-1-Infected Cell Clones Using Integration Site-Specific qPCR”
by Leah D. B., Shuang G. et al.
Viruses 2021, 13(7), 1235; https://doi.org/10.3390/v13071235
Available online: https://www.mdpi.com/1999-4915/13/7/1235

“Modular Evolution of Coronavirus Genomes”
by Yulia V., Andrei D., Jan F. D. and Alexander L.
Viruses 2021, 13(7), 1270; https://doi.org/10.3390/v13071270
Available online: https://www.mdpi.com/1999-4915/13/7/1270

“A New Master Donor Virus for the Development of Live-Attenuated Influenza B Virus Vaccines”
by Chantelle L. W., Kevin C., Daniel R. P., Jefferson S., Stivalis C. G., Aitor N. and Luis M. S.
Viruses 2021, 13(7), 1278; https://doi.org/10.3390/v13071278
Available online: https://www.mdpi.com/1999-4915/13/7/1278

“Molecular Evolution and Epidemiological Characteristics of SARS COV-2 in (Northwestern) Poland”
by Karol S., Andrzej O. et al.
Viruses 2021, 13(7), 1295; https://doi.org/10.3390/v13071295
Available online: https://www.mdpi.com/1999-4915/13/7/1295

“Effects of Basic Amino Acids and Their Derivatives on SARS-CoV-2 and Influenza-A Virus Infection”
by Ivonne M., Li-Lan K., Yan-Chung L., Po-Wei S., Ni T. and Wen-Chi S.
Viruses 2021, 13(7), 1301; https://doi.org/10.3390/v13071301
Available online: https://www.mdpi.com/1999-4915/13/7/1301

“A Diverse Viral Community from Predatory Wasps in Their Native and Invaded Range, with a New Virus Infectious to Honey Bees“
by Emily J. R., James W. B., Mariana B., Jana D., Oliver Q., Monica A. M. G. and Philip J. L.
Viruses 2021, 13(8), 1431; https://doi.org/10.3390/v13081431
Available online: https://www.mdpi.com/1999-4915/13/8/1431  

“Characterization of the Roles of SGT1/RAR1, EDS1/NDR1, NPR1, and NRC/ADR1/NRG1 in Sw-5b-Mediated Resistance to Tomato Spotted Wilt Virus”
by Zhengqiang C., Qian W., Cong T., Hongyu C., Dan M., Xin Q., Xiaohui Z., Lei J. and Xiaorong T.
Viruses 2021, 13(8), 1447; https://doi.org/10.3390/v13081447
Available online: https://www.mdpi.com/1999-4915/13/8/1447

“Understanding the Genetic Diversity of Picobirnavirus: A Classification Update Based on Phylogenetic and Pairwise Sequence Comparison Approaches”

by Lester J. P., Gavin A. C. and Michael G. B.
Viruses 2021, 13(8), 1476; https://doi.org/10.3390/v13081476
Available online: https://www.mdpi.com/1999-4915/13/8/1476

“An Absolutely Conserved Tryptophan in the Stem of the Envelope Protein E of Flaviviruses Is Essential for the Formation of Stable Particles”
by Iris M., Franz X. H. and Karin S.
Viruses 2021, 13(9), 1727; https://doi.org/10.3390/v13091727
Available online: https://www.mdpi.com/1999-4915/13/9/1727

“Examining the Effects of an Anti-Salmonella Bacteriophage Preparation, BAFASAL®, on Ex-Vivo Human Gut Microbiome Composition and Function Using a Multi-Omics Approach”
by Janice M., Xu Z., James B., Krystal W., Zhibin N., Ewelina W., Jarosław D., Alain S. and Daniel F.
Viruses 2021, 13(9), 1734; https://doi.org/10.3390/v13091734
Available online: https://www.mdpi.com/1999-4915/13/9/1734

“Structure-Guided Creation of an Anti-HA Stalk Antibody F11 Derivative That Neutralizes Both F11-Sensitive and -Resistant Influenza A(H1N1)pdm09 Viruses“
by Osamu K., Yasushi S. et al.
Viruses 2021, 13(9), 1733; https://doi.org/10.3390/v13091733
Available online: https://www.mdpi.com/1999-4915/13/9/1733

“Report of One-Year Prospective Surveillance of SARS-CoV-2 in Dogs and Cats in France with Various Exposure Risks: Confirmation of a Low Prevalence of Shedding, Detection and Complete Sequencing of an Alpha Variant in a Cat”
by Emilie K., Solène D. et al.
Viruses 2021, 13(9), 1759; https://doi.org/10.3390/v13091759
Available online: https://www.mdpi.com/1999-4915/13/9/1759

“Histotype-Dependent Oligodendroglial PrP Pathology in Sporadic CJD: A Frequent Feature of the M2C “Strain”
by Ellen G., Sigrid K., Nuria V. R., Gerda R., Günther R., Thomas S., Ognian K., Marlene L., Herbert B. and Gabor G. K.
Viruses 2021, 13(9), 1796; https://doi.org/10.3390/v13091796
Available online: https://www.mdpi.com/1999-4915/13/9/1796

“The Isolated in Utero Environment Is Conducive to the Emergence of RNA and DNA Virus Variants”
by Daniel U., Ivan T.,  Henry M., Nathalie B. and Uladzimir K.
Viruses 2021, 13(9), 1827; https://doi.org/10.3390/v13091827
Available online: https://www.mdpi.com/1999-4915/13/9/1827

“Phylogenomic Characterization of Lopma Virus and Praja Virus, Two Novel Rodent-Borne Arteriviruses”
by Bert V., Zafeiro Z., Sophie G., Joëlle G. B., Bram V., Philippe L., Piet M. and Magda B.
Viruses 2021, 13(9), 1842; https://doi.org/10.3390/v13091842
Available online: https://www.mdpi.com/1999-4915/13/9/1842

“The Pathobiology of H7N3 Low and High Pathogenicity Avian Influenza Viruses from the United States Outbreak in 2020 Differs between Turkeys and Chickens”
by Miriã F. C., Christina M. L. et al.
Viruses 2021, 13(9), 1851; https://doi.org/10.3390/v13091851
Available online: https://www.mdpi.com/1999-4915/13/9/1851

“VP8, the Major Tegument Protein of Bovine Herpesvirus-1, Is Partially Packaged during Early Tegument Formation in a VP22-Dependent Manner”
by Soumya S., Kuan Z. and Sylvia D. L. H.
Viruses 2021, 13(9), 1854; https://doi.org/10.3390/v13091854
Available online: https://www.mdpi.com/1999-4915/13/9/1854

“Reduced Infection Efficiency of Phage NCTC 12673 on Non-Motile Campylobacter jejuni Strains Is Related to Oxidative Stress”
by Jessica C. S., Muhammad A. J., Clay S. C., James B., Annika F., Alain S. and Christine M. S.
Viruses 2021, 13(10), 1955; https://doi.org/10.3390/v13101955
Available online: https://www.mdpi.com/1999-4915/13/10/1955

“Phage Therapy Related Microbial Succession Associated with Successful Clinical Outcome for a Recurrent Urinary Tract Infection”
by Austen T., Justin C., Maile K., Haroldo H. S., Sabrina G., Saima A. and Anthony M.
Viruses 2021, 13(10), 2049; https://doi.org/10.3390/v13102049
Available online: https://www.mdpi.com/1999-4915/13/10/2049

“Spillover of West Caucasian Bat Lyssavirus (WCBV) in a Domestic Cat and Westward Expansion in the Palearctic Region”
by Stefania L., Ettore B. et al.
Viruses 2021, 13(10), 2064; https://doi.org/10.3390/v13102064
Available online: https://www.mdpi.com/1999-4915/13/10/2064

“Herpes Simplex Virus 1 and 2 Infections during Differentiation of Human Cortical Neurons”
by Petra B., Edward T. et al.
Viruses 2021, 13(10), 2072; https://doi.org/10.3390/v13102072
Available online: https://www.mdpi.com/1999-4915/13/10/2072

“Comparison of the Proteomes of Porcine Macrophages and a Stable Porcine Cell Line after Infection with African Swine Fever Virus”
by Elisabeth W., Walter F., Luise H., Ulrike B., Sandra B., Thomas C. M. and Axel K.
Viruses 2021, 13(11), 2198; https://doi.org/10.3390/v13112198
Available online: https://www.mdpi.com/1999-4915/13/11/2198

“SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism”
by Nitin K., Yu Z., Srilakshmi Y., Kristina L. H., Jason S. K., Yogendra K., Andrea T. O. and Santhi K. G.
Viruses 2021, 13(11), 2209; https://doi.org/10.3390/v13112209
Available online: https://www.mdpi.com/1999-4915/13/11/2209

“Downregulation of Cell Surface Major Histocompatibility Complex Class I Expression Is Mediated by the Left-End Transcription Unit of Fowl Adenovirus 9”
by Bryan D. G., Juan C. C., Yanlong P. and Éva N.
Viruses 2021, 13(11), 2211; https://doi.org/10.3390/v13112211
Available online: https://www.mdpi.com/1999-4915/13/11/2211

“Impact of Phage CDHS-1 on the Transcription, Physiology and Pathogenicity of a Clostridioides difficile Ribotype 027 Strain, R20291”
by Janet Y. N., Thekra S. A-T., Shaun H. and Martha R. J. C.
Viruses 2021, 13(11), 2262; https://doi.org/10.3390/v13112262
Available online: https://www.mdpi.com/1999-4915/13/11/2262

“Analyses of Leishmania-LRV Co-Phylogenetic Patterns and Evolutionary Variability of Viral Proteins”
by Alexei Y. K., Danyil G., Yulia K., Daniil S. C., Alexander N. L., Evgeny S. G. and Vyacheslav Y.
Viruses 2021, 13(11), 2305; https://doi.org/10.3390/v13112305
Available online: https://www.mdpi.com/1999-4915/13/11/2305

“Heterogeneity of Early Host Response to Infection with Four Low-Pathogenic H7 Viruses with a Different Evolutionary History in the Field”
by Gianpiero Z., Alice B. et al.
Viruses 2021, 13(11), 2323; https://doi.org/10.3390/v13112323
Available online: https://www.mdpi.com/1999-4915/13/11/2323

“Plasma Proteome Fingerprints Reveal Distinctiveness and Clinical Outcome of SARS-CoV-2 Infection”
by Wolfgang B., Marcus W. et al.
Viruses 2021, 13(12), 2456; https://doi.org/10.3390/v13122456
Available online: https://www.mdpi.com/1999-4915/13/12/2456

“Characterization and Tissue Tropism of Newly Identified Iflavirus and Negeviruses in Glossina morsitans morsitans Tsetse Flies”
by Irene K. M., Hannah-Isadora H. et al.
Viruses 2021, 13(12), 2472; https://doi.org/10.3390/v13122472
Available online: https://www.mdpi.com/1999-4915/13/12/2472

 

13 October 2022
Viruses 2022 Early Career Investigator Award—Open for Nominations


We are pleased to announce that Viruses (ISSN: 1999-4915) is now welcoming nominations for the Viruses 2022 Early Career Investigator Award. This prize will be awarded to two early career investigators demonstrating excellence in virology. The nominations will be assessed by an Evaluation Committee chaired by the journal’s Editor-in-Chief, Dr. Eric O. Freed.

Prizes:

  • Prize of CHF 1000;
  • Invitation to publish one paper free of charge in the journal in 2023, following peer review;
  • An invitation to speak at the Viruses international virology conference in 2024, and an engraved plaque.

Award Terms and Conditions:

  • Nominees should be early career researchers with untenured positions who are within 10 years of having completed their most recent degree (Ph.D., M.D., or equivalent);
  • Nominees must have produced ground-breaking research and made a significant contribution to the field of virology.

List of Documents for Nomination:

  • A detailed curriculum vitae, including an updated publication list;
  • Signed nomination letters and letters of recommendation from two established senior scientists.

Find more information about the award and how to nominate here.

To request further information, please contact the Viruses Editorial Office (viruses@mdpi.com).

28 September 2022
Peer Review Week 2022 – Research Integrity: Creating and Supporting Trust in Research

Peer Review Week began 19 September 2022 under the theme of “Research Integrity: Creating and Supporting Trust in Research”. Through various blog articles, podcast, and webinar, we discussed this crucial subject throughout the week, celebrating the essential role peer review plays in maintaining research quality.

To begin, we held a Webinar on the topic. Professor Peter W. Choate and Dr. Emmanuel Obeng-Gyasi joined Dr. Ioana Craciun, one of MDPI’s scientific officers, for an in-depth discussion.

We invite you to view the event recording:

During the week, the MDPI Blog in a series articles highlighted how good Peer Review safeguards research integrity. The following topics were covered:

In a new edition of Insight Faster, an MDPI podcast, we were delighted to talk to the co-chairs of the Peer Review Week committee, Jayashree Rajagopalan (Senior Manager of Global Community Engagement for CACTUS) and Danielle Padula (Head of Marketing and Community Development at Scholastica) to get their take on this year’s event and its related topics.

You can find the Podcast here.

We hope you enjoy the contents!

14 September 2022
Viruses | Top Cited Papers in 2021

1. “Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech)”
by Johannes Korth et al.
Viruses 2021, 13(5), 756; https://doi.org/10.3390/v13050756
Available online: https://www.mdpi.com/1999-4915/13/5/756
Cited by 92 | Viewed by 2845

2. “Domains and Functions of Spike Protein in SARS-Cov-2 in the Context of Vaccine Design”
by Xuhua Xia
Viruses 2021, 13(1), 109; https://doi.org/10.3390/v13010109
Available online: https://www.mdpi.com/1999-4915/13/1/109
Cited by 91 | Viewed by 16009

3. “Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice”
by Pratima Kumari et al.
Viruses 2021, 13(1), 132; https://doi.org/10.3390/v13010132
Available online: https://www.mdpi.com/1999-4915/13/1/132
Cited by 82 | Viewed by 30382

4. “Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection”
by Federico Gobbi et al.
Viruses 2021, 13(3), 422; https://doi.org/10.3390/v13030422
Available online: https://www.mdpi.com/1999-4915/13/3/422
Cited by 80 | Viewed by 12495

5. “Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?”
by Ivana Lazarevic et al.
Viruses 2021, 13(7), 1192; https://doi.org/10.3390/v13071192
Available online: https://www.mdpi.com/1999-4915/13/7/1192
Cited by 79 | Viewed by 8279

6. “A Roadmap for Genome-Based Phage Taxonomy”
by Dann Turner et al.
Viruses 2021, 13(3), 506; https://doi.org/10.3390/v13030506
Available online: https://www.mdpi.com/1999-4915/13/3/506
Cited by 75 | Viewed by 5498

7. “Attitudes towards Anti-SARS-CoV2 Vaccination among Healthcare Workers: Results from a National Survey in Italy”
by Francesco Di Gennaro et al.
Viruses 2021, 13(3), 371; https://doi.org/10.3390/v13030371
Available online: https://www.mdpi.com/1999-4915/13/3/371
Cited by 72 | Viewed by 3020

8. “Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms”
by Bruno Silva Andrade et al.
Viruses 2021, 13(4), 700; https://doi.org/10.3390/v13040700
Available online: https://www.mdpi.com/1999-4915/13/4/700
Cited by 69 | Viewed by 12025

9. “Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications”
by Jasdeep Singh et al.
Viruses 2021, 13(3), 439; https://doi.org/10.3390/v13030439
Available online: https://www.mdpi.com/1999-4915/13/3/439
Cited by 65 | Viewed by 5564

10. “Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease”
by Lukas van de Sand et al.
Viruses 2021, 13(4), 609; https://doi.org/10.3390/v13040609
Available online: https://www.mdpi.com/1999-4915/13/4/609
Cited by 59 | Viewed by 4984

14 September 2022
Viruses | Top Cited Papers in 2020

1. “Virology, Epidemiology, Pathogenesis, and Control of COVID-19”
by Yuefei Jin et al.
Viruses 2020, 12(4), 372; https://doi.org/10.3390/v12040372
Available online: https://www.mdpi.com/1999-4915/12/4/372
Cited by 751 | Viewed by 75036

2. “Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies”
by Syed Faraz Ahmed et al.
Viruses 2020, 12(3), 254; https://doi.org/10.3390/v12030254
Available online: https://www.mdpi.com/1999-4915/12/3/254
Cited by 687 | Viewed by 59383

3. “Return of the Coronavirus: 2019-nCoV”
by Lisa E. Gralinski et al.
Viruses 2020, 12(2), 135; https://doi.org/10.3390/v12020135
Available online: https://www.mdpi.com/1999-4915/12/2/135
Cited by 684 | Viewed by 91557

4. “Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections”
by David A. Schwartz et al.
Viruses 2020, 12(2), 194; https://doi.org/10.3390/v12020194
Available online: https://www.mdpi.com/1999-4915/12/2/194
Cited by 545 | Viewed by 32959

5. “Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV”
by Jiabao Xu et al.
Viruses 2020, 12(2), 244; https://doi.org/10.3390/v12020244
Available online: https://www.mdpi.com/1999-4915/12/2/244
Cited by 399 | Viewed by 37502

6. “Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays”
by Katharine H. D. Crawford et al.
Viruses 2020, 12(5), 513; https://doi.org/10.3390/v12050513
Available online: https://www.mdpi.com/1999-4915/12/5/513
Cited by 341 | Viewed by 13192

7. “Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2”
by Nadin Younes et al.
Viruses 2020, 12(6), 582; https://doi.org/10.3390/v12060582
Available online: https://www.mdpi.com/1999-4915/12/6/582
Cited by 202 | Viewed by 13646

8. “Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins”
by Suhas Srinivasan et al.
Viruses 2020, 12(4), 360; https://doi.org/10.3390/v12040360
Available online: https://www.mdpi.com/1999-4915/12/4/360
Cited by 134 | Viewed by 16756

9. “The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner”
by Mizuki Yamamoto et al.
Viruses 2020, 12(6), 629; https://doi.org/10.3390/v12060629
Available online: https://www.mdpi.com/1999-4915/12/6/629
Cited by 133 | Viewed by 4236

10. “SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions”
by Mohammed Uddin et al.
Viruses 2020, 12(5), 526; https://doi.org/10.3390/v12050526
Available online: https://www.mdpi.com/1999-4915/12/5/526
Cited by 125 | Viewed by 14756

28 June 2022
2021 Impact Factors - Released

The 2021 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:

Journal Impact Factor Rank Category
Antioxidants 7.675 Q1 Food Science & Technology
Biochemistry & Molecular Biology
Chemistry, Medicinal
Cells 7.666 Q2 Cell Biology
Nutrients 6.706 Q1 Nutrition & Dietetics
Cancers 6.575 Q1 Oncology
Pharmaceutics 6.525 Q1 Pharmacology & Pharmacy
International Journal of Molecular Sciences 6.208 Q1 Biochemistry & Molecular Biology
Q2 Chemistry, Multidisciplinary
Marine Drugs 6.085 Q1 Chemistry, Medicinal
Pharmacology & Pharmacy
Biomolecules 6.064 Q2 Biochemistry & Molecular Biology
Batteries * 5.938 Q2 Electrochemistry
Energy & Fuels
Materials Science, Multidisciplinary
Viruses 5.818 Q2 Virology
Biosensors 5.743 Q1 Chemistry, Analytical
Instruments & Instrumentation
Q2 Nanoscience & Nanotechnology
Journal of Fungi 5.724 Q1 Mycology
Q2 Microbiology
Nanomaterials 5.719 Q1 Physics, Applied
Q2 Chemistry, Multidisciplinary
Materials Science, Multidisciplinary
Nanoscience & Nanotechnology
Metabolites 5.581 Q2 Biochemistry & Molecular Biology
Foods 5.561 Q1 Food Science & Technology
Drones * 5.532 Q2 Remote Sensing
Remote Sensing 5.349 Q1 Geosciences, Multidisciplinary
Imaging Science & Photographic Technology
Q2 Remote Sensing
Environmental Sciences
Journal of Theoretical and Applied Electronic Commerce Research 5.318 Q2 Business
Antibiotics 5.222 Q1 Pharmacology & Pharmacy
Q2 Infectious Diseases
Pharmaceuticals 5.215 Q1 Pharmacology & Pharmacy
Q2 Chemistry, Medicinal
Biology 5.168 Q1 Biology
Fermentation 5.123 Q2 Biotechnology & Applied Microbiology
Toxins 5.075 Q1 Toxicology
Q2 Food Science & Technology
Bioengineering * 5.046 Q2 Engineering, Biomedical
Polymers 4.967 Q1 Polymer Science
Journal of Clinical Medicine 4.964 Q2 Medicine, General & Internal
Vaccines 4.961 Q2 Immunology
Medicine, Research & Experimental
Molecules 4.927 Q2 Chemistry, Multidisciplinary
Biochemistry & Molecular Biology
Microorganisms 4.926 Q2 Microbiology
Journal of Functional Biomaterials * 4.901 Q2 Engineering, Biomedical
Materials Science, Biomaterials
Biomedicines 4.757 Q2 Medicine, Research & Experimental
Pharmacology & Pharmacy
Biochemistry & Molecular Biology
Plants 4.658 Q1 Plant Sciences
International Journal of Environmental Research and Public Health 4.614 Q1 Public, Environmental & Occupational Health (SSCI)
Q2 Public, Environmental & Occupational Health (SCIE)
Environmental Sciences (SCIE)
Membranes 4.562 Q1 Polymer Science
Q2 Engineering, Chemical
Materials Science, Multidisciplinary
Chemistry, Physical
Pathogens 4.531 Q2 Microbiology
Catalysts 4.501 Q2 Chemistry, Physical
Toxics 4.472 Q2 Toxicology
Environmental Sciences
Gels 4.432 Q1 Polymer Science
Journal of Cardiovascular Development and Disease 4.415 Q2 Cardiac & Cardiovascular Systems
Chemosensors 4.229 Q1 Instruments & Instrumentation
Q2 Chemistry, Analytical
Q3 Electrochemistry
Genes 4.141 Q2 Genetics & Heredity
Diagnostics 3.992 Q2 Medicine, General & Internal
Agronomy 3.949 Q1 Agronomy
Plant Sciences
Land 3.905 Q2 Environmental Studies
Sustainability 3.889 Q2 Environmental Sciences (SCIE)
Environmental Studies (SSCI)
Q3 Green & Sustainable Science & Technology (SCIE)
Q4 Green & Sustainable Science & Technology (SSCI)
Sensors 3.847 Q2 Instruments & Instrumentation
Chemistry, Analytical
Engineering, Electrical & Electronic
Materials 3.748 Q1 Metallurgy & Metallurgical Engineering
Q2 Physics, Applied
Physics, Condensed Matter
Q3 Materials Science, Multidisciplinary
Chemistry, Physical
Biomimetics * 3.743 Q2 Engineering, Multidisciplinary
Q3 Materials Science, Biomaterials
Tropical Medicine and Infectious Disease * 3.711 Q1 Tropical Medicine
Q2 Parasitology
Q3 Infectious Diseases
Lubricants * 3.584 Q2 Engineering, Mechanical
Fractal and Fractional 3.577 Q1 Mathematics, Interdisciplinary Applications
Water 3.530 Q2 Water Resources
Q3 Environmental Sciences
Micromachines 3.523 Q2 Instruments & Instrumentation
Physics, Applied
Chemistry, Analytical
Q3 Nanoscience & Nanotechnology
Journal of Personalized Medicine 3.508 Q2 Medicine, General & Internal
Health Care Sciences & Services
Agriculture 3.408 Q1 Agronomy
Processes 3.352 Q2 Engineering, Chemical
Separations 3.344 Q2 Chemistry, Analytical
Magnetochemistry 3.336 Q2 Chemistry, Inorganic & Nuclear
Q3 Chemistry, Physical
Materials Science, Multidisciplinary
Brain Sciences 3.333 Q3 Neurosciences
Buildings 3.324 Q2 Construction & Building Technology
Engineering, Civil
Forests 3.282 Q1 Forestry
Energies 3.252 Q3 Energy & Fuels
Life 3.251 Q2 Biology
Coatings 3.236 Q2 Materials Science, Coatings & Films
Physics, Applied
Q3 Materials Science, Multidisciplinary
Animals 3.231 Q1 Agriculture, Dairy & Animal Science
Veterinary Sciences
Journal of Intelligence * 3.176 Q2 Psychology, Multidisciplinary
Fishes 3.170 Q1 Marine & Freshwater Biology
Q2 Fisheries
Healthcare 3.160 Q2 Health Policy & Services (SSCI)
Health Care Sciences & Services (SCIE)
Inorganics * 3.149 Q2 Chemistry, Inorganic & Nuclear
Insects 3.139 Q1 Entomology
Atmosphere 3.110 Q3 Meteorology & Atmospheric Sciences
Environmental Sciences
Current Oncology 3.109 Q3 Oncology
ISPRS International Journal of Geo-Information 3.099 Q2 Geography, Physical
Q3 Computer Science, Information Systems
Remote Sensing
Diversity 3.029 Q2 Biodiversity Conservation
Ecology
Tomography 3.000 Q3 Radiology, Nuclear Medicine & Medical Imaging
Current Issues in Molecular Biology 2.976 Q3 Biochemistry & Molecular Biology
Medicina 2.948 Q3 Medicine, General & Internal
Symmetry 2.940 Q2 Multidisciplinary Sciences
Horticulturae 2.923 Q1 Horticulture
Machines 2.899 Q2 Engineering, Mechanical
Engineering, Electrical & Electronic
Systems * 2.895 Q2 Social Sciences, Interdisciplinary
Applied Sciences 2.838 Q2 Engineering, Multidisciplinary
Physics, Applied
Q3 Chemistry, Multidisciplinary
Materials Science, Multidisciplinary
Children 2.835 Q2 Pediatrics
Minerals 2.818 Q2 Mining & Mineral Processing
Mineralogy
Geochemistry & Geophysics
Universe 2.813 Q2 Astronomy & Astrophysics
Q3 Physics, Particles & Fields
Journal of Marine Science and Engineering 2.744 Q1 Engineering, Marine
Q2 Oceanography
Engineering, Ocean
Entropy 2.738 Q2 Physics, Multidisciplinary
Fire * 2.726 Q2 Forestry
Q3 Ecology
Metals 2.695 Q2 Metallurgy & Metallurgical Engineering
Q3 Materials Science, Multidisciplinary
Electronics 2.690 Q3 Engineering, Electrical & Electronic
Computer Science, Information Systems
Physics, Applied
Crystals 2.670 Q2 Crystallography
Q3 Materials Science, Multidisciplinary
Aerospace 2.660 Q1 Engineering, Aerospace
Mathematics 2.592 Q1 Mathematics
Photonics 2.536 Q3 Optics
Actuators 2.523 Q2 Instruments & Instrumentation
Q3 Engineering, Mechanical
Veterinary Sciences 2.518 Q2 Veterinary Sciences
Behavioral Sciences * 2.286 Q3 Psychology, Multidisciplinary
Axioms * 1.824 Q2 Mathematics, Applied

For more information on Impact Factors and what it means to index academic journals, please visit our related blog posts.

 

* Journals given their first Impact Factor in 2022

Source: 2021 Journal Impact Factors, Journal Citation Reports TM (Clarivate, 2022)

 

9 June 2022
2021 CiteScores - Released


The 2021 citation metrics have been officially released in Scopus!

We are pleased to announce that 182 MDPI journals are included, of which:

● 21 journals received their first CiteScore.
● 85% of journals increased their CiteScore from 2020.
● 155 journals (85%) ranked above average, in at least one category.

The following 65 MDPI journals (36%) ranked among the top 25% of journals, in at least one category:

Journal

CiteScore

Quartile

Category

Non-coding RNA

10.1

Q1

Genetics

Journal of Functional Biomaterials

10.0

Q1

Biomedical Engineering

Marine Drugs

8.1

Q1

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Batteries

7.9

Q1

Electrical and Electronic Engineering

Nutrients

7.9

Q1

Nutrition and Dietetics

Remote Sensing

7.4

Q1

General Earth and Planetary Sciences

Drones

7.2

Q1

Computer Science Applications

International Journal of Molecular Sciences

6.9

Q1

Inorganic Chemistry

Journal of Sensor and Actuator Networks

6.9

Q1

Computer Networks and Communications

Cells

6.7

Q1

General Biochemistry, Genetics and Molecular Biology

Nanomaterials

6.6

Q1

General Chemical Engineering

Toxins

6.6

Q1

Health, Toxicology and Mutagenesis

Viruses

6.6

Q1

Infectious Diseases

Antioxidants

6.5

Q1

Food Science

Fibers

6.5

Q1

Civil and Structural Engineering

Resources

6.4

Q1

Nature and Landscape Conservation

Sensors

6.4

Q1

Instrumentation

Big Data and Cognitive Computing

6.1

Q1

Management Information Systems

Molecules

5.9

Q1

Chemistry (miscellaneous)

Polymers

5.7

Q1

Polymers and Plastics

Biosensors

5.6

Q1

Engineering (miscellaneous)

Catalysts

5.5

Q1

General Environmental Science

Smart Cities

5.5

Q1

Urban Studies

Future Internet

5.4

Q2

Computer Networks and Communications

Beverages

5.3

Q1

Food Science

Fermentation

5.3

Q1

Plant Science

Environments

5.2

Q1

Ecology, Evolution, Behavior and Systematics

Inventions

5.2

Q1

General Engineering

Journal of Open Innovation: Technology, Market, and Complexity

5.1

Q1

Development

Colloids and Interfaces

5.0

Q1

Chemistry (miscellaneous)

Energies

5.0

Q1

Control and Optimization

ISPRS International Journal of Geo-Information

5.0

Q1

Geography, Planning and Development

Sustainability

5.0

Q1

Geography, Planning and Development

Fire

4.9

Q1

Forestry

Robotics

4.9

Q1

Control and Optimization

Soil Systems

4.9

Q1

Soil Science

Geosciences

4.8

Q1

General Earth and Planetary Sciences

Journal of Manufacturing and Materials Processing

4.8

Q1

Mechanical Engineering

Tropical Medicine and Infectious Disease

4.8

Q1

Public Health, Environmental and Occupational Health

Water

4.8

Q1

Geography, Planning and Development

International Journal of Environmental Research and Public Health

4.5

Q1

Public Health, Environmental and Occupational Health

Sports

4.5

Q1

Physical Therapy, Sports Therapy and Rehabilitation

Entropy

4.4

Q1

Mathematical Physics

Journal of Clinical Medicine

4.4

Q1

General Medicine

Symmetry

4.3

Q1

General Mathematics

Cosmetics

4.2

Q1

Surgery

Foods

4.1

Q1

Health Professions (miscellaneous)

Journal of Fungi

4.1

Q1

Plant Science

ChemEngineering

4.0

Q1

General Engineering

Forests

4.0

Q1

Forestry

Journal of Intelligence

4.0

Q1

Education

Antibiotics

3.9

Q1

General Pharmacology, Toxicology and Pharmaceutics

Cryptography

3.9

Q1

Applied Mathematics

Behavioral Sciences

3.8

Q1

Development

Buildings

3.8

Q1

Architecture

Metals

3.8

Q1

Metals and Alloys

Publications

3.5

Q1

Communication

Social Sciences

3.4

Q1

General Social Sciences

Mathematics

2.9

Q1

General Mathematics

Fractal and Fractional

2.8

Q1

Analysis

Animals

2.7

Q1

General Veterinary

Axioms

2.6

Q1

Algebra and Number Theory

Heritage

1.8

Q1

Conservation

Religions

1.0

Q1

Religious Studies

Philosophies

0.9

Q1

Philosophy

Source: 2021 CiteScores™ (Elsevier)

2 June 2022
MDPI’s 2021 Outstanding Reviewer Awards in “Biology & Life Sciences”—Winners Announced

In order to acknowledge our reviewers, who so generously dedicate their time to reviewing papers and demonstrate diligence, professionalism, and timeliness when reviewing manuscripts, MDPI journals regularly offer outstanding reviewer awards to scholars who participate in the peer-review process.

We are proud to recognize winners for the year 2021 in the “Biology & Life Sciences” category for their outstanding contributions among extensive competition by presenting them with an Outstanding Reviewer Award.

We would like to take this opportunity to congratulate all the winners on their achievement.

MDPI will continue to provide support and recognition to the academic community.

Biology:

  • Enrico Vito Perrino, CIHEAM, Mediterranean Agronomic Institute of Bari, Italy
  • Dhirendra Kumar, National Institute of Environmental Health Sciences, Research Triangle Park, USA
  • Carlos A. Viegas, Univesity of Trás-os-Montes e Alto Douro, Portugal
  • Yuri Shavrukov, Flinders University, Australia
  • Bipin Gaihre, Mayo Clinic, USA

Brain Sciences:

  • Craig D. Workman, University of Iowa, USA
  • Vivian Ciaramitaro, University of Massachusetts Boston, USA
  • Yang Zhang, University of Minnesota, USA

Cells:

  • Bonam Srinivasa Reddy, Université de Paris, France
  • Homma Takujiro, Yamagata University, Japan
  • Hwang, In Koo, Seoul National University, South Korea
  • Kobeissy Firas, University of Florida, USA
  • Rebelo, Sandra, University of Aveiro, Portugal

Diversity:

  • Günter Gollmann, University of Vienna, Austria
  • Stephan Koblmüller, University of Graz, Austria
  • Emiliano Mori, Istituto di Ricerca sugli Ecosistemi Terrestri, Italy

Horticulturae:

  • Joshua D. Klein, Agricultural Research Organization—The Volcani Center, Israel
  • Ana Cristina S Figueiredo, Faculdade de Ciências da Universidade de Lisboa, Portugal

Insects:

  • Carmelo Peter Bonsignore, Università Mediterranea di Reggio Calabria, Italy
  • Klaus H. Hoffmann, University of Bayreuth, Germany
  • Ivan Milosavljević, University of California, USA

Metabolites:

  • Remigiusz Bachor, University of Wrocław, Poland
  • Nguyen Phuoc Long, Inje University College of Medicine, South Korea
  • Chi Chen, University of Minnesota, USA

Nutrients:

  • Jadwiga Hamułka, Warsaw University of Life Sciences, Poland
  • Grace Campbell, University of Sydney, Australia
  • Nicholas Norwitz, Harvard Medical School, USA
  • Stefan Kabisch, Charité University Hospital Berlin, Germany
  • Luis Rodrigo, University of Oviedo, Spain

Veterinary Sciences:

  • Carlos Viegas, Univesity of Trás-os-Montes e Alto Douro, Portugal
  • Arvind Sharma, The University of Queensland, Australia

2 June 2022
MDPI’s 2021 Young Investigator Awards in “Biology & Life Sciences”—Winners Announced

MDPI’s Young Investigator Awards recognize promising junior researchers, acknowledge their contributions, and enhance communication among scientists. We are proud to present the 2021 winners in the “Biology & Life Sciences” category. The winners were selected by the journals’ editors.

We warmly congratulate the awarded young investigators for their outstanding contributions.

MDPI will continue to provide support and recognition to the academic community.

Agriculture:

  • Carlos Guzmán, University of Cordoba, Spain

Animals:

  • Katharina Hohlbaum, Freie Universität Berlin, Germany

Cells:

  • Uri Ben-David, Tel Aviv University, Israel

Diversity:

  • Enrico Lunghi, Institute of Zoology Chinese Academy of Sciences in Beijing, China

Foods:

  • Guodong Zhang, University of Massachusetts Amherst, USA

Horticulturae:

  • Luke Bell, Temperate Horticulture, University of Reading, UK

International Journal of Molecular Sciences:

  • Alessandro D’Urso, University of Catania, Italy.
  • Apostolos Zaravinos, University of Cyprus, Cyprus
  • Cesar de la Fuente-Nunez, University of Pennsylvania, USA
  • Maria Teresa Caccamo, Messina University, Italy
  • Tiziana Bonifacino, University of Genoa, Italy

Journal of Fungi:

  • Federico Baltar, University of Vienna, Austria
  • Rebecca Drummond, University of Birmingham, UK
  • Miriam Oses-Ruiz, Public University of Navarre, Spain

Life:

  • João Pedro da Silva Machado Lobo, University of Porto, Portugal
  • Vincenzo Russo, University of Campania Luigi Vanvitelli, Italy

Metabolites:

  • Gabriele Rocchetti, Catholic University of Sacred Heart, Italy

Nutrients:

  • Fiona Lavelle, Queen's University Belfast, UK
  • Matthew Snelson, Monash University, Australia

Pathogens:

  • Si Ming Man, Australian National University, Australia
  • Jasper Fuk-Woo Chan, University of Hong Kong, China

Plants:

  • Stefania Sut, University of Padova, Italy
  • Mohamed Ahmed El-Esawi, Tanta University, Tanta, Egypt

Vaccines:

  • Nicholas M. Provine, University of Oxford, UK

Viruses:

  • Nicholas S. Heaton, Duke University, USA

2 June 2022
MDPI’s 2021 Travel Awards in “Biology & Life Sciences”—Winners Announced

We are proud to recognize the winners of MDPI’s 2021 Travel Awards in the “Biology & Life Sciences” category for their outstanding presentations and to present them with the prize.

MDPI journals regularly offer travel awards to encourage talented junior scientists to present their latest research at academic conferences in specific fields, which helps to increase their influence.

The winners mentioned below were carefully selected by the journal editors based on an outline of their research and the work to be presented at an academic conference.

We would like to warmly congratulate the winners of 2021 Travel Awards and wish them the greatest success with their future research endeavors. MDPI will continue to enhance communication among scientists.

Agriculture:

  • Zahra Bitarafan, Norwegian Institute of Bioeconomy Research (NIBIO), Norway
  • Nikolaos Tsoulias, Leibniz Institute for Agricultural Engineering and Bioeconomy (ATB), Germany

Fermentation:

  • Michela Verni, University of Bari, Italy
  • Philipp Demling, RWTH Aachen University, Germany

Horticulturae:

  • Jagveer Singh, Punjab Agricultural University, India
  • Ibrar Hussain, State University of Londrina, Brazil

Microorganisms:

  • Francis Muchaamba, University of Zurich, Switzerland

Methods and Protocols:

  • Tanja Eisemann, SBP Medical Discovery Institute, USA

Nutrients:

  • Mrinalini Dey, National Institute for Health Research, UK
  • Ben Kirk, University of Melbourne, Australia
  • Kirrilly Pursey, University of Newcastle, Australia
  • Dieuwertje Kok, Wageningen University, the Netherlands
  • Hanna Huber, University of Bonn, Germany
  • Marlene Lages, University of Porto, Portugal
  • Zohra S. Lassi, University of Adelaide, Australia
  • Rik Olde Engberink, Amsterdam University Medicial Center, the Netherlands
  • Sarah Warkentin, University of Porto (ISPUP), Portugal
  • Álvaro Hernáez, Norwegian Institute of Public Health, Norway
  • Leila Abdelhamid, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, USA
  • Maria Michela Cesare, University of Siena, Italy
  • Kaisa Hiippala, University of Helsinki, Finland

Pathogens:

  • Vanessa Silva, University of Trás-os-Montes and Alto Douro, Portugal
  • Hejun Liu, Scripps Research Institute, USA
  • Tomokazu Tamura, Princeton University, USA

Toxins:

  • Cecilie Knudsen, Technical University of Denmark, Denmark
  • Laura Biessy, Cawthron Institute, New Zealand
  • Marcelo Mendes Rabelo, University of Florida, USA

Vaccines:

  • Hee Chun Chung, Seoul National University, South Korea
  • Alejandro Marin Lopez, Yale University, USA

2 June 2022
MDPI’s 2021 Best Paper Awards in “Biology & Life Sciences”—Winners Announced

The purpose of our Best Paper Awards is to promote and recognize the most impactful contributions published within MDPI journals.

The editors of each journal carefully selected reviews and research papers through a rigorous judging process based on criteria such as the scientific merit, overall impact, and the quality of presentation of the papers published in the journal last year.

We are honored to present the winners in the subject areas of “Biology & Life Sciences”, who were selected amongst extensive competition, and congratulate the authors for their outstanding scientific publications.

MDPI will continue to provide support and recognition to the academic community.

Animals:

by Wenchao Liu, Yilin Yuan, Chenyu Sun, Balamuralikrishnan Balasubramanian, Zhihui Zhao and Lilong An

Animals 2019, 9(8), 506, doi 10.3390/ani9080506

by Peter Coals, Dawn Burnham, Andrew Loveridge, David W. Macdonald, Michael ’t Sas-Rolfes, Vivienne L. Williams and John A. Vucetich

Animals 2019, 9(2), 52; doi 10.3390/ani9020052

by Giovanni Sogari, Mario Amato, Ilaria Biasato, Silvana Chiesa and Laura Gasco

Animals 2019, 9(4), 119; doi 10.3390/ani9040119

Antibodies:

by Mark L. Chiu; Dennis R. Goulet; Alexey Teplyakov and Gary L. Gilliland

Antibodies 2019, 8(4), 55; doi 10.3390/antib8040055

Antioxidants:

by Luca Frattaruolo, Gabriele Carullo, Matteo Brindisi, Sarah Mazzotta, Luca Bellissimo, Vittoria Rago, Rosita Curcio, Vincenza Dolce, Francesca Aiello and Anna Rita Cappello

Antioxidants 2019, 8(6), 186; doi 10.3390/antiox8060186

by Chunhe Gu, Kate Howell, Frank R. Dunshea and Hafiz A. R. Suleria

Antioxidants 2019, 8(9), 405; doi 10.3390/antiox8090405

by Spyridon A. Petropoulos, Ângela Fernandes, Maria Inês Dias, Ioannis B. Vasilakoglou, Konstantinos Petrotos, Lillian Barros and Isabel C. F. R. Ferreira

Antioxidants 2019, 8(8), 293; doi 10.3390/antiox8080293

by Rubén Domínguez, Mirian Pateiro, Mohammed Gagaoua, Francisco J. Barba, Wangang Zhang and José M. Lorenzo

Antioxidants 2019, 8(10), 429; doi 10.3390/antiox8100429

Biology:

by Michael H. Hastings, Elizabeth S. Maywood and Marco Brancaccio

Biology 2019, 8(1), 13; doi 10.3390/biology8010013

by Gail D. Schwieterman, Daniel P. Crear, Brooke N. Anderson, Danielle R. Lavoie, James A. Sulikowski, Peter G. Bushnell and Richard W. Brill

Biology 2019, 8(3), 56; doi 10.3390/biology8030056

Biomolecules:

by Shuichi Nakamura and Tohru Minamino

Biomolecules 2019, 9(7), 279; doi 10.3390/biom9070279

by Dmitrii Usoltsev, Vera Sitnikovaandrey Kajava and Mayya Uspenskaya

Biomolecules 2019, 9(8), 359; doi 10.3390/biom9080359

by Gerhard Liebisch, Josef Ecker, Sebastian Roth, Sabine Schweizer, Veronika Öttl, Hans-Frieder Schött, Hongsup Yoon, Dirk Haller, Ernst Holler, Ralph Burkhardt and Silke Matysik

Biomolecules 2019, 9(4), 121; doi 10.3390/biom9040121

by Anna Janaszewska, Joanna Lazniewska, Przemysław Trzepiński, Monika Marcinkowska and Barbara Klajnert-Maculewicz

Biomolecules 2019, 9(8), 330; doi 10.3390/biom9080330

Cells:

by Heng Sheng Sow, Jiang Ren, Marcel Camps, Ferry Ossendorp and Peter ten Dijke

Cells 2019, 8(4), 320; doi 10.3390/cells8040320

by Dinender K. Singla, Taylor A. Johnson and Zahra Tavakoli Dargani

Cells 2019, 8(10), 1224; doi 10.3390/cells8101224

by Laura M. Doyle and Michael Zhuo Wang

Cells 2019, 8(7), 727; doi 10.3390/cells8070727

by Yu Han, Xuezhou Li, Yanbo Zhang, Yuping Han, Fei Chang and Jianxun Ding

Cells 2019, 8(8), 886; doi 10.3390/cells8080886

Genes:

by Sarah B. Kingan, Haynes Heaton, Juliana Cudini, Christine C. Lambert, Primo Baybayan, Brendan D. Galvin, Richard Durbin, Jonas Korlach and Mara K. N. Lawniczak

Genes 2019, 10(1), 62; doi 10.3390/genes10010062

by Katherine E Bohnsack, Claudia Höbartner and Markus T Bohnsack

Genes 2019, 10(2), 102; doi 10.3390/genes10020102

by Laura M. Boykin, Peter Sseruwagi, Titus Alicai, Elijah Ateka, Ibrahim Umar Mohammed, Jo-Ann L. Stanton, Charles Kayuki, Deogratius Mark, Tarcisius Fute, Joel Erasto, Hilda Bachwenkizi, Brenda Muga, Naomi Mumo, Jenniffer Mwangi, Phillip Abidrabo, Geoffrey Okao-Okuja, Geresemu Omuut, Jacinta Akol, Hellen B. Apio, Francis Osingada, Monica A. Kehoe, David Eccles, Anders Savill, Stephen Lamb, Tonny Kinene, Christopher B. Rawle, Abishek Muralidhar, Kirsty Mayall, Fred Tairo and Joseph Ndunguru

Genes 2019, 10(9), 632; doi 10.3390/genes10090632

by Elamin Hafiz Baillo, Roy Njoroge Kimotho, Zhengbin Zhang and Ping Xu

Genes 2019, 10(10), 771; doi 10.3390/genes10100771

Horticulturae:

by Lida Fuentes, Carlos R. Figueroa and Monika Valdenegro

Horticulturae 2019, 5(2), 45; doi 10.3390/horticulturae5020045

by Marta Guarise, Gigliola Borgonovo, Angela Bassoli and Antonio Ferrante

Horticulturae 2019, 5(1), 13; doi 10.3390/horticulturae5010013

Insects:

by Rik Clymans, Vincent Van Kerckvoorde, Eva Bangels, Wannes Akkermans, Ammar Alhmedi, Patrick De Clercq, Tim Beliën and Dany bylemans

Insects 2019, 10(7), 200; doi 10.3390/insects10070200

by Marc Kenis, Hannalene du Plessis, Johnnie Van den Berg, Malick Niango Ba, Georg Goergen, Koffi Eric Kwadjo, Ibrahim Baoua, Tadele Tefera, Alan Buddie, Giovanni Cafà, Lisa Offord, Ivan Rwomushana and Andrew Polaszek

Insects 2019, 10(4), 92; doi 10.3390/insects10040092

by Rafael R. da Costa, Haofu Hu, Hongjie Li and Michael Poulsen

Insects 2019, 10(4), 87; doi 10.3390/insects10040087

International Journal of Molecular Sciences:

by Rüdiger Hardeland

Int. J. Mol. Sci. 2019, 20(5), 1223; doi 10.3390/ijms20051223

by Elise Lévy, Nadine El Banna, Dorothée Baïlle, Amélie Heneman-Masurel, Sandrine Truchet, Human Rezaei, Meng-Er Huang, Vincent Béringue, Davy Martin and Laurence Vernis

Int. J. Mol. Sci. 2019, 20(16), 3896; doi 10.3390/ijms20163896

by Beatriz Herrero-Fernandez, Raquel Gomez-Bris, Beatriz Somovilla-Crespo and Jose Maria Gonzalez-Granado

Int. J. Mol. Sci. 2019, 20(21), 5293; doi 10.3390/ijms20215293

by Claudia Beaurivage, Elena Naumovska, Yee Xiang Chang, Edo D. Elstak, Arnaud Nicolas, Heidi Wouters, Guido van Moolenbroek, Henriëtte L. Lanz, Sebastiaan J. Trietsch, Jos Joore, Paul Vulto, Richard A.J. Janssen, Kai S. Erdmann, Jan Stallen and Dorota Kurek

Int. J. Mol. Sci. 2019, 20(22), 5661; doi 10.3390/ijms20225661

by Maiko Okano, Masanori Oshi, Ali Linsk Butash, Eriko Katsuta, Kazunoshin Tachibana, Katsuharu Saito, Hirokazu Okayama, Xuan Peng, Li Yan, Koji Kono, Toru Ohtake and Kazuaki Takabe

Int. J. Mol. Sci. 2019, 20(17), 4197; doi 10.3390/ijms20174197

by Shaista Afroz, Rieko Arakaki, Takuma Iwasa, Masamitsu Oshima, Maki Hosoki, Miho Inoue, Otto Baba, Yoshihiro Okayama and Yoshizo Matsuka

Int. J. Mol. Sci. 2019, 20(3), 711; doi 10.3390/ijms20030711

Life:

by Márió Gajdács, Zoltán Bátori, Marianna Ábrók, Andrea Lázár and Katalin Burián

Life 2020, 10(2), 16; doi 10.3390/life10020016

by Carla Ferreira, Catarina Almeida, Sandra Tenreiro and Alexandre Quintas

Life 2020, 10(6), 86; doi 10.3390/life10060086

Nutrients:

by Ronald D. Hills, Benjamin A. Pontefract, Hillary R. Mishcon, Cody A. Black, Steven C. Sutton and Cory R. Theberge

Nutrients 2019, 11(7), 1613; doi 10.3390/nu11071613

by Harri Hemilä and Elizabeth Chalker

Nutrients 2019, 11(4), 708; doi 10.3390/nu11040708

by Humaira Jamshed, Robbie A. Beyl, Deborah L. Della Manna, Eddy S. Yang, Eric Ravussin and Courtney M. Peterson

Nutrients 2019, 11(6), 1234; doi 10.3390/nu11061234

Pathogens:

by Israr Kha, Naeem Ullah, Lajia Zha, Yanrui Bai, Ashiq Khan, Tang Zhao, Tuanjie Che and Chunjiang Zhang

Pathogens 2019, 8(3), 126; doi 10.3390/pathogens8030126

by Spyridoula-Angeliki Nikou,Nessim Kichik, Rhys Brown, Nicole O. Ponde, Jemima Ho, Julian R. Naglik and Jonathan P. Richardson

Pathogens 2019, 8(2), 53; doi 10.3390/pathogens8020053

by Steven Batinovic, Flavia Wassef, Sarah A. Knowler, Daniel T.F. Rice, Cassandra R. Stanton, Jayson Rose, Joseph Tucci, Tadashi Nittami, Antony Vinh, Grant R. Drummond, Christopher G. Sobey, Hiu Tat Chan, Robert J. Seviour, Steve Petrovski and Ashley E. Franks

Pathogens 2019, 8(3), 100; doi 10.3390/pathogens8030100

Plants:

by Muhammad Hammad Saleem, Johan Potgieter and Khalid Mahmood Arif 

Plants 20198(11), 468; doi 10.3390/plants8110468

by Ida Linić, Dunja Šamec, Jiří Grúz, Valerija Vujčić Bok, Miroslav Strnad and Branka Salopek-Sondi

Plants 20198(6), 155; doi 10.3390/plants8060155

by Marie Agatha Mohn, Besarta Thaqi and Katrin Fischer-Schrader

Plants 20198(3), 67; doi 10.3390/plants8030067

by Chiara Biselliandrea Volante, Francesca Desiderio, Alessandro Tondelli, Alberto Gianinetti, Franca Finocchiaro, Federica Taddei, Laura Gazza, Daniela Sgrulletta, Luigi Cattivelli and Giampiero Valè

Plants 20198(8), 292; doi 10.3390/plants8080292

1 April 2022
Welcoming New Editorial Board Members of Viruses

We are pleased to announce that Prof. Dr. Barry Slobedman, Dr. Carla S. Coffin, Prof. Dr. Charles Grose, Dr. Charles J. Russell, Prof. Dr. Fabien Zoulim, Prof. Dr. HuaJi Qiu, Dr. Koichi Watashi, Prof. Dr. Laurent Gillet, Prof. Dr. Manuel Ramos-Casals, Dr. Manuela Sironi, Dr. Maria Cecilia Garibaldi Marcondes, Prof. Dr. Mark J. Mulligan, Dr. Ruian Ke, Prof. Dr. Shuwen Liu and Prof. Dr. Tina Dalianis have joined the Editorial Board of Viruses (ISSN: 1999-4915).

11 March 2022
First Virtual Viruses-Sponsored International COVID-19 Workshop Held Successfully

Eric O. Freed, Editor-in-Chief of Viruses (ISSN: 1999-4915), recently organized a virtual 3-day COVID-19 workshop featuring many of the world’s leaders in coronavirus research (see below). The workshop was held from 1 to 3 March 2022, with technical and logistical support provided by MDPI conference staff. The talks were organized into three sessions: coronavirus biology, pathogenesis and immunity; vaccine development and antivirals; and neutralization and resistance. Time was allocated at the end of each morning and afternoon session for open discussion.

Participants in the workshop included: Drs. Charlie Rice, Dan Barouch, Brenda Hogue, Ralph Baric, Gary Whittaker, Linda Saif, Michael Worobey, Mike Diamond, Barney Graham, Matt Frieman, Angie Rasmussen, Alex Compton, Akiko Iwasaki, Adolfo Garcia-Sastre, Malik Peiris, Kathryn Holmes, Stanley Perlman, Jason McLellan, Yize (Henry) Li, Drew Weissman, Zhengli Shi, Olivier Schwartz, Luis Enjuanes, Pamela Bjorkman, David Veesler, Kizzmekia Corbett, Linfa Wang, Bart Haynes, Britt Glaunsinger, Mark Denison, Vineet Menachery, Kanta Subbarao, Penny Moore, Stefan Pohlmann, Vincent Munster, Shan-Lu Liu, Erica Ollmann-Saphire, Michel Nussenzweig, Pei-Yong Shi, George Gao, Jesse Bloom, Paul Bieniasz, Jeremy Luban, and Susan Weiss.

16 December 2021
Welcoming New Editorial Board Members of Viruses

We are pleased to announce that Prof. Dr. Qiang Ding, Prof. Dr. Gong Cheng, Prof. Dr. Hualan Chen, Prof. Dr. Lianpan Dai, Dr. Eugene V. Ryabov, and Dr. Huoqing Zheng are joining the Editoral Board of Viruses (ISSN: 1999-4915).

22 November 2021
722 MDPI Editorial Board Members Receiving "2021 Highly Cited Researchers" Distinction

It is our great honor to congratulate the Editorial Board Members and Editors in MDPI's journals who have been distinguished as 2021 Highly Cited Researchers by Clarivate, according to Web of Science data. We herewith express our gratitude for the immense impact the named researchers continue to make on scientific progress and on our journals' development.

Clarivate's annual list of Highly Cited ResearchersTM identifies the most highly cited scientists for the past decade. Their impactful papers are among the top 1 per cent in the citation distribution of one or more of 22 fields analyzed in the "Essential Science Indicators", distinguishing them as hugely influential among their peers.

Abate, Antonio
Abatzoglou, John T.
Abbaszadeh, Mostafa
Acharya, U. Rajendra
Acharya, Viral V.
Agarwal, Ravi P.
Ahn, Myung-Ju
Airoldi, Laura
Ali, Imran
Allakhverdiev, Suleyman I.
Aluko, Rotimi E.
Anasori, Babak
Andersson, Dan I.
Andes, David
Anker, Stefan D.
Apergis, Nicholas
Ariga, Katsuhiko
Arqub, Omar Abu
Aschner, Michael
Assaraf, Yehuda G.
Astruc, Didier
Atala, Anthony
Atanasov, Atanas G.
Atangana, Abdon
Bahram, Mohammad
Bakris, George L.
Balandin, Alexander A.
Baleanu, Dumitru
Balsamo, Gianpaolo
Bando, Yoshio
Banks, William A.
Bansal-Travers, Maansi
Barba, Francisco J.
Barros, Lillian
Basit, Abdul W.
Baskonus, Haci Mehmet
Bassetti, Matteo
Battino, Maurizio
Bell, Jordana T.
Bellomo, Nicola
Benediktsson, Jon Atli
Benelli, Giovanni
Benjakul, Soottawat
Bhatnagar, Amit
Biddle, Stuart J. H.
Biondi, Antonio
Biondi-Zoccai, Giuseppe
Bjarnsholt, Thomas
Blaabjerg, Frede
Blaschke, Thomas
Blay, Jean-Yves
Blumwald, Eduardo
Blunt, John W.
Boffetta, Paolo
Bogers, Marcel
Bonomo, Robert A.
Bowman, David M.J.S.
Boyer, Cyrille
Brestic, Marian
Brevik, Eric C.
Buhalis, Dimitrios
Burdick, Jason A.
Byrd, John C.
Cabeza, Luisa F.
Cai, Xingjuan
Cai, Jianchao
Calhoun, Vince D.
Calin, George
Cao, Jinde
Cao, Guozhong
Carvalho, Andre F.
Castellanos-Gomez, Andres
Cerqueira, Miguel Ângelo Parente Ribeiro
Chang, Jo-Shu
Chang, Chih-Hao
Chastin, Sebastien
Chau, Kwok-wing
Chemat, Farid
Chen, Xiaobo
Chen, YangQuan
Chen, Jianmin
Chen, Chaoji
Chen, Min
Chen, Qi
Chen, Jun
Chen, Xi
Chen, Peng
Chen, Yulin
Chen, Bo
Chen, Chen
Chen, Zhi-Gang
Chen, Wei-Hsin
Chen, Gang
Chen, Yongsheng
Chen, Xiang
Chen, Yimin
Chen, Runsheng
Chen, Lidong
Chen, Shaowei
Chen, Qian
Chen, Yu
Chen, Shuangming
Chiclana, Francisco
Cho, Sun Young
Choi, Wonyong
Chowdhary, Anuradha
Choyke, Peter L.
Cichocki, Andrzej
Corella, Dolores
Corma, Avelino
Cortes, Javier
Cortes, Jorge
Costanza, Robert
Crommie, Michael F.
Cui, Yi
Cui, Haiying
Cui, Qinghua
Cummings, Kenneth Michael
Dai, Shifeng
Dai, Sheng
Daiber, Andreas
Davis, Steven J.
Dawson, Ted M.
de la Fuente-Nunez, Cesar
Decker, Eric Andrew
Dekel, Avishai
Demaria, Marco
Deng, Yong
Deng, Xiangzheng
DePinho, Ronald A.
Desneux, Nicolas
Dimopoulos, Meletios-Athanasios
Ding, Aijun
Dionysiou, Dionysios D.
Dokmeci, Mehmet Remzi
Dolgui, Alexandre
Dong, Fan
Dou, Shi Xue
Dou, Letian
Du, Qian
Du, Bo
Dube, Shanta Rishi
Dufresne, Alain
Dummer, Reinhard
Dupont, Didier
Edwards, David
Elaissari, Abdelhamid
Elhoseny, Mohamed
Ellahi, Rahmat
Ellis, Erle C.
ElMasry, Gamal
Esteller, Manel
Estévez, Mario
Fabbro, Doriano
Facchetti, Antonio
Fan, Zhanxi
Fang, Chuanglin
Fasano, Alessio
Fečkan, Michal
Felser, Claudia
Feng, Liangzhu
Fensholt, Rasmus
Ferdinandy, Péter
Fernandez-Lafuente, Roberto
Ferreira, Isabel C. F. R.
Filippi, Massimo
Fisher, Helen
Fortino, Giancarlo
Fosso Wamba, Samuel
Franceschi, Claudio
Fujita, Hamido
Fujita, Masayuki
Gai, Francesco
Gaisford, Simon
Galanakis, Charis M.
Galluzzi, Lorenzo
Galvano, Fabio
Gan, Ren-You
Gan, Lihua
Gandomi, Amir H.
Gao, Bin
Gao, Feng
Gao, Minrui
Gao, Huijun
Gao, Wei
Gao, Huile
Garbe, Claus
Garcia, Hermenegildo
Gasbarrini, Antonio
Gasco, Laura
Gautret, Philippe
Geng, Yong
Gerdts, Gunnar
Geschwind, Daniel H.
Ghadimi, Noradin
Ghaffari, Roozbeh
Ghamisi, Pedram
Giampieri, Francesca
Glick, Bernard R.
Gnant, Michael
Goel, Ajay
Gogotsi, Yury
Goldewijk, Kees Klein
Gong, Jinlong
Gong, Yongji
Govindan, Kannan
Granato, Daniel
Grancini, Giulia
Green, Douglas R.
Grosso, Giuseppe
Gu, Ke
Guan, Cao
Guastella, Adam J.
Guerrero, Josep M.
Gui, Guan
Guizani, Mohsen
Guo, Zaiping
Gupta, Rangan
Gutzmer, Ralf
Haase, Dagmar
Habibi-Yangjeh, Aziz
Hagemann, Stefan
Hagger, Martin
Hamblin, Michael R.
Hammoudeh, Shawkat
Han, Heesup
Hanes, Justin
Harrison, Roy M.
Hartung, Hans-Peter
Hasanuzzaman, Mirza
He, Jr-Hau
He, Hongwen
He, Jiaqing
He, Debiao
Henseler, Jörg
Herrera, Francisco
Herrera-Viedma, Enrique
Hetz, Claudio
Ho Kim, Jung
Holmes, Elaine
Hossain, Ekram
Hsueh, Po-Ren
Hu, Xiaosong
Hu, Wenbin
Huang, Jianping
Huang, Hongwei
Huang, Yu
Huang, Jianying
Huang, Peng
Huang, Baibiao
Huang, Shaoming
Hubacek, Klaus

Iqbal, Hafiz M. N.
Ismail, Ahmad Fauzi
Izzo, Angelo A.
Jacobson, Kenneth A.
Jain, Atul
Jankovic, Joseph
Jelezko, Fedor
Ji, Xiaobo
Ji, Guangbin
Jiang, Hai-Long
Jiang, Lei
Jiang, Junjun
Jiang, Qing
Jiang, Shibo
Jin, Shi
Jones, Peter A.
Kalantar-zadeh, Kourosh
Kaner, Richard B.
Kannan, Kurunthachalam
Kappos, Ludwig
Karagiannidis, George K.
Karimi, Hamid Reza
Karimi-Maleh, Hassan
Karp, Peter D.
Kataoka, Kazunori
Katritch, Vsevolod
Kawi, Sibudjing
Keesstra, Saskia
Kepp, Oliver
Keyzers, Robert A.
Khademhosseini, Ali
Khan, Nafees A.
Kiessling, Fabian
Kim, Ki-Hyun
Kim, Haegyeom
Kim, Jeonghun
Kim, Jong Seung
Kirkwood, John M.
Kisi, Ozgur
Kivshar, Yuri
Klenk, Hans-Peter
Ko, Wen-Chien
Konopleva, Marina Y.
Kontoyiannis, Dimitrios P.
Koonin, Eugene V.
Kou, Gang
Krausmann, Fridolin
Krebs, Frederik C.
Kroemer, Guido
Kuca, Kamil
Kudo, Masatoshi
Kuhn, Jens H.
Kumar, Devendra
Kumar, Alan Prem
Kumar, Sudhir
Kumar Sangaiah, Arun
Kurths, Juergen
Kuznetsov, Nikolay V.
Kuzyakov, Yakov
Kwan, Mei-Po
Kyrpides, Nikos C.
La Vecchia, Carlo
Lai, Yuekun
Lam, James
Lammers, Twan
Lamuela-Raventos, Rosa M.
Lancellotti, Patrizio
Landi, Francesco
Laurent, Sophie
Lavie, Carl J.
Laxminarayan, Ramanan
Lee, Sang Soo
Lee, Jin-Wook
Lee, Pooi See
Lehmann, Johannes
Lei, Yaguo
Lei, Ting
Leng, Lijian
Leung, Dennis Y. C.
Leung, Victor C. M.
Levine, Ross
Li, Wei
Li, Jie
Li, Jinghong
Li, Jun
Li, Heng
Li, Gang
Li, Yat
Li, Peng
Li, Hailong
Li, Changpin
Li, Yan
Li, Yurui
Li, Xiaodi
Li, Hong
Li, Shutao
Li, Hongyi
Li, Zhijun
Li, Peiyue
Lin, Yuehe
Lin, Hongjun
Lin, Lin
Lip, Gregory Y. H.
Liu, Jian
Liu, Meng
Liu, Hong
Liu, Tao
Liu, Lei
Liu, Jianxing
Liu, Wei
Liu, Gang
Liu, Yang
Liu, Peide
Lockhart, Shawn R.
Long, Hualou
Löscher, Wolfgang
Lu, Jun
Lu, Jianquan
Lu, Nanshu
Lucey, Brian
Lund, Henrik
Luo, Jun
Luo, Yi
Luo, Jingshan
Luo, Yangchao
Lupton, Deborah
Luque, Rafael
Lv, Wei
Lvov, Yuri M.
Lyons, Timothy W.
Ma, Tianyi
Ma, Jun
Ma, Jiayi
Ma, Wen-Xiu
Ma, Yanming
Maggioni, Aldo Pietro
Mahmood, Nasir
Mahmoudi, Morteza
Mai, Liqiang
Mallavarapu, Megharaj
M